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1.	INTRODUCTION		
	
The	 oral	 cavity	 is	 a	 complex	 ecosystem	 characterized	 by	 an	 environmental	
moderate	temperature	and	high	humidity,	due	to	the	presence	of	oral	fluids.	
	
1.1	Saliva	
	
Saliva	 is	 the	most	 important	 element	 in	 the	manteinance	 of	 equilibrium	within	
the	oral	mouth.	 It	 is	an	hypotonic	fluid	produced	by	three	major	salivary	glands	
(the	parotyd	gland,	the	submandibular	gland	and	the	sublingual	gland)	and	several	
minor	salivary	glands.	
	
	
	
Fig.1	Major	salivary	glands	
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Under	physiologic	conditions	human	beings	produce	between	800	and	1.500	ml	
of	 saliva	 per	 day:	 during	 rest	 conditions	most	 of	 this	 liquid	 is	 produced	 by	 the	
submandibular	gland,	while	only	20%	relies	on	the	parotyd	gland.	Instead,	in	case	
of	 the	 presence	 of	 a	 chemycal	 or	 mechanical	 stimulus,	 over	 50%	 of	 saliva	 	 is	
produced	by	the	parotyd	gland.	
The	 role	 of	 minor	 salivary	 glands	 in	 salivary	 production	 seems	 to	 be	 less	
important	in	quantitative	terms.	
	
	
									 	
	
										
Fig.2	Salivary	production	rates	in	different	conditions.		
	
Salivary	 production	 is	 regulated	 by	 parasympathetic	 and	 sympathetic	 nervous	
system;	 within	 salivary	 glands,	 primary	 saliva	 is	 produced	 by	 acinar	 cells	
localized	in	the	secretory	area,	then	it	is	passes	through	secretory	ducts	where	it	
is	modified,	and	finally	it	is	poured	in	the	oral	cavity.		The	parotid	gland	and		the	
submandibular	 gland	 have	 a	 single	 duct,	 called	 Stensen’s	 duct	 	 and	Wharton’s	
duct	 	 respectively	 .	 The	 sublingual	 gland	 has	multiple	 ducts,	 known	 as	 Rivinus	
duct	and	Bartholin’s	duct.	
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Fig.	3	Salivary	glands	and	ducts	
	
1.2	Salivary	Composition	and	Functions	
	
Saliva	contains	different	elements:	
• α-amilase	 (ptyalin)	 is	 an	 enzyme	 mainly	 produced	 by	 the	 parotyd	 gland	
which	is	responsible	for	digestion	
• mucins	are	high-molecular-weight	glycoproteins	
• proteic	compounds	(cortisol,	glucose,	urea,	sexual	hormones)	
• electrolytes	such	as	bicarbonate	sodium,	chlorine,	calcium	
	
This	oral	fluid	performs	several	functions	which	are	essential	for	the	maintenance	
of	oral	health:	
		
- digestive	functions,	due	to	the	presence	of	α-amylase;	
- emollient	and	lubricant	functions,	thanks	to	water	and	mucins;	
- protective	functions	for	dental	elements,	oral	mucosa	and	esophagus	due	to	
the	 presence	 of	 antiviral,	 antibacterial	 and	 antifungal	 substances:	
Immunoglobulins	 A,	 Lysozyme,	 Lactoferrin,	 Histatins,	 Peroxydase,	
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Antimicrobial	peptides	(AMPs,	divided	in	cathelicidin	LL-37,	α-defensins	and	
ß-defensins	 )	 .	 An	 alteration	 in	 their	 composition	 or	 function	may	 explain	
how	 several	 subjects	 are	 more	 predisposed	 to	 infections	 than	 others.	
Besides,	it	has	been	shown	than	AMPs	participate	in	immunomodulation;	so	
an	 alteration	 in	 their	 quantity	 could	 be	 related	 to	 the	 pathogenesis	 of	
several	infective	or	autoimmune	diseases.		
- the	 buffering	 capacity,	 due	 to	 the	 presence	 of	 bicarbonate,	 proteins	 and	
phosphates	
- many	proteins	coming	 from	the	bloodstream	may	be	 found	 in	saliva,	such	
as	Albumins,	Epithelial	Growth	Factor	(EGF),	TGF-α,	TGF-ß	and	Fibroblast	
Growth	 Factor	 (FGF),	 which	 could	 be	 helpful	 in	wound	healing	and	 tissue	
repairing.		
	
	
Fig.4	Salivary	functions	(Adapted	from:	Levine	MJ,	Am	NY	Acad	Sci	1993;	694:	11-
16)		
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1.3	Saliva	collection	
Saliva	 is	 an	 accessible	 biofluid	 that	 can	 potentially	 provide	 an	 insight	 into	 the	
relationship	between	the	host	and	the	environment.	
	
Only	few	well-standardized	protocols	for	collecting	saliva	samples	are	described.	
Its	 constant	 variabilty	 during	 the	 day,	 according	 to	 circadian	 rythm,	makes	 the	
operation	hard.	
Saliva	production	is	influenced	by	indipendent	variables,	which	can	not	be	taken	
under	 control	 during	 collection.	 They	 are:	 age,	 sex,	 body	 weight,	 drugs	
assumption,	glands	dimension	and	general	health.	On	the	other	hand,	dependent	
variables,	which	have	to	be	controlled	during	sampling	are:	chemical	or	physical	
stimulation,	 time	of	 the	day,	 temperature,	 body	position	 and	 light	 exposition.	A	
proper	 collection	 can	 be	 performed	 only	 if	 	 homogeneous	 environmental	
conditions	are	mantained.	
In	 particular	 the	 time	 of	 day	 in	 which	 collection	 is	 done	 repesents	 the	 most	
significant	variable	to	be	considered;	the	mornig	hours	(between	8.00	and	11.00	
a.m.)	should	be	preferred	[1].	
	When	 a	 precise	 time	 is	 established,	 it	 has	 to	 be	 mantained	 in	 order	 to	 better	
compare	 results	 from	 different	 examinations.	 Also	 enviroment	 light	 and	
temperature	must	be	kept	constant.	
	In	 addition,	 eating	 or	 drinking	 during	 90	 minutes	 before	 examination	 is	 not	
reccomended	.	An	appropriate	collection	should	last	about	15	minutes.	
Finally,	 patient’s	 head	 has	 to	 be	 maintained	 in	 the	 same	 position	 as	 far	 as	
possible.	
	
Several	techniques	described	in	the	international	literature	for	salivary	collection	
are	known.	
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Unstimulated	saliva	can	be	collected	in	two	main	different	ways:	
- The	 spitting	method:	 patient	 is	 sitting	 on	 a	 chair	 and	 is	 asked	 to	 spit	 the	
salivary	content	of	his	mouth	every	minute	for	at	least	10-15	minutes.	
- The	drooling	method:	this	technique	is	similar	to	the	previous	one,	however	
the	patient	does	not	spit	but	lets	his	saliva	drain	in	a	test	tube.	
	
A) 																				B)			 		
Fig.5a:	the	spitting	method;	5b:	the	drooling	method,	from	Sreebny	LM	and	
Vissink	A	[2]	
	
	
	
	
The	most	used	methods	for	collecting	stimulated	saliva	are	represented	by:	
	
- The	absorbent	technique:	a	cotton	roll	is	inserted	in	the	oral	cavity	and	left	
there	 to	 be	 passively	 wet	 by	 saliva	 	 (in	 this	 case	 salivary	 production	 is	
stimulated	by	the	presence	of	a	foreign	body	in	the	mouth).	
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- The	 chewing	 technique:	 A	 small	 piece	 of	 paraffin	 wax	 is	 chewed	 by	 the	
patient	for	5	minutes;	then	saliva	has	to	be	spitted	into	a	test	tube.	
- The	 taste	 technique:	 few	 drops	 of	 citric	 acid	 2%	 	 solution	 are	 inserted	 in	
patient	mouth	to	stimulate	salivary	production	
	
All	previous	methods	allow	to	collect	the	whole	mixed	saliva	of	the	oral	cavity,	but	
they	do	not	permit	to	distinguish	saliva	produced	by	a	single	salivary		gland	from	
that	produced		by	another	one[2].	
	
Some	techniques	that	allow	to	collect	salivary	samples	from	a	specific	single	gland	
are:	Lashley	cup	for	the	parotyd	gland	and	Wolff’s	device	for	submandibular	and	
sublingual	glands	[3].		 	
However,	these	methods	are	not	often	used	because	of	their	high	costs.	
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A) 	
B) 		
C) 		 	
Fig.6a:	Lashley’s	cup	in	position	on	the	Stensens	duct’s	outlet;	6b-c:	Wolff’s	device	
for	saliva	collection	(from	Sreebny	LM	and	Vissink	A	[2])	
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1.4	Crevicular	fluid:	composition	and	functions	
	
The	crevicular	fluid,	also	known	as	gingival	liquid,	is	produced	by	the	epithelium	
localized	 in	the	gingival	sulcus	surrounding	teeth	crowns.	 It	 is	produced	 in	very	
small	 amounts	 (about	 	 0,5-2,5	 ml	 per	 day	 )	 in	 healthy	 conditions	 and	 in	 huge	
quantities	when	gums	are	inflammed.	
	
	
		
	
Fig.7	Gingival	sulcus	anatomy	
	
It	 cleanses	 material	 from	 the	 sulcus	 and	 contains	 proteins	 useful	 to	 improve	
adhesion	 of	 the	 epithelim	 to	 the	 tooth.	 Furthermore,	 it	 possesses	 antimicrobial	
properties	and	exerts	an	antibody	activity	in	defense	of	gingiva.	
	
Its	composition	is	similar	to	that	one	of		insterstitial	fluid,	in	fact	it	contains:	
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• Cellular	elements:	epithelial	cells,	leukocytes	and	bacteria	
• Electrolyte:	sodium,	potassium,	calcium	
• Organic	compounds	
• Metabolic	acid	end	products:	prostaglandines,	urea,	antibacterial	factors	
	
	
Fig.	8		Crevicular	fluid	composition	
	
Analysis	of	crevicular	fluid	becomes	important	to	detect	periodontal	pathogens	or	
to	measure	inflammation	indeces	in	presence	of	a	chronic	inflammatory	disease.		
	
1.5	Crevicular	Fluid	collection	
The	crevicular	fluid	is	generally	collected	by	use	of		nitrocellulose	paper	cones	or	
filter	paper	strips	inserted	in	the	crevice	for	about	one	minute	in	order	to	become	
soaked	 for	 capillarity.	 These	methods	 are	 quick,	 easy	 to	 use	 and	 not-traumatic.	
Moreover,	these	techniques	and	can	be	applied	for	a	superficial	(in	the	upper	part	
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of	the	crevice)	or	a	deep	(the	cones	are	inserted	and	pushed	into	the	crevice	until	
a	minimum	of	resistance	is	felt)	collection[4].		
	
	
 
 
Fig.	9a	Crevicular	fluid	collection	with	a	paper	cone	
 
 
 
 
Fig.	9b	Crevicular	fluid	collection	with	a	paper	strip	
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In	the	present	study	sterile,	endodontic,	medium	size	(diameter	0.30	mm)	paper	
cones	were	inserted	in	the	gingival	sulcus	for	60	seconds	in	order	to	collect	
crevicular	fluid	samples.	
An	alternative	is	represented	by	the	“washing	method”,	which	uses	the	
installation	and	continuous	reaspiration	of	specific	solutions	(	Hanks'	balanced	
salt	solution31	or	PBS	32	at	the	gingival	crevice);	in	this	case		a	specific	
instrument	is	required:	it	is	composed	by	two	injection	needles	fitted	one	within	
the	other.	The	thinner	"ejection	needle"	is	at	the	bottom	of	the	periodontal	pocket	
and	the	"collection	needle"	at	the	gingival	margin.	A	special	solution	is	ejected	
into	the	crevice	and	immediately	drained	through	the	collection	needle	into	a	
sample	tube	by	continuous	suction	[5].	
	
 
	
Fig.	10	Schematic	illustration	of	the	washing	method	for	crevicular	fluid	sampling	
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Although	 this	 technique	 is	 highly	 sensitive,	 it	 requires	 training	 and	 experience,	
since	it	is	not	easy	to	be	apllied.	
	
1.6	Periodontal	Anatomy	
	
The	 term	 "periodontium"	 usually	 refers	 to	 the	 area	 around	 the	 tooth	 (Peri	 =	
around,	Odontos=	tooth)	whose	main	function	is	to	to	keep	the	tooth	attached	to	
the	tissues	of	the	the	jawbone,	thus	allowing		the	masticatory	function.	
It	 is	a	dynamic	 structure	 that	 is	 involved	 in	a	 continuous,	 longlife,	 transforming	
process,	 which	 is	 remodels	 naturally	 in	 relation	 to	 age,	 chewing	 and	 oral	
environment	conditions.	
	
	
	
	
Fig.	11	Schematic	representation	of	periodontum	
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The	periodontium	is	composed	by	hard	tissues	(root	cement	and	alveolar	bone)	
and	soft	tissues	(periodontal	ligament	and	gum).	
Gingiva	
Gum	is	only	a	part	of	the	entire	oral	mucosa,	which	cover	the	oral	cavity.	
In	particular	oral	mucosa	can	be	divided	in:	
• Masticatory	mucosa	(so	called	because	this	tissue	can	withstand	the	impact	
of	 food	 during	 chewing)	 formed	 by	 keratinized	 stratified	 squamous	
epithelium,	which	 can	be	 found	on	 the	dorsum	of	 the	 tongue,	 hard	palate	
and	attached	gingiva.				
• Lining	 mucosa,	 non-keratinized	 stratified	 squamous	 epithelium,	 covering	
the	remaining	part	of	 the	oral	cavity	(it	can	be	further	divided	 into	buccal	
mucosa,	labial	mucosa,	alveolar	mucosa)	
• Specialized	mucosa,	which	can	be	observed	only	on	the	dorsal	surface	of	the	
tongue	 in	 those	 regions	 containing		 taste	 	 buds,	 essential	 for	 taste	
perception.		
  
 
 
 
Fig. 12 Anatomical	relationship	of	normal	gingiva	in	facial	view	(A)and	in	cross-
section	(B).	From	Darby	and	Walsh,	1994.	
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Gum	is	 the	part	of	masticatory	mucosa	which	covers	 the	alveolar	processes	and	
surrounds	the	cervical	part	of	a	tooth.	
	
In	 coronal	 direction	 it	 ends	 next	 to	 the	 tooth	 surface	with	 the	 gingival	margin,	
while	 in	 apical	 direction	 it	 is	 separated	 from	 the	 lining	mucosa	 	 by	means	 of	 a	
clearly	recognizable	boundary	line	called	 	mucogingival	 junction	(in	the	palate	a	
mucogingival		line	can	not	be	observed	because	the	hard	palate	and	the	maxillary	
alveolar	process	are	both	covered	by	masticatory	gums).	
	
	
	
Fig.	13	Dental	probe	indicating	the	mucogingival	junction	
	
	While	alveolar	mucosa	is	mobile	over	deep	tissues	and	is	red-colored,	gingiva	
appears	pink		and	can	be	divided	into	free	gum	and	adherent	gum.	
	
The	adherent	gingiva	is	delimited	by	gingival	groove	in	the	coronal	direction	and	
by	mucogingival	junction	in	apical	direction.	
It	 shows	a	 compact	 consistency,	 coral	pink	 color	 and	 	 is	firm	and	resilient,	since	
it	is	bound	to	the	underlying	cementum	and		bone.	
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The	free	gum	is	delimited	in	the	apical	direction	by	gingival	groove	and	in	coronal	
direction	 by	 gingival	 mrgin.	 Free	 gingiva	 also	 includes	 oral	 tissue	 in	 the	
interdental	spaces	called		papilla.	
The	 shape	of	 the	 interdental	papilla	 is	determined	by	 the	 contact	area	between	
teeth.		
	
	
Fig.	14	Free	gingiva	between	teeth	is	called	papilla	
	
In	the	anterior	regions	the	papillae	have	a	pyramidal	shape,	since	the	teeth	have	
single	contact	points	 in	correspondence	of	 the	approximal	surfaces.	However	 in	
premolar	 and	 molar	 regions	 teeth	 show	 contact	 surfaces	 and	 papillae	 have	 a	
blunted	shape.	
	
	
Periodontal	Ligament	
	
The	periodontal	ligament		is	a	group	of	specialized	connective	tissue	fibers,	
inserting	into	root	cementum	on	one	side	and	onto	alveolar	bone	on	the	other	[6].	
It	has	an	“hourglass	shape”	with	its	narrower	part	positioned	at	the	middle	of	root	
height,	where	its	width	is	between	0.2	and	0.4	mm.	This	tissue	works	as	a	shock	
absorber;	it	allows	the	distribution	of	chewing	forces	to	alveolar	bone:	the	
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pressure	exerted	on	the	tooth	by	chewing	leads	to	a	stretching	of	fibers	,	
converting	the	masticatory	pressure	into	a	traction	onto	the	cement	and	bone.		
	
It	 consists	 of	 cells,	 nerve	 fibers,	 blood	 and	 lymphatic	 vessels,	 inserted	 in	 an	
extracellular	 matrix	 mainly	 formed	 by	 connective	 fibers	 with	 different	
orientation:	
• Alveolar	 crest	 fibers,	 running	 from	 the	 crestal	 portion	 of	 the	 root	 to	 the	
alveolar	ridge	
• Horizontal	fibers,	located	in	the		coronal	portion	of	the	ligament	
• Oblique	 fibers,	 running	 from	 the	 root	 in	 coronal	 direction	 towards	 the	
alveolar	bone	
• Apical	 fibers,	 running	 from	 the	 apex	 of	 the	 root	 to	 the	 bottom	 of	 the	
alveolus	with	various	orientations.		
	
	
Fig.	15	Periodontal	fibres	orientation	
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These	main	fibers	develop	simultaneously	with	the	eruption	of	the	tooth	and	their	
orientation	varies	continuously	throughout	the	eruption	phase;	only	at	the	end	of	
this	 process	 a	 stabilization	 occurs,	 however	 constant	 remodelling	 (with	
reabsorption	 of	 the	 old	 fibres	 and	 the	 formation	 of	 the	 new	 ones)	 is	 always	
observed.	
The	main	 fibres,	 penetrating	 the	 cement	 on	 one	 side	 and	 alveolar	 bone	 on	 the	
other,	 are	 called	Sharpey	 fibres.	 In	 addition,	 some	elastic	 fibres	 associated	with	
blood	vessels	and	oxitalanic	fibres	have	been	described.	
	
Periodontal	cells	are:	fibroblasts	aligned	along	the	main	fibers,	osteoblasts	on	the	
bone	 surface	 and	 cementoblasts	 on	 the	 root	 surface,	 epithelial	 cells	 (Malassez	
residues),	 nerve	 fibres,	 endothelial	 cells,	 macrophages,	 eosinophils	 and	
mastocells.			
	
	
Radicular	Cement	
	
Radicular	cement	is	a	calcified	tissue	that	covers	the	surface	of	the	tooth	root;	it	
consists	of	collagen	fibres	in	an	organic	matrix	and	hydroxyapatite	(about	65%	of	
its	weight).	It	is	linked	to	the	fibres	of	the	periodontal	ligament,	fixing	them	to	the	
tooth	 and	 contributes	 to	 the	 repair	 processes	 of	 the	 root.	 The	 thickness	 of	 this	
tissue	increases	with	age	(it	may	range	from	0.05	to	0.6	mm)	.	It	is	thicker	apically	
than	cervically.		
	 23	
	
Fig.	16	Distribution	of	cementum	on	the	tooth	surface	
	
	
Cementum	may	be	classified	in	the	following	ways	[7]:		
		
1)	By	location:	
	
• Radicular	cementum:	cementum	that	is	found	on	the	root	surface.	
• Coronal	 cementum:	 cementum	 that	 forms	 on	 the	 enamel	 covering	 the	
crown.	
		
2)	By	cellularity:	
	
• Cellular	 cementum:	 cementum	 containing	 cementocytes	 in	 lacunae	within	
the	cementum	matrix	
• Acellular	cementum:	cementum	without	any	cells	in	its	matrix	
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3)	By	the	presence	of	collagen	fibrils	in	the	matrix:	
		
• Fibrillar	 cementum:	 cementum	 with	 a	 matrix	 that	 contains	 well-defined	
type	I	collagen	fibrils	
• Afibrillar	cementum:	cementum	that	has	a	matrix	devoid	of	detectable	type	I	
collagen	 fibrils.	 Instead,	 the	 matrix	 tends	 to	 have	 a	 fine,	 granular	
consistency.	
		
4)	By	the	origin	of	the	matrix	fibers	:	
		
• Extrinsic	 fiber	 cementum:	 cementum	 containing	 primarily	 extrinsic	 fibers	
(i.e.	 Sharpey's	 fibers	 that	 are	 continuous	 with	 the	 principal	 fibers	 of	 the	
periodontal	 ligament;	 they	 are	 produced	 by	 periodontal	 ligament	
fibroblasts).	Fibers	orientation	is	perpendicularly	to	the	cementum	surface;	
it	has	a	role	in	tooth	anchorage.	
• Intrinsic	fiber	cementum:	cementum	that	contains	primarily	intrinsic	fibers,	
(i.e.	 fibers	 produced	 by	 cementoblasts	 and	 oriented	 parallel	 to	 the	
cementum	 surface).	 It	 is	 located	 predominantly	 in	 areas	where	 repairing	
processes	are	occurring,	after	surface	resorption.	
• Mixed	fiber	cementum:	 cementum	 that	 contains	 a	mixture	of	 extrinsic	 and	
intrinsic	fiber	cementum.	
		
	
	
	
The	alveolar	bone	
	
	 The	 alveolar	 process	 is	 that	 part	 of	 the	 jaw	 and	 the	mandible	which	 contains	
teeth.	Only	the	thin	layer	of	compact	bone	forming	the	wall	of	a	dental	alveolus	is	
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considered	a	part	of	periodontum	and	it	is	called	“bundle	bone”.	It	is	linked	with	
lingual	 and	 buccal	 cortical	 bones	 of	 the	 alveolar	 process,	 while	 the	 remaining	
middle	area	is	occupied	by	cancellous	bone.	
	
	
	
	
Fig.	17	Alveolar	bone	of	upper	jaw,	with	arrows	indicating	bundle	bone	
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Fig.	18	Alveolar	bone.	1	Bundle	bone,	2	Trabecular	bone,	3	cortical	bone	
	
	
The	 bundle	 bone	 is	 peforated	 by	 several	 small	 channels,	 known	 as	 Volkmann	
channels,	through	which	blood	vessels,	lymphatics	and	nerve	fibers	pass	from	the	
alveolar	 bone	 to	 the	periodontal	 ligament.	 The	bundle	 bone	disappears	when	 a	
tooth	is	extracted.		
	
Thickness	of	the	alveolar	bone	varies	from	region	to	region,	for	exemple	it	can	be	
thin	in	the	incisal	vestibular	region,	while	it	is	generally	thick	in	molar	vestibular	
region	 of	 the	 mandible	 .The	 entire	 alveolar	 bone	 is	 continually	 renewed	 and	
remodelled	by	osteobalsts	and	osteoclasts	according	to	functional	needs.	
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1.7	Oral	Microbiota	
The	oral	cavity	is	a	complex	ecosystem,	characterized	by	the	presence	of	different	
habitats,	such	as	teeth,	tongue,	gums,	cheeks	,	gingival	sulcus,	tonsils.	These	areas	
are		populated	by	opportunistic	microorganisms	perfectly	adapted	to	the	
environment,	such	as	Protozoa,	Mycetes,	Viruses	and,	above	all,		Bacteria.	Only		
280	bacterial	species		have	been	isolated	in	culture	from	the	oral	cavity,	since	
they	can	be	cultivated	by	means	of	traditional	microbiological	method,	but	the	
total	number	of	species	is	thought	to	be	between	500	and	700	[8].  
The	Human	Oral	Microbiome	Database	(HOMD)	includes	619	taxa	in	13	phyla,	as	
follows:	 Actinobacteria,	 Bacteroidetes,	 Chlamydiae,	 Chloroflexi,	 Euryarchaeota,	
Firmicutes,	 Fusobacteria,	 Proteobacteria,	 Spirochaetes,	 SR1,	 Synergistetes,	
Tenericutes,	and	TM7.	
According	 to	 a	 recent	 study,	 the	 six	 major	 phyla	 (Spirochaetes	 ,	 Fusobacteria,	
Proteobacteria,	Actinobacteria,		Bacteroidetes	and	Firmicutes)	contain	96%	of	the	
taxa.	 The	 remaining	 phyla	 (Chlamydia,	 SR1,	 TM7,	 Euryarchaeota,	 Synergistetes,	
Tenericutes	and	Chloroflexi)		contain	the	remaining	4%	of	the	taxa	[9].		
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Fig.	19	Part	of	the	Neighbor-joining	tree	for	human	oral	taxa,	from	Human	Oral	
DataBase	[9]	
	
	
This	 complex	 ecosystem	 is	 also	 characterized	 by	 a	 high	 dynamism,	 due	 to	 the	
continuous	 elimination	 and	 introduction	 of	 liquids	 and	 food.	 Although	 a	 rather	
constant	 resident	 bacterial	 population	 is	 present,	 some	 microorganisms	 that	
usually	colonize	other	sites	of	the	host	can	occasionally	be	detected	in	this	area.	
Factors	 influencing	 and	 modifying	 the	 oral	 ecosystem	 are:	 presence	 of	 plaque,	
oral	hygiene,	dental	treatments,	personal	physical	conditions	and	diet.	
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1.8	Bacterial	Biofilm	
In	 the	 past	 only	 individual	 microorganisms	 were	 considered	 responsible	 for	 a	
specific	disease,	so	they	were	analyzed	in	pure	cultures,	according	to	well-known	
Koch’s	 postulates.	 The	 discovery	 of	 complex	 biofilms	 over	 most	 of	 human	 and	
inanimate	surfaces	has	completely	changed	the	target	of	modern	research.	
Nowadays	most	of	oral	diseases,	such	as	caries,	periodontitis	and	other	infections	
are	known		to	be	caused	by	multiple	microrganisms,	organized	in	a	biofilm	rather	
than	by	a	single	bacterium	[10].		
	
	
Bacterial	 biofilm	 is	 a	 micro-community	 composed	 by	 bacteria	 within	 a	
polysaccharide	matrix,	that	coexist	and	iteract	together.		
The	biofilm	adheres	intimately	to	the	dental	surface	thanks	to	the	presence	of	the	
“aquired	enamel	pellicle”,	which	is	a	protein	film	formed	on	the	enamel	surface	by	
selective	 binding	 of	 salivar	 glycoproteins	immediatly	 after	 a	 tooth	 is	 cleaned	 or	
after	 chewing.	 This	 creates	 the	 necessary	 substrate	 for	 the	 adhesion	 of	 early-
bacterial	 microorganisms.	 These	 first	 ones	 are	 basically	 aerobic	 or	 facultative	
anaerobic	bacteria,	 such	as	 streptococci,	 and	 they	begin	 to	 subtract	oxygen	and	
produce	carbon	dioxide	and	waste	elements,	which	become	food	for	new	bacteria.	
Secondary	colonizers	attach	to	receptors	positioned	on	already	attached	bacteria	
(coadhesion).	 	 Furthermore,	 bacteria	 start	 synthesizing	 several	 polymers	 and	
creating	a	matrix,	which	is	more	than	a	structural	passive	scaffold	because	it	can	
retain	and	bind	molecules	and	enzymes	[11].	
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Fig.	20	Oral	biofilm	over	tooth	surface	
	
Living	 in	 community,	 some	 bacteria	 acquire	 the	 ability	 to	 synthesize	 new	
enzymes	capable	of	breaking	down	antibacterial	molecules	and	so	 they	become	
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tolerant	to	drugs	and	host	defenses.	
As	 the	 biofilm	 becomes	 structurally	 and	 functionally	 organized	 and	 the	
periodontal	 pocket	 keeps	 getting	 deeper	 and	 deeper	 ,	 favourable	 conditions	
stimulate	the	accumulation	of	dangerous	periodontopathic	anaerobic	pathogens,	
such	as	Prevotella,	Porphyromonas,	Fusobacterium,	Treponema,	and	Tannerella.		
	
	
	
	
	
	
	Fig.	21	Subgingival	Microbial	complexes	[12].		
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1.9	Periodontal	Disease	
Periodontal	 disease	 is	 one	 of	 the	most	 common	 oral	 disease,	 affecting	 globally	
about	half	of	the	adult	population.		It		is	an	infectious	inflammatory	multifactorial	
disease	caused	by	several	bacterial	strains	present	in	dental	plaque.	
In	 physiological	 conditions	 the	 oral	 cavity	 is	 colonized	 by	 a	 huge	 number	 of	
bacteria,	 living	 togheter	 in	 polymicrobial	 communities	 called	 biofilm.	 Although	
early	 theories	 focusing	 on	 identifying	 a	 single	 bacterium	 responsible	 for	 oral	
diseases	 such	 as	 dental	 caries	 and	 chronic	 periodontitis,	 it	 is	 now	 generally	
accepted	that	these	conditions	result	 from	the	concerted	actions	of	multispecies	
microbial	communities	[13].		
In	case	of	periodontal	disease	a	microbial	shift	can	be	observed:	an	increase	in	the	
number	of	pathogens	from	one	side	and	a	decrease	 in	the	number	of	symbionts	
on	the	other.	However	it	is	not	possible	to	identify	a	single	and	specific	infectious	
bacterium	responsible	for	this	process.		
Among	 oral	 bacteria	 ,	 expecially	 those	 belonging	 to	 "red"	 complex	 (Treponema	
denticola,	 Porphyromonas	 gingivalis,	 and	 Bacteroides	 forsythus)	 and	 "orange"	
complex	 (Prevotella	 intermedia,	 Prevotella	 nigrescens,	 Peptostreptococcus	
micros,	 F.	 nucleatum	 subspecies,	 Eubacterium	 nodatum,	 Streptococcus	
constellatus,	 and	 three	 Campylobacter	 species)	 are	 considered	 dangerous	 in	
development	of	the	disease.	
Periodontitis	 is	 the	 major	 cause	 of	 tooth	 loss	 in	 the	 adult	 population	 of	
industrialized	countries	with	esthetic	consequences	and	damages	in	masticatory	
and	phonatory	functions.	The	prevalence	of	periodontal	disease	in	the	population	
seems	 to	 vary	 according	 to	 race,	 geographical	 area	 and	 age	 (it	 can	 be	 rarely	
observed	in	pediatric	age	but	this	disease	affects	about	30%	of	adult	population).				
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A	 	 	 	 	 	 	 	 	 B	
	
Fig.	 22	 A:	 Periodotal	 pocket	 and	 healty	 tissue;	 B:	 Gingivitis-periodontitis	
progression	
	
The	 classification	 of	 periodontal	 diseases	 proposed	 in	 1993	 by	 the	 European	
Federation	 of	 Periodontology	 was	 modified	 in	 1999	 at	 the	 International	
Workshop	in	collaboration	with	the	American	Academy	of	Periodontology	.	
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Fig.	23	Abbreviated	version	of	1999	Classification	of	Periodontal	Diseases	and	
Conditions	[14]	
 
Gingivitis	is	defined	as	gingival	inflammation	in	the	absence	attachment	loss	and	
alveolar	bone	destruction,	in	response	to	biofilm	present	near	the	gingival	
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margin.		Clinical	signs	are	redness,	swelling,	edema,	change	in	tissue	consistency.	
This	can	lead	to	bleeding,	halitosis	and	an	increase	in	dental	probing.	It	is	a	
reversible	condition	and	the	treatment	consists	of	the	control	of	the	dental	plaque	
and	its	retention	factors.	
On	the	contrary,	in	chronic	periodontitis	alveolar	bone	destruction	and	
attachment	loss	is	irreversible	and	it	is	consistent	with	the	amount	of	plaque	and	
other	local	factors,	such	as	anatomic	conditions,	overhanging	restorations,	open	
contacts	and	palato-radicular	grooves.	In	general	the	disease	progresses	slowly	
but	there	may	be	peaks	of	destruction.	Smoking,	systemic	diseases	and	specific	
local	factors	can	influence	disease	progression[15]	.	 
	In	chronic	periodontitis	both	dental	arches	can	be	affected	and	the	disease	is		
defined	as	localized	or	generalized	depending	on	number	of	involved	theeth	
(respectively	less	or	more	than	30%	of	dental	elements)	.	Often		an	irregular	and	
localized	spread	is	described,		with	involvement	of	the	molars	and	incisors.	
Clinically,	the	gum	shows	inflammation	with	edema,	erythema,	bleeding	on	
probing	and	sometimes	suppuration.	Loss	of	attachment	with	formation	of	a	
periodontal	pocket	and	destruction	of	alveolar	bone	are	always	present.	The	
disease		can	manifest	as	gingivitis	already	in	adolescence	and	slowly	progresses.	
During	the	course	of	life,	the	pathological	effects	accumulate	until	destructive	
effects	are	revealed.	The	extent	of	destruction	depends	on	plaque	levels,	stress,	
diabetes	and	the	efficiency	of	the	immune	system.	Furthermore,	the	risk	is	
increased	in	smokers,	who	show	also	a	more	unfavourable	prognosis,	even	
though	the	mitigation	of	inflammation	process	induced	by	this	habit	tends	to	hide	
the	real	severity	of	the	disease.	Periodontal	therapy	involves	the	removal	of		
dental	plaque	(above	and	below	the	gum)	and	instructions	to	manatin	oral	
hygene	and	health.		
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Aggressive	periodontitis	includes	rare	forms	of	periodontitis	characterized	by	
rapid	progression.	Both	the	localized	and	the	generalized	form	require	a	genetic	
predisposition,	but	while	the	localized	form	appears	to	arise	from	an	infection	
with	Aggregatibacter	Actinomycetmcomitans,	in	the	generalized	form	the	role	of	
Porphyromonas	gingivalis	and	Bacteroides	forsythus	is	more	important.	Smoking	
is	again	a	risk	factor	in	this	aggressive	form.	The	diagnosis	of	aggressive	
periodontitis	is	done	looking	at	rapid	loss	of	attachment	and	bone	destruction	in	
patients	with	a	positive	family	history	and	disproportion	between	bacterial	
plaque	amount	and	the	severity	of	periodontal	destruction,	in	absence	of	other	
significant	systemic	diseases.	It	mainly	affects	the	first	molars	and	incisors	in	a	
characteristic	way.	
Periodontitis	as	manifestatation	of	systemic	diseases	identifies	all	periodontal	
diseases	associated	with	systemic	conditions	causing	a	reduction	in	patient's	
immune	response,	such	as	neutropenia	and	leukemia	or	Periodontitis	associated	
with	genetic	diseases	such	as	Down's	syndrome	and	the	Papillon-Lefevre	
syndrome.	
Necrotizing	ulcerative	gingivitis	and	necrotizing	ulcerative	periodontitis	are	the	
most	serious	inflammatory	and	infectious	periodontal	diseases,	showing	a	very	
rapid	destruction	of	periodontal	attachment	and	bone	loss.	Clinically	gums	are	
ulcerated	and	necrotic	papillae	and	gum	margins	are	observed.	Ulcers	can	be	
covered	with	soft	yellowish-white	pseudomembrane.	Lesions	are	rarely	
associated	with	periodontal	pockets	because	the	rapid	extended	necrosis	
coincides	with	loss	of	alveolar	bone.		Treatment	of	the	acute	phase	involves	
removal	of	tartar,	as	long	as	possible,	associated	with	chemical	plaque	control	
systems	and	systemic	administration	of	antibiotics.	Affected	individuals	should	be	
monitored	daily	throughout	the	duration	of	the	acute	phase.	
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In	2018	during	the	EuroPerio	Conference	in	Amsterdam,	a	new	classification	
system	was	presented,	updating	the	previous	one.	For	the	first	time,	the	
periodontal	health	condition	was	scientifically	defined	and	periodontitis	was	
described	and	codified	in	four	stages.		
	
A)	
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B)	
Tab.	1A-1B	Staging	and	Grading	Periodontitis;	Tables	from	Tonetti,	Greenwell,	
Kornman	[16].	
	
	
The	four	Stages	of	periodontitis	are	based	on	the	amount	of	damage	which	has	
already	occurred,	including	attachment	loss,	radiographic	bone	loss,	tooth	loss	
and	probing	depths	for	Stages	I	and	II.	In	addition,	furcation	involvement,	ridge	
defects	and	bite	collapse	are	involved	in	Stages	III	and	IV.	
Grading	allows	dentist	to	determine	the	risk	of	patient	for	further	progression	of	
the	disease,	according	to	bone	loss,	age,	case	phenotype,	biofilm	deposits,	
smoking	and	systemic	diseseases.		
	
	
Diagnosis	of	periodontitis	is	obtained	on	the	basis	of	medical	history,		clinical	
examination,	RX	images.	In	some	cases	,	such	as	in	the	management	of	patients	
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with	juvenile	Periodontitis	and	refractory	forms	of	periodontal	disease,	
laboratory	and	microbiological	tests	can	be	performed.	
	
The	most	important	factors	that	have	to	be	considered	in	medical	history	include	
smoking,	drugs	(	ciclosporin,	nifedipine,		diphenylhydantoin)	and	systemic		
diseases,		such	as	diabetes,	Ehlers	syndrome,	Papillon-Lefevre	syndrome.	
	
Clinical	inspection	evaluates	Topography,	colour	and	shape	of	the	gingiva,	dental	
migrations,	 presence	 of	 bacterial	 plaque	 and	 of	 retention	 factors	 (tartar,	 caries,	
overflowing	restorations,	dental	crowding).	
	
Dental	mobility	may	increase	due	to	periodontal	disease	associated	with	plaque.	
Differential	 diagnosis	 must	 be	 performed	 with	 other	 causes	 of	 hypermobility,	
such	 as	 occlusal	 trauma,	 reduction	 of	 supporting	 bone,	 orthodontic	 treatment.	
Dental	 mobility	 is	 assested	 by	 tapping	 the	 thooth	 between	 two	 instrument	
handles,	 evaluating	the	 movement	 of	 the	tooth	between	 the	 two	 extreme	
positions.	
Three	grades	of	mobility	are	defined:	grade	1	shows	horizontal	movement	of	no	
more	than	1	mm,	grade	2	is	characterized	by	horizontal	movement	between	1	and	
2	mm,	degree	3	shows	horizontal	mobility	higher	than	2	mm	or	vertical	mobility.	
			
	
	
	
Fig.	 23	 Technique	 for	 assessing	 dental	
mobility		
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Dental	probing	is	carried	out	by	means	of	a	periodontal	probe,	applying	a	force	of	
about	30	grams,	along	the	entire	circumference	of	each	tooth	between	the	tooth	
and	 the	 gum.	 It	 allows	 the	 detection	 of	 	 periodontal	 pockets,	 level	 of	 clinical	
attachment,	 involvement	 of	 forcations,	 presence	 of	 subgingival	 tartar	 and/or	
incongruous	 restorations.	 Presence	 of	 bleeding	 during	 dental	 probing	 is	 an	
important	risk	factor	for	periodontitis	progression.	
The	PSR	system	is	a	clinical	method	created	to	evaluate	the	severity	of	periodontal	
disease	 by	 introducing	 a	 specific	 calibrated	dental	 probe	 into	 gingival	 sulcus	 of	
each	 tooth	 (Six	 measurements	 for	 each	 tooth	 are	 obtained	 along	 the	 entire	
circumference).	 A	 score	 between	 0	 and	 4	 is	 assigned	 to	 each	 quadrant	 of	 the	
mouth,	considering	the	deepest	periodontal	pocket	of	each	quadrant:	
	
	
Fig.	24	PSR	score	system	
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Fig.	25	The	specific	dental	probe	used	in	PSR	analysis	
	
Periapical	radiography	and	cone-beam	computed	tomography	(CBCT)	are	
nowadays	used	to	observe,	measure	and	evaluate	bone	loss	around	the	theet.	
	
	
Fig.	 26	 	 Periapical	 radiography	 of	 a	 tooth	 with	 alveolar	 bone	 loss	 caused	 by	
periodontitis	
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2.	FIRST	STUDY:	COLORECTAL	CANCER	AND	PERIODONTAL	DISEASE	
	
	
2.1	INTRODUCTION	
	
	
2.1.1	Colorectal	cancer:	incidence	and	prognosis		
Colorectal	cancer	is	the	third	most	common	cancer	and	the	fourth	most	common	
cancer	cause	of	death	globally,	accounting	for	roughly	1.2	million	new	cases	and	
600	000	deaths	per	year	[17].	
Incidence	 is	 low	 among	 young	 peolpe	 (less	 than	 50	 years	 old)	 but	 strongly	
increases	with	age.	
Median	age	at	diagnosis	is	about	70	years	in	developed	countries	[18].		
Incidence	is	higher	in	Europe,	North	America,	and	Oceania	than	in	Asia	and	Africa.	
Despite	this,	incidence	in	those	countries	which	were	considered	at	low-risk	a	few	
years	ago	(for	exemple	Spain	and	west	Asia),	has	been	increasing	more	and	more,	
probably	due		to	changes	in	dietary	patterns	and	lifestyle	habits.	On	the	other	end,	
in	 the	 USA	 incidence	 started	 to	 decrease,	 probably	 thanks	 to	 improved	 early	
detection	and	treatment	techniques	(for	example	an	increased	use	of	colonoscopy	
with	polypectomy)	[19,20].		
	
In	2008	mortality	ranged	from	2.7	per	100	000	people	in	central	Africa	to	12.2	in	
central	and	eastern	Europe	in	women,	and	from	3.5	to	20.1	in	men.		
	
Prognosis	has	been	improving	in	the	last	decades	with	a	5-year	relative	survival	
rate	of	65%	in	developed	countries,	but	it	is	still	less	than	50%	in	less	developes	
areas	of	the	world.	
Similarly	 to	 other	 cancers,	 the	 most	 critical	 prognostic	 factor	 seems	 to	 be	 the	
represented	by	the	stage	at	the	moment	of	the	diagnosis.		
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Tab.	 2	 	 Age-standardised	 rates	for	 coloncancer	 in	 both	 sexes,	 World	 Cancer	
Research	Fund	
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Tab.	 3	 Age-standardised	 rates	for	 coloncancer	 in	 men,	 World	 Cancer	 Research	
Fund	
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Tab.	4.	Age-standardised	rates	for	coloncancer	in	women,	World	Cancer	Research	
Fund	
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Fig.	27		Estimated	age-standardised	incidence	for	colorectal	tumor	in	men	in	
2008,	Globocan	2008.	[17] 
 
	
Fig.	28	Colorectal	cancer	mortality	trends	for	men,	1955–2010,	WHO	mortality	
database.	
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2.1.2	Carcinogenesis:	risk	and	preventive	factors	
	
Carcinogenesis	is	a	complex,	multiphase	process	in	which	genetic	alterations	and	
enviromental	 factors	 can	 lead	 to	 the	 transformation	 of	 healty	 mucosa	 into	
adenocarcinoma.		
Genetic	predisposition	is	definetly	significant:	some		authors	stated	that	in	up	to	
30%	of	cases,	malignant	lesions	develop	in	patients	with	a	strong	family	history	
[21].	 
In	 colorectal	 cancer	 malignant	 transformation	 is	 generally	 slow	 (it	 takes	 more	
than	 10	 years)	 and	 is	 characterized	 by	 parallel	 changes	 in	 the	 molecular	 and	
histological	side.	
This	 tumor	 is	 often	 preceded	 by	 precursor	 lesions	 like	 dysplastic	 adenomas	
(intestinal	adenomatous	polyps).	
Intestinal	polyps	are	esophitic	lesions	rising	from	the	intestinal	mucosa,	which	
protrude	towards	the	intestinal	lumen.	Most	of	them	are	benign	and	
asymptomatic.	They	are	generally	classified	as	adenomatous	(adenomas),	
hamartomatous	and	hyperplastic	polyps.	Adenomas	can	be	ulteriorly	divided		
into	tubular,	tubulovillous	and	villous,	with	approximately	87%	of	adenomas	
being	tubular,	8%	tubulovillous	and	5%	villous	[22].	 
	
Altough	generally	benign,	the	probability	of	tumoral	transformation	increases	
with	polyp	size:	a	diameter	higher	than	1	cm	is	considered	dangerous	[23].	
 
 
In	addition	to	dimension,	the	number	of	polyps	could	be	crucial.	
Polyposis	is	a	pathological	condition	characterized	by	a	high	number	of	polyps	in	
different	segments	of	the	entire	digestive	tract.	Some	genetic	syndromes,	such	as	
Familial	 Adenomatous	 Polyposis	 (FAP)	 and	 its	 variants	 (Gardner's	 syndrome,	
Turcot's	 syndrome	 and	 Zanca's	 syndrome)	 have	 been	 related	 to	 a	 higher	
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probability	of	developing	colorectal	cancer;	according	to	some	authors	about	2%–
5%	 of	 all	 colorectal	 cancers	 can	 develop	 from	 a	 defined	 inherited	 cancer	
syndrome	[24].		
	
Familial	Adenomatous	Polyposis	(FAP)	is	a	hereditary	condition	characterized	by	
multiple	 (usually	 more	 than	 100)	 colorectal	 adenomatous	 polyps.	 Incidence	 is	
approximately	 1	 in	 10,000	 cases	 and	 it	 is	 responsible	 for	 1%	 of	 all	 colorectal	
cancers	in	the	United	States	[25].		
In	 this	 condition,	 specific	 mutations	 occur	 in	 the	 APC	 gene,	 located	 on	
chromosome	5.	It	is	precisely	this	gene	that	is	thought	to	play	an	important	role	in	
tumor	 development,	 in	 fact	 APC	 gene	 mutations	 	 occur	 in	 more	 than	 70%	 of	
adenomas	as	early	events	[26].	
Furthermore		mutations	of	the	KRAS	oncogene	and	TP53	tumour	suppressor	gene	
can	be	appreciated	[27].	 
In	 FAP	 the	 risk	 of	 malignant	 transformation	 is	 estimated	 at	 60-80%	 and	 it	 is	
related	to	the	number	of	polyps	and	to	the	age	of	the	patient.	
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Fig.	29			Endoscopic	image	of	the	sigma	colon	in	a	patient	with	FAP	
	
A	 different	 genetic	 condition	 not	 related	 with	 intestinal	 polyposis	 is	 Lynch	
Syndrome	or		Hereditary	Nonpolyposis	Colorectal	Cancer	(HNPCC),	an	autosomal	
dominant	genetic	disease,	showing	a	50%–70%	lifetime	risk	of	colorectal	cancer,	
40%–60%	 risk	 of	 endometrial	 cancer	 and	 increased	 risks	 of	 several	 other	
malignancies.	It	is	caused	by	mutations	in	important	DNA	mismatch	repair	genes	
such	as	MLH1,	MSH2,	MSH6	and	PMS2	[28].	
 
	
In	HNPCC	about	90%	of	colorectal	cancers	and	80%	of	adenomas	have	
microsatellite	instability,too	.	In	the	type	I	variant,	the	most	affected	area	is	the	
right	colon	and	the	neoplasms	tend	to	be	multiple,	synchronous	or	metachronous.	
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In	the	type	II	variant	a	predisposition	for	the	development	of	extra-intestinal	
tumours	(such	as	ovary,	renal	pelvis,	stomach,	ureter	and	endometrium)	can	be	
observed.	
	
Peutz-Jeghers	 syndrome	 is	 a	 less	 less	 frequent	 condition	 (incidence	 is	 between	
1:10,000	and	1:100,000	births),	characterized	by	the	appearance	 in	 first	decade	
of	 life	 of	 multiple	 hamartomatous	 polyps	 (	 affecting	 the	 entire	 gastrointestinal	
tract),	 mucocutanous	 melanosis,	 luminal	 gastro-intestinal	 cancer	 and	
extraintestinal	cancer.	
	
Similarly,	 Juvenile	Polyposis	Syndrome	(JPS)	 is	characterized	by	 the	appearence	
of	several	juvenile	polyps	in	the	gastro-intestinal	tract.	The	incidence	is	estimated		
between	1:100.000	to1:160	000	[29].	 
In this case alterations	in	the	transforming	growth	factor	(TGF-beta)	pathway	are	
often	observed:	a	mutation	in	BMPR1A	gene	or	SMAD4	gene		is	present	in	20-
30%	of	patients.		
Despite	these	polyps	are	not	generally	malignant,	both	these	last	two	syndromes	
have	 been	 proved	 to	 be	 a	 predisposing	 conditions	 for	 the	 development	 of	
colorectal	cancer.	
	
Although	genetic	seems	to	play	a	major	role	in	carcinogenesis,	and,	as	some	
authors	said,	35%	of	colorectal	cancer	risk	might	be	attributable	to	heritable		
factors,[30]	other	parameters	which	have	to	be	considered	in	the	analysis:	age,	
sex,		inflammatory	bowel	disease,	smoking,	excessive	alcohol	consumption,	high	
consumption	of	red	and	processed	meat,	obesity	and	diabetes. 
	
Age	 and	 sex:	 colorectal	 tumor	 are	 more	 diffused	 among	 elderly	 people;	 in	
particular	 incidence	 rate	 increases	 after	 60	 years,	 expecially	 in	 male.	 Among	
people	 younger	 than	50	 years	 old,	when	 the	disease	 is	 less	diffused,	 	 the	male-
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female	ratio	is	about	1:1.	
	
Ethnic	factors:	colorectal	neoplasms	are	frequent	in	industrialized	countries	such	
as	Europe,	North	America	and	Japan,	while	they	are	rare	in	Africa,	South	America	
and	Asia.	Ethnic	factors	are	particularly	evident	considering	citizens	of	different	
ethnicity,	residing	in	the	same	country:	in	the	United	States	of	America,	for	
example,	the	highest	incidence	and	mortality	is	found	in	the	African	American	
population,	vice	versa	the	lowest	rates	are	recorded	in	the	Hispanic	community	
[31].		
	
Food	habits:	obesity,	a	high-calorie	diet	and	excessive	consumption	of	animal	fats	
and	red-and-processed	meat	have	been	related	to	an	increased	risk	of	cancer	[32]	
.		
Studies	have	shown	that	individuals	from	low-risk	areas	can	develop,	over	time,	
the	 same	 rate	 of	 incidence	 of	 the	 host	 country	 polulation,	 due	 to	 new	 eating	
habits.	 On	 the	 contrary	 it	 is	 widely	 established	 that	 a	 diet	 that	 favours	 the	
consumption	of	fresh	fruit	and	vegetables	can	play	a	preventive	role	and	reduces	
the	risk	of	occurrence.		
	
Excessive	alcohol	consumption	and	smoking:		both	these	habits	can	be	considered	
risk	factors.	Some	authors	support	the	concept	that	ethanol,	under	certain	
experimental	conditions,	could	represent	a	cocarcinogen	and/or	tumour	
promoter	for	upper	alimentary	tract	and	large	intestine	malignant	lesions	[33].	
In	addition	a	recent	meta-alaysis	stated	that	cigarette	smoking	is	significantly	
associated	with	colorectal	cancer	incidence	and	mortality	[34].	
Similarly	to	oral	squamous	cell	carcinoma,	the	association	of	these	factors	
appears	to	be	extremely	dangerous:	it	seems	that	the	risk	in	patients	exposed	to	
both,	smoking	and	large	alcohol	consumption,	could	be	greater	than	additive.		
	
	 53	
	
	Hormone	therapy	and	anti-inflammatory	drugs:	data	on	the	possible	role	of	
female	hormones,	in	particular	hormone	replacement	therapies,	in	the	
development	of	colorectal	neoplasms	are	reassuring:	various	studies	have	shown	
that	hormone	replacement	therapy	reduces	the	incidence	of	adenomas	and	
colorectal	carcinomas	in	women	in	menopause	[35].		
Similarly,	data	obtained	from	observational	studies	on	the	role	of	acetyl-salicylic	
acid	and	non-steroidal	anti-inflammatory	drugs	in	carcinogenesis	have	confirmed	
that	assumption	of	these	drugs	is	associated	with	a	reduction	in	the	risk	of	
colorectal	cancer	of	about	20-30%	[36].	 
	
Physical	activity:	poor	physical	activity	is	considered	an	independent	risk	factor	
and	a	statistically	significant	association	has	been	found	with	the	development	of	
colon	cancer	(especially	of	the	proximal	tract);	on	the	contrary	regular	exercise	
seems	to	represent	an	important	preventive	factor	[37].		
	
 
	
2.1.3	Prevention	
Early	detection	is	the	key	objective	of	modern	clinical	practice.	Primary	
prevention	aims	at	reducing	exposure	to	etiological	factors	or	the	susceptibility	of	
the	host	to	them.	The	main	goal	is	to	prevent	the	onset	of	genetic	damage	and	to	
oppose	its	progression.	However	the	difficulty	of	changing	life	habits	(such	as		
nutrition	and	physical	exercise)	represents	a	real	challenge.	Recently,	chemo-
prevention	has	been	proposed	as	an	alternative	primary	preventive	method.	It	
can	be	defined	as	the	use	of	natural	or	synthetic	substances	which	have	
demostrated	to	be	free	of	toxicity	and	capable	of	preventing	the	processes	of	
initiation,	promotion	and	progression	of	cancer,	before	or	during	the	
preneoplastic	phase,	in	animal	models	or	in	vitro	studies.	To	be	precise,	different	
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kinds	of	chemoprevention	are	known:	primary	chemoprevention,	directed	to	the	
general	population	or	to	population	groups	at	risk,	which	represents	a	public	
health	intervention	and	aims	to	inhibit	the	onset	of	cancer.	Secondary	
chemoprevention	is	applied	when	the	tumour	is	already	present,	in	order	to	block	
progression	(	or	possibly	induce	regression	of	lesions)	or	prevent	recurrences.	
Finally	tertiary	chemoprevention	is	performed	in	association	with	chemotherapy	
and	aims	to	reduce	its	toxic	effects	and	possibly	increase	its	effectiveness.	Among	
the	synthetic	substances,	a	possible	chemo-preventive	role	of	non-steroidal	anti-
inflammatory	drugs	(NSAIDs)	has	been	noted	in	those	patients	who	have	been	
taking	them	for	a	long	time,	reporting	a	reduction	in	incidence	and	mortality	of	
gastrointestinal	malignant	tumours	of	40-50%	[38].		
	
The	 likelihood	of	 the	onset	of	new	adenomas	after	treatment	 for	previous	colon	
cancer	also	seems	to	decrease	with	these	medications.	Their	efficacy	is	reported	
both	when	the	therapy	is	administered	at	an	extremely	early	stage	of	the	disease	
(intact	 colic	 mucosa)	 and	 when	 it	 is	 performed	 at	 a	 later	 stage	 (presence	 of	
adenomas),	regardless	of	age,	sex	and	colic	segment	involved.	The	problem	is	that	
the	protective	effect	is	closely	linked	to	a	continuous	and	long	intake	and	stops	at	
the	suspension	of	the	drug.	
	Among	 medicines	 particular	 attention	 has	 been	 paid	 to	 selective	 inhibitors	 of	
COX-2	(such	as	celecoxib	and	rofecoxib),	an	inducible	enzyme	responsible	for	the	
synthesis	 of	 prostaglandins,	 thromboxanes	 and	 leukotrienes	 from	 arachidonic	
acid,	whose	activity	is	increased	in	both	inflammatory	and	neoplastic	diseases.	In	
fact	in	colon	carcinomas	a	greater	expression	of	COX-2	and	its	products	has	been	
demonstrated	than	in	healthy	tissues.		
	
Secondary	 prevention	 includes	 those	 methods	 aiming	 at	 identification	 of	 the	
disease	at	an	early	stage,	when	it	is	not	yet	clinically	manifest.		
At	present	the	most	effective	measure	to	reduce	mortality	from	this	disease	is	still	
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early	diagnosis,	in	fact	the	recognition	of	cancer	lesions	in	the	early	stages	allows	
a	 5-year	 survival	 rate	 of	 about	 90%.	 The	 transformation	 from	 adenoma	 to	
carcinoma	 is	 generally	 quite	 slow	 (it	 can	 last	 10	 years):	 this	 period	 gives	 the	
patient	 the	possibility	 to	diagnose	an	asimptomatic	 lesion	at	 an	early	 stage	and	
eliminate	it.	These	so	important	screening	methods	are	based	on	search	for	occult	
blood	 in	 the	 stool	 (Hemoccult),	 sigmoidoscopy	 with	 flexible	 instrument,	
colonoscopy	and	double-contrast	 clism.	Other	 tests,	 such	as	 research	 in	 stool	of	
altered	DNA	and	virtual	colonoscopy,	are	also	being	 tested,	but	 further	data	are	
needed.		
Today	 in	 many	 countries	 medical	 guidelines	 recommend	 colorectal	 cancer	
screening	 programs	 from	 age	 of	 50	 for	 people	 at	 average	 risk:	 they	 generally	
consist	of	annual	or	biannual	guaiac	faecal	occult	blood	or	faecal	immunochemical	
tests,	 flexible	 sigmoidoscopy	 every	 5	 years,	 or	 colonoscopy	 every	 10	 years	
[39,40].	
A	 positive	 faecal	 immunochemical	 test	 or	 guaiac	 faecal	 occult	 blood	 requires	 a	
mandatory	colonoscopy.	If	adenomas	and		hyperplastic	polyps	are	detected,	they	
have	to	be	removed	and	an	histologiacal	analysis	has	to	be	performed.	
Individuals	 with	 increased	 risk	 (for	 exemple	 first-degree	 relatives	 of	 young	
patients	 diagnosed	 with	 colorectal	 cancer,	 familial	 adenomatous	 polyposis,	
hereditary	 nonpolyposis	 colon	 cancer,	 or	 inflammatory	 bowel	 disease)	 should	
start	screening	programs	at	least	10	years	before.	
	
	
	
	
2.1.4	Diagnosis	and	staging		
Diagnosis	of	colorectal	cancer	is	initially	based	on	medical	history	and	search	for	
clinical	signs	and	symptoms.	The	suspicion	is	mainly	posed	by	the	appearance	of	
rectal	 bleeding	 and/or	 alvus	 alterations	 in	 elderly	 patients	with	 risk	 factors.	 In	
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Italy,	 screening	 programs	 are	 based	 on	 the	 detection	 of	 occult	 blood	 in	 stools.	
Peolpe	of	both	sexes,	aged	between	50	and	69	years,	are	 invited	to	perform	the	
exam	every	2	years	without	dietary	restrictions.	If	the	test	result	is	positive,	it	is	
indicated	 to	 perform	 further	 investigations	 (colonoscopy	 or	 opaque	 clism)	 in	
order	to	identify	the	main	cause	of	the	bleeding.		
The	clinical	examination	can	help	to	make	an	initial	assessment	of	rectum,	since	
this	 district	 represents	 one	 of	 the	 most	 frequent	 locations	 of	 large	 intestine	
neoplasms.	However,	the	accuracy	of	the	exam	can	change	according	to	clinician	
experience.	 Furthermore,	 it	 is	 not	 clinically	 possible	 to	 distinguish	 between	 an	
inflammatory	disease	and	a	tumor.		
Among	 instrumental	 examinations	 the	 endoscopic	 analysis	 is	 essential	 and	
represents	 the	gold	standard	 for	diagnosis.	This	procedure	allows	 to	explore	all	
segments	 of	 the	 colon	 and	 gives	 the	 possibility	 to	 take	 biopsy	 samples	 of	 a	
suspected	 lesion	 in	 order	 to	 analyse	 it	 from	 an	 histological	 point	 of	 view.	
Furthermore,	 this	 colonscopy	 has	 a	 possible	 preventive	 role,	 allowing	 the	
definitive	 removal	 of	 precancerous	 lesions	 like	 polyps.	 A	complemetary	
examination	 is	 represented	 by	 double-contrast	 barium	 enema,	 which	is	 a	 form	
of	contrast	 radiography	:	 a	 liquid	 containing	barium	and	 air	are	 put	 into	 the	
rectum	 and	 colon	 to	 evaluate	 the	 morphology	 of	 the	 intestine	 and	 detect	 the	
presence	 of	 even	 small	 alterations	 (up	 to	 one	 centimeter	 in	 diameter).	 This	
method,	as	well	as	the	most	recent	virtual	colonoscopy,	is	useful	especially	in	the	
presence	of	stenotic	lesions	that	not	allow	a	complete	preoperative	evaluation	of	
the	whole	colon.	
Other	 instrumental	 diagnostic	 investigations,	 such	 as	 Computed	 Tomography	
(CT)	 of	 the	 abdomen	 and	 eco-endoscopy,	 are	 mainly	 used	 for	 cancer	 staging	
purposes,	 as	 they	document	possible	dissemination	at	 a	distance,	however	 they	
play	a	limited	role	in	diagnosis.		
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Laboratory	 tests	 can	 also	 help	 diagnostic	 procedures;	 tumour	markers,	 such	 as	
CEA	(carcinoembryonic	antigen),	gastrointestinal	tumour	antigen	CA	19.9	and	CA	
125,	 which	 are	 generally	 present	 at	 low	 levels	 in	 samples	 taken	 from	 healthy	
subjects,	 can	 raise	 in	 patients	 affected	 by	 cancer,	 so	 they	 may	 represent	 an	
indicator	of	the	presence	of	neoplastic	disease.	Unfortunately,	the	value	of	these	
substances	 is	 often	 influenced	 by	 other	 non-neoplastic	 factors	 such	 as	 drug	
therapies	 (some	antihypertensive	drugs)	 and/or	 the	presence	of	 other	diseases	
(colon	 chronic	 inflammatory	 diseases)	 or	 smoking	 habits.	 Because	 of	 their	 low	
specificity,	they	are	not	sufficient	on	their	own	to	make	a	diagnosis,	but	they	play	
a	role	both	at	a	prognostic	 level	and	in	post-surgical	follow-up,	representing	the	
indicator	of	a	possible	resumption	of	asymptomatic	tumour	disease.	
	
Despite	 these	 considerations,	 final	 diagnosis	 of	 this	 cancer	 is	 made	 only	 by	
histological	analysis	from	biopsy	samples.		
	
Synchronous	 malignant	 lesions	 are	 present	 in	 about	 2–4%	 of	 cases	 and	 a	
Complete	colonoscopy	or	CT	colonography	is	essential	to	find	them.	
By	means	of	Endoscopic	ultrasononography	determination	of	the	T-stage	of	rectal	
cancer	and	is	possible,	even	though	the	most	accurate	method	to	define	advanced	
T-stages	is	MRI	[41,42].	
Distant	metastases	can	be	discovered	in	about	20%	of	patients	newly	diagnosed	
with	 colorectal	 cancer,	 expecially	 in	 liver	 (thus	 liver	 imaging	 should	 be	
mandatory	in	case	of	diagnosis	of	colorectal	cancer);	less	frequent	metastases	can	
be	found	in	lungs,	bone	and	brain.		
	
Several	 classification	 	 systems	 can	 be	 used.	 Although	 modern	 TNM	 method	 is	
generally	 adopted,	 Dukes	 classification,	 proposed	 by	 Dr.	 Cuthbert	 E.	 Dukes	 in	
1932,	 is	 still	 diffused	 as	 it	 is	 simple,	 essential	 and	 reproducible	 and	 focuses	 on	
tissue	 infiltration,	 lymph	 node	 involvement	 and	 the	 presence	 of	 distant	
	 58	
metastases.		
According	to	this	method	three	stages	can	be	defined	A,	B	and	C	and	each	of	them	
is	associated	with	a	different	survival	rate.	
			
A	=	Tumour	confined	within	the	intestinal	wall		
B	=	Tumour	extending	beyond	the	intestinal	wall		
C	=	Any	tumour	with	lymph	node	metastases		
		
In	1954	Astler	and	Coller	modified	stages	B	and	C	by	dividing	them	into	two	sub-
groups	each:	B1	and	B2,	C1	and	C2	[43]. 
Turnball	in	1967	added	category	D	to	indicate	the	presence	of	distant	
metastases[44]	.	 
	
	
	
		
Fig.	30	Modified	Classification	of	colorectal	cancer	according	to	Astler-Coller.	
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Finally	 in	 1978	 the	American	 Joint	 Committee	 for	 Cancer	 (AJCC)	 developed	 the	
modern	TNM	system,	valid	for	both	colic	and	rectal	tumours.	This	establishes	the	
stage	of	 neoplasm	on	 the	basis	 of	 the	 extension	of	 the	primary	 tumour	 (T),	 the	
presence	of	lymph	node	involvement	(N)	and	distant	metastases	(M)		
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Fig.	31	TNM	classification	of	colorectal	cancer.		
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Three	different	levels	of	classification	are	also	recognized:		
➢	c-TNM:	clinical-diagnostic	evaluation;		
➢	s-TNM:	surgical	evaluation;		
➢	p-TNM:	post-surgical	evaluation,	antomopathology.		
However,	the	first	two	types	of	classification	have	proved	to	be	inadequate	with	
regard	 to	 their	 prognostic	 value,	 so	 the	 focus	 is	 expecially	 posed	 on	 the	
anatomopathological	staging	p-TNM.	
	
In	the	1980s,	Jass	and	his	collaborators	developed	a	way	of	assigning	a	score	to	
intestinal	lesions,	depending	on	four	histological	variables:	depth	of	tumour	
invasion,	tumour	growth	pattern,	peritumoral	lymphocyte	infiltration,	lymph	
node	involvement.	For	each	one	of	these,	a	score		is	assigned	by	the	pathologist	:	
the	sum	of	the	scores	determines	the	stage	of	the	tumor	[45].		
	
Stage	I:	score	0-1	
Stage	II:	score	2	
Stage	III:	score	3	
Stage	IV:	score	4-5	
	 62	
							
Fig.	32	Parameters	and	method	of	assignment	of	the	score	in	Jass	classification		
	
	
	
2.1.5	Surgery	
The	surgical	procedure	for	rectal	cancer	includes	removal	of	the	rectum	together	
with	the	mesorectum	and	the	mesorectal	fascia	[46].		
The	surgeon	should	leave	at	least	1mm	clear	circumferential	margin	(distance	of	
more	than	1	mm	between	the	tumour	border	and	the	resection	margin)	in	order	
to	reduce	tumor	recurrence.	
In	case	of	colon	cancer	tumor,	 the	 lesion	together	with	 its	corresponding	 lymph	
vessels	should	be	removed.		
Open	 surgery	 tecnique	 has	 been	 the	 only	 option	 available	 for	 many	 years,	 but	
laparoscopic	 technique	 is	 a	 valid	 alternative	 nowadays.	 This	 method	 lets	 the	
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patient	 	achieve	similar	 long-term	results	as	open	surgery	 , with	a	reduced	need	
for	 blood	 transfusions	 (3.4%	 vs	 12.2%),	 faster	 return	 of	 bowel	 function	 and	 a	
shorter	 hospitalization	 (9.1	 days	 vs	 11.7	 days);	 despite	 these	 advantages,	 costs	
are	higher	and		operating	times	are	longer	(208	min	vs	167	min)	[47,48]. 
	
2.1.6	Neoadjuvant		and	Adjuvant	therapy	
Data	 for	 the	 role	 of	 neoadjuvant	 radiotherapy	 in	 locally	 advanced	 colon	 cancer	
are	not	so	clear.	 	The	main	goal	of	 this	 treatment	 is	 to	reduce	the	probability	of	
local	 recurrence	but	 several	 side	 effects	 have	 to	be	 considered.	 Stage	 I	 patients	
should	not	 be	 treated	 in	 addition	 to	 surgery	 because	 of	 the	 the	 low	 recurrence	
rate	(less	than	3%)	[49].	
Stage	 III	 patients	may	 benefit	 from	 additional	 treatment,	 whereas	 opinions	 for	
patients	with	stage	II	are	controversial	[50].	
	
Otherwise,	 adjiuvant	 chemoterapy	 is	 reccomendef	 for	 patients	 with	 stage	 III	
disease.	 Fluorouracil	 and	 capecitabine	 are	 the	most	 common	 drugs.	 In	 stage	 II	
colon	cancer	patients	 the	survival	benefits	 from	adjuvant	chemotherapy	are	not	
so	many,	so	it	is	reccomended	only	in	cases	with	higher	risk	of	relapse.		
Considering	 distant	 metastases,	 patients	 with	 resectable	 liver	 or	 lung	 lesions	
should	undergo	surgical	resection	while	those	with	irresectable	metastases	might	
benefit	 from	 palliative	 chemotherapy,	 depending	 on	 age,	 comorbidities,	 and	
extent	of	the	tumor.		
	
	
2.1.7	 Human	microbiota	 and	 colorectal	 cancer:	 Fusobacterium	 nucleatum	
and	Phorpyromonas	gingivalis	
	
	
Similarly	to	the	link	between	H.	pylori	infection	and	gastric	cancer,	a	connection	
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between	 human	 microbiota	 	 and	 other	 gastrointestinal	 tumours	 could	 be	
hypotized.	 Recent	 data	 suggests	 some	 bactaeria	 can	 have	 a	 role	 in	 the	
pathogenesis	 of	 colorectal	 carcinoma,	 in	 fact	 they	 have	 been	 detected	 in	 tumor	
microenvironment;	 in	 particular	 an	 association	 between	 Fusobacterium	
nucleatum	(FN)	and	the	colonic	mucosa	of	colorectal	cancer	has	been	hypotized	
[51,52].	
Although	oral	microbiota	has	been	proven	to	be	responsible	for	different	
dangerous	pathways	[53,54]	(production	of	DNA	damaging	genotoxins	and	
superoxide	radicals,	induction	of	cell	proliferation	mediated	by	T-helper	cells	,	
induction	of	procarcinogenic	pathways	due	to	Toll-like receptor action),	a	direct	
relationship	between	human	microbioma	colonization	of	intestinal	lumen	and	
colorectal	cancer	has	not	be	demostrated	yet	.	
	
Fusobacterium	Nucleatum	is	a	common	gram-negative	anaerobic	bacterium	of	the	
oral	cavity	playing	an	important	role	in	human	periodontal	disease,	even	tough	it	
can	be	detected	in	extra-oral	diseases.	
	
	
Fig.	33	Fusobacterium	nucleatum	culture	
	
	For	 exemple	 It	 has	 been	 associated	 with	 oral	 cancer	 and	 premature	
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stillbirths[55],	pancreatic	cancer.		
In	 addition,	 	 a	 correlation	with	 liver	 abscess,	 appendicitis,	 sinusitis,	mastoiditis	
and	tonsillitis	has	to	be	considered	[56,57,58].	
In	this	specific	case,	some	recent	studies	found	Fusobacterium	nucleatum	rates	to	
be	 highly	 inceased	 in	 colorectal	 cancer	 and	 also	 in	 benign	 precancerous	 polyps	
[59].	
	
This	microrganism	has	the	ability	to	colonize	and	spread	throgh	tissues	expecially	
due	 to	 its	 	 intrinsic	 aptitude	 to	 adhere	 and	 invade	 human	 epithelial	 and	
endothelial	cells.	
That	is	the	reason	why	the	hypotesis	that	human	oral	microbiota	is	not	confined	
to	 the	mouth	 but	 is	 able	 to	move	 in	 the	 body,	 causing	 extra-oral	 infection	 and	
inflammation,	is	plausible.	
It	 is	 true	 that	 the	 presence	 of	 this	 bacterium	 in	 the	 colorectal	 adenomas	 and	
carcinomas	is	not	sufficent	to	demostrate	a	direct	causality,	but	the	fact	that	oral	
cavity	 is	 the	 starting	 point	 of	 the	 digestive	 tract	 has	 to	 be	 considered:	 some	
bacteria	could	be	able	to	move	towards	the	bowel.		
The	 surface	 adhesin	 FadA	 expressed	 by	 this	 micoorganism	 is	 essential	 in	 cell	
attachment	and	invasion	processes	[60].		
Furthermore,	 FadA	 can	 bind	 to	 endothelial-cadherin	 on	 endothelialn	 vascular	
cells,	increasing	their	permeability	and	allowing	bacteria	to	penetrate.	This	could	
result	 in	 an	 increased	 bacterium	 penetration	 and	may	 represent	 a	 strategy	 for	
sistemic	dissemination.	 	 This	 adhesin	 is	 unique	 to	 and	highly	 conserved	 among	
Fn,	but	is	absent	in	non-oral	fusobacteria	[60].	
FadA	exists	in	2	forms:	the	intact	pre-FadA	(	about	129	amino-acid	residues)		and	
the	mature	FadA	(mFadA,	consisting	of	111	amino-acid	residues)	.	Both	forms	are	
essential	to	create	the	active	complex	required	for	binding	and	invasion	processes	
[61].		
Furthermore,	Fn	is	not	only	invasive	by	itself,	but	is	can	facilitate	tissue	invasion	
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by	other	species,	such	as	Streptococcus	cristatus	and	E.	coli.	[62].		
That	is	probably	the	main	reason	baceause	this	bacterium	is	frequently	detected	
in	mixed	infections.	
	Some	authors	are	convinced	that	Fusobacterium	nucleatum	represents	a	driver	
of	 colorectal	 cancer,	 in	 fact	 they	 showed	 that	 FadA	 (Fusobacterium	 Nucleatum	
adhesin	 A)	 adhesion	 on	 epitelium	 and	 endothelial	 cells	 can	 induce	 human	
colorectal	cancer	tissue	growth	[63].		
F.	nucleatum	can	binds	to	both	normal	and	tumoral	epitelium,	but	tissue	growth	
is	 promoted	 only	 in	 the	 second	 case.	 The	 cancerogenetic	 pathway	 could	 be	 the	
following:	 FadA	 binding	 to	 E-cadherin	 on	 epitelial	 tumoral	 cells	 activates	 b-
catenin-regulated	 transcription;	 this	 consequently	 increases	 the	 expression	 of	
oncogenes	 (cyclin	 D1	 and	 c-Myc),	 Wnt	 signalling	 genes	 (Wnt7a,	 Wnt7b,	 and	
Wnt9a)	 and	 inflammatory	 genes	 (NFk-B,	 TNF-alpha,	 IL-6,	 IL-8,	 and	 IL-18;	 the	
result	 is	 the	 creation	 of	 an	 inflammatory	 microenvironment	 which	 helps	 the	
progression	 of	 tumor).	 	 If	 	 FadA	 binding	 site	 on	 E-cadherin	 is	 blocked	 by	 a	 	 a	
synthetic	 peptide	 the	 cancerogenic	 pathway	 can	 be	 stopped	 and	 tumor	 growth	
can	be	slowed	both	in	vitro	and	in	xenograft	mice	[63].		
	
Kostic	 and	 al	 found	 that	 short-chain	 fatty	 acids	 and	 short-peptides	
(formylmethionyl-leucyl-phenylalanine)	 released	 by	 the	 bacterium,	 can	 attract	
myeloid-derived	suppressor	cells	(MDSCs)	[64].	
In	addition,	 it	 seems	 that	 infected	cells	 increase	 the	expression	of	microRNA-21	
(miR21)	 by	 activating	 TLR4	 signaling	 to	 MYD88,	 which	 leads	 to	 a	 further	
activation	of	NF-κB,	inducing	the	oncogenic	pathway	[65].	
Furthermore,	 it	 has	 been	 found	 that	 the	 interaction	 between	 bacterial	 Fap2	 (a	
galactose-sensitive	 adhesion	 protein)	 and	 the	 human	 inhibitory	 receptor	 TIGIT	
can	 induce	 human	 lymphocytes	 cell	 death	 and	 generate	 a	 tumor	
immunosuppressive	 microenvironment	 which	 stimulates	 colorectal	 tumor	
progression	[66,67].	
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TIGIT	is	an	inhibitory	receptor		expressed	on	T	cells	and	natural	killer	(NK)	cells,	
so	this	interaction	may	defend	malignant	cells	from	host	immune	system[67].		
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Fig.	34	Fusobacterium	nucleatum	cancerogenetic	pathway	
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Porphyromonas	gingivalis		 is	a	Gram-negative,	 rod-shaped,	anaerobic	pathogenic	
bacterium,	which	has	a	role	in	periodontal	disease,	as	well	as	it	has	been	detected	
in	gastrointestinal	tract,	the	respiratory	tract	and	the	colon.	
Its	 main	 virulence	 factor	 are	 represented	 by	 Arg-gingipain	 (Rgp)	 and	 lys-
gingipain	(Kgp)	,	Capsular	polysaccharide	(CPS)	and		Fimbriae.	
In	 particular	 Arg-gingipain	 (Rgp)	 and	 lys-gingipain	 (Kgp)	
are	endopeptidase	enzymes,	 essential	 for	 bacterial	 collection	 of	 nutrients,	
adhesion,	 invasion	 and	 colonization.	 Furthermore,	 these	 enzymes	 are	 able	 to	
protect	the	bacterium	from	the	host	immune	response.	
P.	gingivalis	plays	a	major	role	in	the	onset	of	chronic	periodontitis	[68].	
	Though	 it	 can	be	detected	 in	 low	abundance	 in	 the	mouth,	 it	 is	 able	 to	 cause	a	
microbial	shift	of	the	oral	cavity,	allowing	for	huge	growth	of	the	miocrobiota.	The	
consequence	 	 is	 represented	 by	 alteration	 of	 the	 local	 host	 homeostasis	 and	
distruption	of		perioddontal	tissues	due	to	adaptive	immune	response[69].		
	
In	addition	to	its	well-known	role	in	periodontal	disease	it	is	interesting	to	notice	
that	 Pg	 is	 able	 to	 alter	 host-microbe	 equilibrium	 and	 cause	 inflammatory	
responses	by	modulating	the	complement	system	in	extra-oral	tissues.		
	
A	 study	 suggested	 a	 role	 of	 PG	 heat-shock	 protein	 in	 infection-triggered	
autoimmune	diseases	[69].		By	means	of	peptidylarginine	deiminase	(PAD),	which	
converts	 arginines	 into	 peptidylcitrulline,	 this	 bacterium	 can	 induce	 anti-
citrullinated	antibodies	and	trigger	autoimmune	inflammation	in	the	host	[70].		
In	some	patients	this	mechanism	can	induces	antibody	response	in	the	joints,	so	a	
role	in	development	of	chronic	arthritis	has	been	hypotized	[71].		
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Furthermore,	colocalization	of	P.	gingivalis	with	CD4+	T	cells	was	observed,	even	
though	the	mechanism	is	still	unknown	[72].		
The	virulence	mechanisms	of	Pg	in	systemic	infections	has	been	recently	studied	
by	means	of	different	animal	models.	For	example	in	a	rat	model	the	consequence	
of	 subcutaneous	 infection	 with	 Pg	 at	 different	 gestation	 periods	 was	 lower	
maternal	weight	gain,	lower	fetus	weight	and	lower	placenta	weight	[73].		
Virulence	 may	 vary	 according	 to	 bacterium	 strain:	 	 in	 a	 mouse	 periodontitis	
model,	 some	 authors	 found	 that	 different	 	 Pg	 strains	 can	 induce	 different		
systemic	responses		and	degrees	of	periodontum	distruction	[74].		
A	similar	strain-dependent	situation	was	described	in	infection	of	murine	placen-
tas	[75].	
Differently	 from	 Fusobacterium	 Nucleatum,	 the	 role	 of	 PG	 in	 colorectal	 cancer	
and	other	gastrointestinal	diseases	has	never	been	analyzed	specifically.	
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2.2	AIM	
	
This	 research	 project	 aimed	 to	 verify	 the	 presence	 of	 a	 possible	 correlation	
between	oral	microbiota	and	colorectal	 carcinoma.	 In	particular	 the	 role	of	 two		
specific	 sub-gingival	 bacteria,	 Fusobacterium	 nucleatum	 and	 Porphyromonas	
gingivalis,	two	pathogens	which	are	present	in	the	oral	cavity	and	increase	their	
load	 in	 case	 of	 periodontal	 disease,	 was	 analized	 in	 order	 to	 detect	 possible	
correlations	with	the	tumoral	changes	leading	to	colorectal	cancer	development.	
	This	discovery	of	such	a	relation	would	represent	an	important	breakthrough	for	
the		prevention	of	this	dangerous	disease,	which	is	so	widespread	nowadays.	
	
	
2.3	MATERIALS	AND	METHODS	
	
2.3.1	Study	population	
	
The	population	investigated	in	this	study	was	represented	by	patients	potentially	
at	 risk	 of	 developing	 colorectal	 cancer,	 who	 needed	 to	 undergo	 a	 diagnostic	
colonscopy	 at	 the	 SC	 Gastroenterology	 of	 ASST	 Sette	 Laghi-	 Circolo	 Hospital	
Fondazione	Macchi	of	Varese.		
	
Inclusion	and	exclusion	criteria	
The	inclusion	criteria	were	represented	by	the	informed	consent	to	the	protocol,	
good	 compliance,	 age	 not	 under	 18	 years.	 Patients	 diagnosed	 with	 metastatic	
colorectal	carcinoma	from	other	anatomical	sites	were	excluded	from	the	study.	
	
	
The	number	of	investigated	patients	was	110.	
Firstly,	patients	were	provided	with	 specific	 information	and	 informed	consent,	
(attached),	in	accordance	with	the	Regulation	on	the	protection		of		personal	data:	
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Fig.	35	Informed	consent	to	the	study	
	
	
2.3.2	Collection	of	saliva	and	crevicular	fluid	samples	
	
Then	patients	were	asked	to	provide	 information	about	 their	medical	 therapies,	
medications,	diseases,	allergies,	smoking,	eating	habits	(consumption	of	red	and	
processed	meat,	 consumption	 of	 vegetables	 and	 fruit,	 consumption	 of	 alcohol),	
physical	 activities,	 BMI	 (body	 mass	 index).	 Data	 were	 recorded	 in	 individual	
registers	and	in	a	table.	
	
	
	
At	this	point	a	dental	examination	was	performed,	by	means	of	a	dental	probe,	in	
order	to	evaluate	the	presence	or	absence	of	pathological	periodontal	pockets	in	
all	four	quadrants	(measurements	ranging	from	1	mm	to	3	mm	generally	indicate	
an	healty	gum;	pockets	deeper	than	3	mm	may	signify	gum	disease,	particularly	if	
bleeding	is	associated;	larger	numbers,	from	3,5	to	12	mm,	reveal	the	presence	of	
periodontal	disease).	
PSR	index	was	calculated	in	each	quadrant	and	registered	in	a	tab.	
		
Gingival	 crevicular	 fluid	was	 collect	 by	 inserting	 4	 sterile	 paper	 cones	 (one	 for	
each	 quadrant)	 into	 the	 deepest	 periodontal	 pocket	 of	 each	 quadrant,	 for	 30	
seconds.	 Furthermore,	 4	 sterile	 paper	 cones	 (one	 for	 each	 quadrant)	 were	
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inserted	 into	 healty	 gingiva.	 These	 paper	 cones	 were	 then	 placed	 in	 separated	
sterile	tubes	and	stored	at	-20°C	until	processing.	
	
	
	
Fig.	36	Crevicular	fluid	sampling	by	means	of	sterile	paper	cones	
	
	
	
	
	
	
	
	
2.3.3	Endoscopic	examination	and	colorectal	biopsy	
	
A	 diagnostic	 colonscopy	 was	 performed	 on	 each	 patient	 in	 order	 to	 verify	 the	
prescence	 of	 colorectal	 lesions.	 All	 lesions	were	 biopsied	 in	 order	 to	 perform	 a	
histological	 analysis	 at	 the	Unit	 of	 Pathological	 Anatomy-	Ospedale	 di	 Circolo	 –	
ASST	Sette	Laghi.		
So	patients	were	divided	into	3	groups:	
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• Patients	with	a	positive	histological	diagnosis	 for	colorecatl	cancer	(group	
1)	
• Patients	 with	 a	 positive	 histological	 diagnosis	 for	 colorectal	 adenoma	
(group	2)	
• Patients	 with	 colorectal	 lesions	 negative	 at	 histological	 examination	
(control	group	or	group	3)	
	
In	group	1	a	2	two	intestinal	samples	(about	5	mm3	)	were	collected	(in	addition	
to	the	one	used	for	histological	analysis):	one	from	pathological	mucosa	and	one	
from	healty	mucosa	(	at	a	distance	of	10	cm	from	the	lesion).	
In	group	3	only	one	intestinal	sample	was	collected	from	healty	mucosa.	
Intestinal	samples	were	placed	into	separate	sterile	tubes	containing	a	stabilizing	
solution	of	RNAlater	and	stored	at	-20°C	until	processing.	
Finally	they	were	sent	to	laboratory	for	microbiological	analysis.	
	
2.3.4	DNA	isolation	
	
The	isolation	of	the	total	DNA	(human	and	bacterial)	 from	the	samples	involved	
an	initial	phase	of	sample	digestion,	which	varied	according	to	the	nature	of	the	
sample,	 and	 a	 subsequent	 phase	 of	 purification,	 common	 to	 all	 two	 types	 of	
sample,	 which	 was	 conducted	 by	 means	 of	 purification	 kit	 QIAamp	 96	 DNA	
QIAcube	HT	(Qiagen),	using	an	automated	extraction	system,	 the	robot	QIAcube	
HT	(Qiagen).	
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Isolation	of	DNA	from	paper	cones	soaked	in	crevicular	liquid	
	
The	paper	cones	were	directly	processed	through	incubation	for	1	hour	at	55	°C,	
with	the	lysis	solution	containing	proteinase	K.	As	described	below	for	intestinal	
biopsy	samples,	automated	purification	using	QIAcube	HT	was	carried	out.	
	
	
Isolation	of	DNA	from	intestinal	biopsies	
	
After	removal	of	the	RNAlater	Preservative	Solution,	the	biopsy	specimens	were	
washed	with	a	1x	PBS	saline	solution.	
The	tissue	was	then	incubated	for	1	hour	at	55	°C	with	a	lysis	solution	containing	
proteinase	K	 (20	mg/ml)	 in	 order	 to	 degrade	 the	 tissue	 and	 digest	 the	 nuclear	
membrane,	thereby	isolating	the	total	DNA	(human	and	bacterial).	
The	 samples	 were	 then	 processed	 automatically	 using	 the	 QIAcube	 HT	
instrument.	This	instrument	uses	an	extraction	kit	that	binds	the	DNA	to	the	resin	
of	 a	 purification	 column,	 two	 successive	 washes	 with	 solutions	 containing	
ethanol,	 and	 finally	 the	 elution	 of	 the	 purified	 DNA	 that	 can	 be	 used	 for	
subsequent	tests.	
	
	
2.3.5	DNA	amplification	by	PCR-RT	
	
Each	sample	was	amplified	by	PCR-RT	to	detect	and	quantify	the	presence	of	the	
bacterium	Fusobacterium	nucleatum	and	Porphyromonas	gingivalis.	
For	 this	 purpose,	 specific	 amplification	 assays	 weree	 designed	 using	 the	
sequences	contained	in	the	"Human	Oral	Microbiome"	database	(HOMD	16S	rRNA	
RefSeq	Version	10.1).	
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Absolute	quantification	was	performed	by	the	Applied	Biosystems	7500	Sequence	
Detection	 System.	 The	 amplification	 profile	 involved	 a	 10-minute	 incubation	 at	
95°C	to	activate	polymerase,	followed	by	two	amplification	steps	of	15	seconds	at	
95°C	and	60	seconds	at	57°C	for	40	cycles.	
Plasmids	containing	the	Fusobacterium	nucleatum	and	Porphyromonas	gingivalis	
sequences	were	used	as	standard	 to	construct	 the	dilution	curves	necessary	 for	
absolute	quantification	by	interpolation	of	the	tested	bacteria.	
	
	
2.3.6	Histological	analysis	of	biopsy	samples	
	
The	 fragments	 of	 intestinal	 mucosa	 subjected	 to	 biopsy,	 taken	 from	 all	 three	
groups	 of	 patients,	 were	 analyzed	 histologically	 to	 verify	 the	 presence	 of	 any	
architectural	and	cytological	changes	in	the	tissue	under	examination,	necessary	
for	effective	diagnosis	of	colorectal	adenocarcinoma.		
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Fig.	37	Study	flow-chart	
	
	
	
2.3.7	Statistical	analysis	
	
Data	were	elaborated	with	the	SPSS	v.20	software	by	means	of	a	PC	with	Window	
10	 operating	 system.	 Descriptive	 statistics	 of	 continuous	 variables	 were	
presented	 as	mean ± standard	 deviation	 (SD)	 whereas	 the	 categorical	 variables	
were	presented	as	numbers	and	frequencies.	
Bacterial	 load	 comparison	between	patients	 groups	was		 performed		 by	ANOVA	
and	 Dunnet	 post	 hoc	 test.	 Data	 were	 also	 processed	 with	 the	 non-parametric	
Kruskal-Wallis	statistics	because	data	did	not	always	fit	the	Gaussian	distribution.	
In	order	to	establish	in	this	study	if	there	were	any	possible	connections	between	
oral	 and	 intestinal	microflora,	 correlation	 analysis	 was	 performed	 to	 statistical	
Patients with risk for Colorectal Cancer (CC) 
(fecal blood; symptoms)
Anamnesis Questionnaire 
(age, sex, smoking, consumption of alcohol and red-processed meat, physical activity, diabetes, other risk factors)
Periodontal analysis 
(saliva, gingival crevicular fluid from periodontal pockets)
Colonscopy 
patients with CC
pathological sample 
healty mucosa sample
patients with Adenoma
pathological sample 
healty mucosa sample
control group 
healty mucosa sample
DNA-RNA ANALYSIS
	 82	
evaluate	the	strength	of	a	relationship	between	oral	and	intestinal	bacterial	load	
in	different	groups	of	patients.		
Results	were	considered	statistically	significant	at	p	value	less	than	0.05.	
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2.4	RESULTS	AND	DISCUSSION	
	
A	total	number	of	110	patients	underwent	the	experimental	procedure:	61	males	
and	49	females.	
According	 to	 coloscopy	 and	 histological	 analysis	 patients	 were	 divided	 in	 3	
gropus:	
- Group	1:	patients	with	colorectal	cancer	
- Group	2:	patients	with	colorectal	adenoma	
- Group	3:	healty	patients	(control	group)	
	
Ages	registered	assessed	between	41	and	89,	with	mean	age	of	64	years.	
	
Descriptive Statistics 
DIAGNOSIS N Minimum Maximum Mean Std. Deviation 
Cancer 
AGE 10 58 89 74.30 10.781 
Valid N (listwise) 10     
Adenoma 
AGE 50 49 82 64.50 7.192 
Valid N (listwise) 50     
Healthy 
AGE 55 41 77 61.00 7.604 
Valid N (listwise) 55     
	
Tab	5	Age	in	3	groups	
	
In	 group	 1	 ages	 registered	 assessed	 between	 58	 and	 89,	 with	mean	 age	 of	 74	
years.	In	group	2	ages	registered	assessed	between	49	and	82,	with	mean	age	of	
64,5	 years.	 In	 group	3	 ages	 registered	 assessed	between	41	 and	77,	with	mean	
age	of	61	years.	
	
SEX * DIAGNOSIS Crosstabulation 
 DIAGNOSIS Total 
Cancer Adenoma Healthy 
SEX Male 
Count 6 34 29 69 
% within SEX 8.7% 49.3% 42.0% 100.0% 
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% within DIAGNOSIS 60.0% 66.7% 50.9% 58.5% 
% of Total 5.1% 28.8% 24.6% 58.5% 
Female 
Count 4 17 28 49 
% within SEX 8.2% 34.7% 57.1% 100.0% 
% within DIAGNOSIS 40.0% 33.3% 49.1% 41.5% 
% of Total 3.4% 14.4% 23.7% 41.5% 
Total 
Count 10 51 57 118 
% within SEX 8.5% 43.2% 48.3% 100.0% 
% within DIAGNOSIS 100.0% 100.0% 100.0% 100.0% 
% of Total 8.5% 43.2% 48.3% 100.0% 
	
Tab	6	Sex	of	patients	in	the	three	groups	
Among	 patients	 belonging	 to	 group	 1,	 6	 (60%)	 were	 male	 and	 4	 (40%)	 were	
female.	
Among	patients	belonging	 to	group	2,	26	 (66%)	were	male	and	17	(34%)	were	
female.	
Among	patients	belonging	 to	group	3,	29	 (51%)	were	male	and	28	(49%)	were	
female.	
	
Fusobacterium	nucleatum	load	and	Phorphyromonas	gingivalis	load	and	the	total	
bacterial	load	was	calculated	for	all	the	patients,	in	healty	gingiva,	in	the	deepest	
periodontal	 pocket,	 in	 healty	 intestinal	 mucosa	 and	 in	 pathological	 intestinal	
mucosa:	
Descriptive Statistics 
 N Minimum Maximum Mean Std. Deviation 
CTRLGINGFN 105 0 618315 15574.13 64257.936 
CTRLGINGPG 105 0 1389416 26321.28 154800.531 
CTRLGIGTOT 105 2828 8471355 686900.42 1275358.242 
PATHGINGFN 105 0 4005968 135482.55 505242.319 
PATHGIGPG 105 0 5426336 119166.04 667728.682 
PATHGINGTOT 105 1795 11266334 1402977.73 2368375.350 
CTRLBOWFN 118 0 2041008 19854.31 187967.399 
CTRLBOWPG 118 0 9654 173.73 1139.774 
CTRLBOWTOT 118 5959 2209906 168561.93 287797.752 
PATHBOWFN 64 0 4278689 68739.33 534621.843 
PATHBOWPG 64 0 3469 78.52 447.350 
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PATHBOWTOT 64 2547 13841040 353473.39 1723649.678 
Valid N (listwise) 54     
	
Tab.	7	Bacterial	load	in	different	tissues	
	
The	same	loads	were	calculated	dividing	the	patients	in	the	three	group	in	order	
to	observe	the	differences	within	each	group	and	among	groups:	
Descriptive Statistics 
DIAGNOSIS N Minimum Maximum Mean Std. Deviation 
Cancer 
CTRLGINGFN 5 0 1949 389.80 871.619 
CTRLGINGPG 5 0 2130 499.40 925.282 
CTRLGIGTOT 5 2935 74367 18147.00 31440.195 
PATHGINGFN 5 0 302936 60664.20 135434.156 
PATHGIGPG 5 0 29469 6076.40 13081.980 
PATHGINGTOT 5 2940 1872731 377555.60 835829.180 
CTRLBOWFN 10 0 2041008 209356.80 643769.750 
CTRLBOWPG 10 0 45 4.50 14.230 
CTRLBOWTOT 10 23631 2209906 414710.70 653272.680 
PATHBOWFN 10 0 4278689 431133.40 1351905.131 
PATHBOWPG 10 0 359 40.10 112.399 
PATHBOWTOT 10 26088 13841040 1492580.30 4339640.495 
Valid N (listwise) 5     
Adenoma 
CTRLGINGFN 46 0 618315 20350.20 91261.136 
CTRLGINGPG 46 0 17619 1917.61 4291.729 
CTRLGIGTOT 46 2828 5166896 491986.15 905009.373 
PATHGINGFN 46 0 4005968 129797.41 591322.450 
PATHGIGPG 46 0 4182093 107644.50 615512.182 
PATHGINGTOT 46 1795 9963334 1157202.09 1937110.075 
CTRLBOWFN 51 0 96270 4239.55 14798.358 
CTRLBOWPG 51 0 21 1.69 3.987 
CTRLBOWTOT 51 5959 1398011 236417.57 289746.108 
PATHBOWFN 51 0 31494 1725.16 5214.099 
PATHBOWPG 51 0 3469 90.63 499.070 
PATHBOWTOT 51 2547 1255353 133558.27 202949.469 
Valid N (listwise) 46     
Healthy 
CTRLGINGFN 54 0 153604 12911.59 31338.028 
CTRLGINGPG 54 0 1389416 49500.50 214194.385 
CTRLGIGTOT 54 2850 8471355 914860.11 1538863.003 
PATHGINGFN 54 0 2462323 147253.07 449379.692 
PATHGIGPG 54 0 5426336 139451.94 742613.442 
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PATHGINGTOT 54 2101 11266334 1707288.67 2742633.218 
CTRLBOWFN 57 0 12320 579.37 1819.122 
 
 
 
 
DIAGNOSIS N Minimum Maximum Mean Std. Deviation 
Healthy CTRLBOWPG 57 0 9654 357.35 1627.183 
CTRLBOWTOT 57 18877 299456 64665.00 59204.433 
PATHBOWFN 3 0 0 .00 .000 
PATHBOWPG 3 0 2 .67 1.155 
PATHBOWTOT 3 29135 602340 295007.33 288842.885 
Valid N (listwise) 3     
	
	
Tab.	8	Bacterial	loads	in	different	groups	
	
	
PSR	index	was	calculated	in	104	patients	(5	belonging	to	group	1,	45	to	group	2	
and	54	 to	group	3).	 In	6	patients	 it	was	not	possible	 to	measure	all	periodontal	
pockets	of	the	tooth	so	a	valid	PSR	could	not	be	registered.	
Condidering	all	patients	mean	PSR	value	was	2,83.	
In	group	1	mean	PSR	value	was	2,60.	
In	group	2	mean	PSR	value	was	2,93.	
In	group	3	mean	PSR	value	was	2,76.	
	
Periodontal	pocktes	were	measured	in	all	4	quadrants.	
Considering	all	patients	mean	periodontal	pocket	depth	was	4,	28mm	in	the	first	
quadrant,		4,	52	mm	in	the	second	quadrant,	4,49	mm	in	the	third	and	4,68	in	the	
fourth.	
	
Descriptive Statistics 
 N Minimum Maximum Mean Std. Deviation 
POCKET1 82 2 8 4.28 1.552 
POCKET2 81 2 9 4.52 1.811 
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POCKET3 87 2 10 4.49 1.776 
POCKET4 85 2 10 4.68 1.907 
      
Tab.	9	Periodontal	pocket	depth	in	4	quadrants	considering	all	patients	
	
	
The	 same	 measures	 were	 calculated	 in	 the	 3	 groups	 in	 order	 to	 observe	
differences	in	each	group	and	among	groups.	
	
Descriptive Statistics 
DIAGNOSIS N Minimum Maximum Mean Std. Deviation 
Cancer 
POCKET1 3 2 4 3.00 1.000 
POCKET2 2 2 3 2.50 .707 
POCKET3 4 3 5 3.38 .750 
POCKET4 4 2 5 3.25 1.258 
      
Adenoma 
POCKET1 33 2 7 4.47 1.541 
POCKET2 33 2 9 4.59 1.839 
POCKET3 38 2 9 4.41 1.766 
POCKET4 36 2 10 4.68 1.852 
      
Healthy 
POCKET1 46 2 8 4.23 1.570 
POCKET2 46 2 9 4.57 1.797 
POCKET3 45 2 10 4.67 1.831 
POCKET4 45 2 10 4.81 1.975 
      
	
	
Tab.	10	Periodontal	pocket	depth	in	different	groups	
	
	
Looking	 at	 intestinal	 samples,	 Fusobacterium	 nucleatum	 load,	 Phorpyromonas	
gingivalis	load	and	the	total	bacterial	load	was	calculated	in	the	three	groups	on	
healty	and	pathological	mucosa	and	Oneway	ANOVA	was	performed	 in	order	 to	
find	 statistically	 significant	 differences	 between	mean	 values	 considering	 the	 3	
intestinal	conditions	:	
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ANOVA 
 Sum of Squares df Mean Square F Sig. 
CTRLBOWFN 
Between Groups 392723628199.908 2 196361814099.954 6.036 .003 
Within Groups 3741090307847.491 115 32531220068.239   
Total 4133813936047.398 117    
CTRLBOWPG 
Between Groups 3717786.859 2 1858893.430 1.442 .241 
Within Groups 148275262.463 115 1289350.108   
Total 151993049.322 117    
CTRLBOWTOT 
Between Groups 1456006549710.848 2 728003274855.424 10.167 .000 
Within Groups 8234816333956.609 115 71607098556.144   
Total 9690822883667.457 117    
PATHBOWFN 
Between Groups 1556505775642.964 2 778252887821.482 2.886 .063 
Within Groups 16450186679037.143 61 269675191459.625   
Total 18006692454680.105 63    
PATHBOWPG 
Between Groups 40420.496 2 20210.248 .098 .907 
Within Groups 12567255.488 61 206020.582   
Total 12607675.984 63    
PATHBOWTOT 
Between Groups 15452395922518.312 2 7726197961259.156 2.745 .072 
Within Groups 171718601435668.900 61 2815059039928.999   
Total 187170997358187.220 63    
	
	
Tab.	11	ANOVA	on	intestinal	samples		
	
A	P	value	of	0,003	was	found	in	Fn	load	on	healty	intestinal	mucosa.	
Similarly	 a	 P	 value	 of	 0.000	 was	 found	 considering	 the	 total	 bacterial	 load	 on	
healty	mucosa.		
On	the	other	hand	the	Pg	load	on	healty	mucosa	is	not	significative.	
Both,	 single	 bacterial	 load	 (Pg	 and	 Fn)	 and	 total	 bacterial	 load	 on	 pathological	
mucosa	do	not	show	significative	values.	
	
These	 differences	 are	 due	 to	 higher	 mean	 values	 of	 Fusobacterium	 nucleatum	
load	 on	 healty	 mucosa	 in	 patients	 with	 diagnosis	 of	 carcinoma	 compared	 to	
control	 group	patients.	 	 This	 result	 is	 similar	 to	 that	 one	 emerging	 from	Kostic	
analysis	[53],		who	found	that	Fusobacterium	sequences	were	significantly	
enriched	in	the	colorectal	cancer	tissues,	if	compared	with	other	bacteria.	
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It	 is	 very	 interesting	 to	note	 that	 intermediate	values	 (fewer	 than	 cancer	group	
but	 higher	 than	 control	 group)	 can	 be	 observed	 in	 patients	with	 a	 diagnosis	 of	
adenoma,	which	can	actually	be	considered	a	potential	precancerous	lesion.	
The	 same	was	observed	on	healty	bowel	mucosa	 considering	 the	 total	bacterial	
load:	
	
	
Multiple Comparisons 
Dunnett t (2-sided) 
Dependent 
Variable 
(I) 
DIAGNOSIS 
(J) 
DIAGNOSIS 
Mean 
Difference (I-
J) 
Std. Error Sig. 95% Confidence Interval 
Lower Bound Upper Bound 
CTRLBOWFN 
Cancer Healthy 208777.432
*
 61837.247 .002 69105.01 348449.86 
Adenoma Healthy 3660.181 34764.784 .993 -74863.39 82183.76 
CTRLBOWPG 
Cancer Healthy -352.851 389.301 .590 -1232.17 526.47 
Adenoma Healthy -355.665 218.864 .198 -850.02 138.69 
CTRLBOWTOT 
Cancer Healthy 350045.700
*
 91744.072 .000 142822.42 557268.98 
Adenoma Healthy 171752.569
*
 51578.345 .002 55252.03 288253.11 
PATHBOWFN 
Cancer Healthy 431133.400 341846.822 .290 -313883.78 1176150.58 
Adenoma Healthy 1725.157 308511.717 1.000 -670641.87 674092.18 
PATHBOWPG 
Cancer Healthy 39.433 298.790 .979 -611.75 690.61 
Adenoma Healthy 89.961 269.654 .881 -497.72 677.64 
PATHBOWTOT 
Cancer Healthy 1197572.967 1104472.235 .379 -1209501.60 3604647.54 
Adenoma Healthy -161449.059 996769.908 .969 -2333798.37 2010900.25 
*. The mean difference is significant at the 0.05 level. 
a. Dunnett t-tests treat one group as a control, and compare all other groups against it. 
 
 
 
Tab.	12		Dunnett	test	used	to	evaluate	the	ANOVA	analysis	
 
 
 
Among	non	parametric	tests	Kruskal-Wallis	Test	and	Median	Test	were	used	to	
compare	 independent	samples	concerning	the	total	bacterial	load:	
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Ranks 
 DIAGNOSIS N Mean Rank 
CTRLBOWTOT 
Cancer 10 79.40 
Adenoma 51 74.06 
Healthy 57 42.98 
Total 118  
 
 
Tab.	13		Non-parametric	Kruskal-Wallis	Test	considering	the	total	bacterial	load	
 
 
A	chi	square	test	confirmed	the	results	(p=0.000):	
 
 
Test Statistics
a,b
 
 CTRLBOWTOT 
Chi-Square 25.912 
df 2 
Asymp. Sig. .000 
a. Kruskal Wallis Test 
b. Grouping Variable: DIAGNOSIS 
 
 
 
 
Frequencies 
 DIAGNOSIS 
Cancer Adenoma Healthy 
CTRLBOWTOT 
> Median 8 36 15 
<= Median 2 15 42 
 
Tab.	14		Non-parametric	Median	Test	considering	the	total	bacterial	load	
	
A	chi	square	test	confirmed	the	results:	
	
Test Statistics
a
 
 CTRLBOWTOT 
N 118 
Median 69709.00 
Chi-Square 25.037
b
 
df 2 
Asymp. Sig. .000 
a. Grouping Variable: DIAGNOSIS 
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b. 0 cells (0.0%) have expected frequencies less than 5. The 
minimum expected cell frequency is 5.0. 
	
	
	
	
	
	
	
	
	
	
	
Similarly	as	done	before,	considering	gingival	samples,	Fusobacterium	nucleatum	
load,	Phorpyromonas	gingivalis	load	and	the	total	bacterial	load	was	calculated	in	
the	 three	 groups	 on	 healty	 and	 pathological	 gums	 and	 non	 parametric	 tests	
Kruskal-Wallis	Test	and	Median	Test	were	performed:	
	
Ranks 
 DIAGNOSIS N Mean Rank 
CTRLGINGFN 
Cancer 5 34.80 
Adenoma 46 53.26 
Healthy 54 54.46 
Total 105  
CTRLGINGPG 
Cancer 5 51.00 
Adenoma 46 52.76 
Healthy 54 53.39 
Total 105  
CTRLGIGTOT 
Cancer 5 58.69 
Adenoma 46 49.78 
Healthy 54 21.20 
Total 105  
PATHGINGFN 
Cancer 5 45.30 
Adenoma 46 56.42 
Healthy 54 50.80 
Total 105  
PATHGIGPG 
Cancer 5 49.00 
Adenoma 46 53.82 
Healthy 54 52.68 
Total 105  
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PATHGINGTOT 
Cancer 5 26.80 
Adenoma 46 52.70 
Healthy 54 55.69 
Total 105  
CTRLBOWTOT 
Cancer 10 79.40 
Adenoma 51 74.06 
Healthy 57 42.98 
Total 118  
	
	
Test Statistics
a,b
 
 CTRLGINGF
N 
CTRLGINGP
G 
CTRLGIGTO
T 
PATHGINGF
N 
PATHGIGP
G 
PATHGINGT
OT 
CTRLBOWT
OT 
Chi-Square 2.196 .040 7.847 1.347 .135 4.125 25.912 
df 2 2 2 2 2 2 2 
Asymp. 
Sig. 
.334 .980 .020 .510 .935 .127 .000 
a. Kruskal Wallis Test 
b. Grouping Variable: DIAGNOSIS 
	
	
	
	
Tab.	15	Non	parametric	Kruskal-Wallis	Test	
	
	
A	significative	difference	have	been	detected	among	groups	considering	the	total	
bacterial	load	in	gingival	tissues	(P=0.020).	
	
	
Frequencies 
 DIAGNOSIS 
Cancer Adenoma Healthy 
CTRLGINGFN 
> Median 1 22 29 
<= Median 4 24 25 
CTRLGINGPG 
> Median 2 20 26 
<= Median 3 26 28 
CTRLGIGTOT 
< Median 0 20 32 
>= Median 5 26 22 
PATHGINGFN 
> Median 1 27 24 
<= Median 4 19 30 
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PATHGIGPG 
> Median 2 25 25 
<= Median 3 21 29 
PATHGINGTOT 
> Median 1 21 30 
<= Median 4 25 24 
CTRLBOWTOT 
> Median 8 36 15 
<= Median 2 15 42 
	
	
Test Statistics
a
 
 CTRLGINGFN CTRLGINGPG CTRLGIGTOT PATHGINGFN PATHGIGPG PATHGINGTO
T 
CTRLBOWTO
T 
N 105 105 105 105 105 105 118 
Median .00 .00 162727.00 385.00 94.00 399975.00 69709.00 
Chi-Square 2.174
b
 .287
c
 7.626
b
 3.849
b
 .835
b
 2.805
b
 25.037
d
 
df 2 2 2 2 2 2 2 
Asymp. Sig. .337 .866 .022 .146 .659 .246 .000 
a. Grouping Variable: DIAGNOSIS 
b. 2 cells (33.3%) have expected frequencies less than 5. The minimum expected cell frequency is 2.5. 
c. 2 cells (33.3%) have expected frequencies less than 5. The minimum expected cell frequency is 2.3. 
d. 0 cells (0.0%) have expected frequencies less than 5. The minimum expected cell frequency is 5.0. 
	
Tab.	16	Non-parametric	Median	Test	
	
The	 previous	 data	were	 confirmed	 ,	 in	 fact	 a	 significative	 difference	 have	 been	
detected	 among	 groups	 considering	 the	 total	 bacterial	 load	 in	 gingival	 tissues	
(P=0.022)	and	a	certain	trend	is	observable	looking	at	Fusobacterium	nucleatum.	
	
	
	
	
	
	
	
	
Finally,	 the	 presence	 of	 correlations	 between	 intestinal	 mucosa	 and	 gingival	
tissue	were	analysed,	firstly	considering	all	patients:	
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Correlations 
 CTRL
GINGF
N 
CTRL
GING
PG 
CTRL
GIGT
OT 
PATH
GINGF
N 
PATH
GIGP
G 
PATH
GINGT
OT 
CTRL
BOWF
N 
CTRL
BOWP
G 
CTRL
BOWT
OT 
PATH
BOWF
N 
PATH
BOWP
G 
PATH
BOWT
OT 
CTRLG
INGFN 
Pearson 
Correlatio
n 
1 -.025 .056 .004 -.021 .032 -.038 -.027 -.041 -.029 -.037 -.032 
Sig. (2-
tailed) 
 
.803 .570 .968 .834 .745 .698 .781 .680 .834 .788 .820 
N 105 105 105 105 105 105 105 105 105 54 54 54 
CTRLG
INGPG 
Pearson 
Correlatio
n 
-.025 1 .398
**
 -.031 .680
**
 .339
**
 -.040 .215
*
 -.042 -.062 -.075 -.075 
Sig. (2-
tailed) 
.803 
 
.000 .750 .000 .000 .689 .028 .669 .657 .588 .590 
N 105 105 105 105 105 105 105 105 105 54 54 54 
CTRLG
IGTOT 
Pearson 
Correlatio
n 
.056 .398
**
 1 -.011 .313
**
 .581
**
 -.108 .093 -.085 -.073 -.098 -.057 
Sig. (2-
tailed) 
.570 .000 
 
.908 .001 .000 .274 .344 .390 .602 .480 .682 
N 105 105 105 105 105 105 105 105 105 54 54 54 
PATHG
INGFN 
Pearson 
Correlatio
n 
.004 -.031 -.011 1 .453
**
 .517
**
 -.010 -.037 -.029 .047 .010 .046 
Sig. (2-
tailed) 
.968 .750 .908 
 
.000 .000 .922 .706 .769 .735 .945 .741 
N 105 105 105 105 105 105 105 105 105 54 54 54 
PATHG
IGPG 
Pearson 
Correlatio
n 
-.021 .680
**
 .313
**
 .453
**
 1 .555
**
 -.033 -.020 -.044 -.016 -.031 -.020 
Sig. (2-
tailed) 
.834 .000 .001 .000 
 
.000 .737 .840 .658 .911 .822 .888 
N 105 105 105 105 105 105 105 105 105 54 54 54 
PATHG
INGTO
T 
Pearson 
Correlatio
n 
.032 .339
**
 .581
**
 .517
**
 .555
**
 1 -.033 -.043 -.022 .060 -.088 .062 
Sig. (2-
tailed) 
.745 .000 .000 .000 .000 
 
.735 .663 .825 .664 .527 .654 
N 105 105 105 105 105 105 105 105 105 54 54 54 
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CTRLB
OWFN 
Pearson 
Correlatio
n 
-.038 -.040 -.108 -.010 -.033 -.033 1 -.016 .666
**
 .011 -.025 -.002 
Sig. (2-
tailed) 
.698 .689 .274 .922 .737 .735 
 
.862 .000 .932 .843 .988 
N 105 105 105 105 105 105 118 118 118 64 64 64 
CTRLB
OWPG 
Pearson 
Correlatio
n 
-.027 .215
*
 .093 -.037 -.020 -.043 -.016 1 -.062 -.041 .146 -.031 
Sig. (2-
tailed) 
.781 .028 .344 .706 .840 .663 .862 
 
.504 .749 .251 .807 
N 105 105 105 105 105 105 118 118 118 64 64 64 
CTRLB
OWTO
T 
Pearson 
Correlatio
n 
-.041 -.042 -.085 -.029 -.044 -.022 .666
**
 -.062 1 .063 .043 .057 
Sig. (2-
tailed) 
.680 .669 .390 .769 .658 .825 .000 .504 
 
.619 .736 .654 
N 105 105 105 105 105 105 118 118 118 64 64 64 
PATHB
OWFN 
Pearson 
Correlatio
n 
-.029 -.062 -.073 .047 -.016 .060 .011 -.041 .063 1 -.023 .993
**
 
Sig. (2-
tailed) 
.834 .657 .602 .735 .911 .664 .932 .749 .619 
 
.857 .000 
N 54 54 54 54 54 54 64 64 64 64 64 64 
PATHB
OWPG 
Pearson 
Correlatio
n 
-.037 -.075 -.098 .010 -.031 -.088 -.025 .146 .043 -.023 1 -.029 
Sig. (2-
tailed) 
.788 .588 .480 .945 .822 .527 .843 .251 .736 .857 
 
.818 
N 54 54 54 54 54 54 64 64 64 64 64 64 
PATHB
OWTO
T 
Pearson 
Correlatio
n 
-.032 -.075 -.057 .046 -.020 .062 -.002 -.031 .057 .993
**
 -.029 1 
Sig. (2-
tailed) 
.820 .590 .682 .741 .888 .654 .988 .807 .654 .000 .818 
 
N 54 54 54 54 54 54 64 64 64 64 64 64 
**. Correlation is significant at the 0.01 level (2-tailed). 
*. Correlation is significant at the 0.05 level (2-tailed). 
	
Tab.	 17	 Correlations	 between	 intestinal	 and	 gingival	 conditions	 considering	 all	
patients	
	
Then	 correlatations	were	 evaluated	 dividing	 the	 three	 groups;	 firstly	 in	 cancer	
group:	
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Correlations
a
 
 CTRL
GINGF
N 
CTRL
GING
PG 
CTRL
GIGT
OT 
PATH
GINGF
N 
PATH
GIGP
G 
PATH
GINGT
OT 
CTRL
BOWF
N 
CTRL
BOWP
G 
CTRL
BOWT
OT 
PATH
BOWF
N 
PATH
BOWP
G 
PATH
BOWT
OT 
CTRLG
INGFN 
Pearson 
Correlatio
n 
1 -.302 -.256 -.249 -.260 -.250 -.255 -.250 .662 -.248 -.250 -.258 
Sig. (2-
tailed) 
 
.622 .678 .687 .673 .685 .679 .685 .224 .687 .685 .675 
N 5 5 5 5 5 5 5 5 5 5 5 5 
CTRLG
INGPG 
Pearson 
Correlatio
n 
-.302 1 -.057 -.302 -.275 -.301 -.304 .985
**
 -.618 -.302 .985
**
 -.297 
Sig. (2-
tailed) 
.622 
 
.927 .621 .654 .623 .619 .002 .266 .621 .002 .627 
N 5 5 5 5 5 5 5 5 5 5 5 5 
CTRLG
IGTOT 
Pearson 
Correlatio
n 
-.256 -.057 1 -.271 -.277 -.271 -.255 -.228 -.548 -.271 -.228 -.274 
Sig. (2-
tailed) 
.678 .927 
 
.659 .651 .659 .679 .713 .339 .659 .713 .655 
N 5 5 5 5 5 5 5 5 5 5 5 5 
PATHG
INGFN 
Pearson 
Correlatio
n 
-.249 -.302 -.271 1 
1.000
*
*
 
1.000
**
 1.000
**
 -.250 .508 1.000
**
 -.250 1.000
**
 
Sig. (2-
tailed) 
.687 .621 .659 
 
.000 .000 .000 .685 .382 .000 .685 .000 
N 5 5 5 5 5 5 5 5 5 5 5 5 
PATHG
IGPG 
Pearson 
Correlatio
n 
-.260 -.275 -.277 1.000
**
 1 1.000
**
 .999
**
 -.223 .495 1.000
**
 -.223 1.000
**
 
Sig. (2-
tailed) 
.673 .654 .651 .000 
 
.000 .000 .719 .397 .000 .719 .000 
N 5 5 5 5 5 5 5 5 5 5 5 5 
PATHG
INGTO
T 
Pearson 
Correlatio
n 
-.250 -.301 -.271 1.000
**
 
1.000
*
*
 
1 1.000
**
 -.249 .507 1.000
**
 -.249 1.000
**
 
Sig. (2-
tailed) 
.685 .623 .659 .000 .000 
 
.000 .687 .384 .000 .687 .000 
N 5 5 5 5 5 5 5 5 5 5 5 5 
CTRLB
OWFN 
Pearson 
Correlatio
n 
-.255 -.304 -.255 1.000
**
 .999
**
 1.000
**
 1 -.114 .968
**
 -.083 -.129 -.094 
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Sig. (2-
tailed) 
.679 .619 .679 .000 .000 .000 
 
.753 .000 .819 .723 .795 
N 5 5 5 5 5 5 10 10 10 10 10 10 
CTRLB
OWPG 
Pearson 
Correlatio
n 
-.250 .985
**
 -.228 -.250 -.223 -.249 -.114 1 -.174 -.112 .997
**
 -.101 
Sig. (2-
tailed) 
.685 .002 .713 .685 .719 .687 .753 
 
.630 .758 .000 .781 
N 5 5 5 5 5 5 10 10 10 10 10 10 
CTRLB
OWTO
T 
Pearson 
Correlatio
n 
.662 -.618 -.548 .508 .495 .507 .968
**
 -.174 1 .013 -.196 .003 
Sig. (2-
tailed) 
.224 .266 .339 .382 .397 .384 .000 .630 
 
.972 .588 .994 
N 5 5 5 5 5 5 10 10 10 10 10 10 
PATHB
OWFN 
Pearson 
Correlatio
n 
-.248 -.302 -.271 1.000
**
 
1.000
*
*
 
1.000
**
 -.083 -.112 .013 1 -.126 1.000
**
 
Sig. (2-
tailed) 
.687 .621 .659 .000 .000 .000 .819 .758 .972 
 
.728 .000 
N 5 5 5 5 5 5 10 10 10 10 10 10 
PATHB
OWPG 
Pearson 
Correlatio
n 
-.250 .985
**
 -.228 -.250 -.223 -.249 -.129 .997
**
 -.196 -.126 1 -.116 
Sig. (2-
tailed) 
.685 .002 .713 .685 .719 .687 .723 .000 .588 .728 
 
.750 
N 5 5 5 5 5 5 10 10 10 10 10 10 
PATHB
OWTO
T 
Pearson 
Correlatio
n 
-.258 -.297 -.274 1.000
**
 
1.000
*
*
 
1.000
**
 -.094 -.101 .003 1.000
**
 -.116 1 
Sig. (2-
tailed) 
.675 .627 .655 .000 .000 .000 .795 .781 .994 .000 .750 
 
N 5 5 5 5 5 5 10 10 10 10 10 10 
**. Correlation is significant at the 0.01 level (2-tailed). 
a. DIAGNOSIS = Cancer 
	
Tab.	18	Correlations	between	intestinal	and	gingival	conditions	cancer	group	
	
	
	
	
Then	in	adenoma	group:	
	
Correlations
a
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 CTRL
GINGF
N 
CTRL
GING
PG 
CTRL
GIGT
OT 
PATH
GINGF
N 
PATH
GIGP
G 
PATH
GINGT
OT 
CTRL
BOWF
N 
CTRL
BOWP
G 
CTRL
BOWT
OT 
PATH
BOWF
N 
PATH
BOWP
G 
PATH
BOWT
OT 
CTRLG
INGFN 
Pearson 
Correlatio
n 
1 .547
**
 .043 -.017 -.011 .014 -.057 .416
**
 -.078 -.061 -.041 -.018 
Sig. (2-
tailed) 
 
.000 .777 .911 .944 .924 .706 .004 .608 .689 .786 .906 
N 46 46 46 46 46 46 46 46 46 46 46 46 
CTRLG
INGPG 
Pearson 
Correlatio
n 
.547
**
 1 -.065 -.057 -.046 .033 -.104 .381
**
 -.099 -.085 -.085 -.130 
Sig. (2-
tailed) 
.000 
 
.669 .706 .763 .826 .491 .009 .513 .575 .574 .389 
N 46 46 46 46 46 46 46 46 46 46 46 46 
CTRLG
IGTOT 
Pearson 
Correlatio
n 
.043 -.065 1 -.036 -.024 .439
**
 -.128 -.112 .012 -.109 -.104 .019 
Sig. (2-
tailed) 
.777 .669 
 
.811 .873 .002 .398 .460 .934 .469 .492 .901 
N 46 46 46 46 46 46 46 46 46 46 46 46 
PATHG
INGFN 
Pearson 
Correlatio
n 
-.017 -.057 -.036 1 .986
**
 .678
**
 -.025 -.043 -.088 -.022 .008 .004 
Sig. (2-
tailed) 
.911 .706 .811 
 
.000 .000 .867 .779 .563 .886 .957 .981 
N 46 46 46 46 46 46 46 46 46 46 46 46 
PATHG
IGPG 
Pearson 
Correlatio
n 
-.011 -.046 -.024 .986
**
 1 .679
**
 -.038 -.047 -.070 -.027 -.034 -.033 
Sig. (2-
tailed) 
.944 .763 .873 .000 
 
.000 .803 .757 .642 .861 .822 .827 
N 46 46 46 46 46 46 46 46 46 46 46 46 
PATHG
INGTO
T 
Pearson 
Correlatio
n 
.014 .033 .439
**
 .678
**
 .679
**
 1 -.037 -.120 .025 -.095 -.092 -.005 
Sig. (2-
tailed) 
.924 .826 .002 .000 .000 
 
.808 .426 .871 .528 .543 .972 
N 46 46 46 46 46 46 46 46 46 46 46 46 
CTRLB
OWFN 
Pearson 
Correlatio
n 
-.057 -.104 -.128 -.025 -.038 -.037 1 .060 .104 .392
**
 -.052 -.126 
Sig. (2-
tailed) 
.706 .491 .398 .867 .803 .808 
 
.675 .470 .004 .716 .379 
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N 46 46 46 46 46 46 51 51 51 51 51 51 
CTRLB
OWPG 
Pearson 
Correlatio
n 
.416
**
 .381
**
 -.112 -.043 -.047 -.120 .060 1 .334
*
 -.124 .133 .046 
Sig. (2-
tailed) 
.004 .009 .460 .779 .757 .426 .675 
 
.017 .385 .354 .749 
N 46 46 46 46 46 46 51 51 51 51 51 51 
CTRLB
OWTO
T 
Pearson 
Correlatio
n 
-.078 -.099 .012 -.088 -.070 .025 .104 .334
*
 1 -.022 .084 .050 
Sig. (2-
tailed) 
.608 .513 .934 .563 .642 .871 .470 .017 
 
.878 .559 .725 
N 46 46 46 46 46 46 51 51 51 51 51 51 
PATHB
OWFN 
Pearson 
Correlatio
n 
-.061 -.085 -.109 -.022 -.027 -.095 .392
**
 -.124 -.022 1 -.061 -.112 
Sig. (2-
tailed) 
.689 .575 .469 .886 .861 .528 .004 .385 .878 
 
.670 .433 
N 46 46 46 46 46 46 51 51 51 51 51 51 
PATHB
OWPG 
Pearson 
Correlatio
n 
-.041 -.085 -.104 .008 -.034 -.092 -.052 .133 .084 -.061 1 -.070 
Sig. (2-
tailed) 
.786 .574 .492 .957 .822 .543 .716 .354 .559 .670 
 
.628 
N 46 46 46 46 46 46 51 51 51 51 51 51 
PATHB
OWTO
T 
Pearson 
Correlatio
n 
-.018 -.130 .019 .004 -.033 -.005 -.126 .046 .050 -.112 -.070 1 
Sig. (2-
tailed) 
.906 .389 .901 .981 .827 .972 .379 .749 .725 .433 .628 
 
N 46 46 46 46 46 46 51 51 51 51 51 51 
**. Correlation is significant at the 0.01 level (2-tailed). 
*. Correlation is significant at the 0.05 level (2-tailed). 
a. DIAGNOSIS = Adenoma 
	
Tab.	 19	 Correlations	 between	 intestinal	 and	 gingival	 conditions	 in	 adenoma	
group	
	
	
And	finally	in	healty	control	group:	
Correlations
a
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 CTRL
GINGF
N 
CTRL
GING
PG 
CTRL
GIGT
OT 
PATH
GINGF
N 
PATH
GIGP
G 
PATH
GINGT
OT 
CTRL
BOWF
N 
CTRL
BOWP
G 
CTRL
BOWT
OT 
PATH
BOWF
N 
PATH
BOWP
G 
PATH
BOWT
OT 
CTRLG
INGFN 
Pearson 
Correlatio
n 
1 -.080 .134 .070 -.055 .091 .192 -.064 .079 .
b
 1.000
**
 -.124 
Sig. (2-
tailed) 
 
.566 .334 .617 .692 .513 .164 .645 .570 . .000 .921 
N 54 54 54 54 54 54 54 54 54 3 3 3 
CTRLG
INGPG 
Pearson 
Correlatio
n 
-.080 1 .434
**
 -.055 .862
**
 .390
**
 -.062 .198 .105 .
b
 1.000
**
 -.124 
Sig. (2-
tailed) 
.566 
 
.001 .693 .000 .004 .654 .152 .448 . .000 .921 
N 54 54 54 54 54 54 54 54 54 3 3 3 
CTRLG
IGTOT 
Pearson 
Correlatio
n 
.134 .434
**
 1 -.009 .455
**
 .619
**
 -.100 .080 -.041 .
b
 -.495 .924 
Sig. (2-
tailed) 
.334 .001 
 
.949 .001 .000 .473 .568 .770 . .671 .250 
N 54 54 54 54 54 54 54 54 54 3 3 3 
PATHG
INGFN 
Pearson 
Correlatio
n 
.070 -.055 -.009 1 -.018 .432
**
 -.065 -.064 .237 .
b
 .
b
 .
b
 
Sig. (2-
tailed) 
.617 .693 .949 
 
.897 .001 .640 .644 .084 . .000 .000 
N 54 54 54 54 54 54 54 54 54 3 3 3 
PATHG
IGPG 
Pearson 
Correlatio
n 
-.055 .862
**
 .455
**
 -.018 1 .498
**
 -.053 -.031 .038 .
b
 .
b
 .
b
 
Sig. (2-
tailed) 
.692 .000 .001 .897 
 
.000 .706 .825 .782 . .000 .000 
N 54 54 54 54 54 54 54 54 54 3 3 3 
PATHG
INGTO
T 
Pearson 
Correlatio
n 
.091 .390
**
 .619
**
 .432
**
 .498
**
 1 -.096 -.075 .098 .
b
 -.501 .921 
Sig. (2-
tailed) 
.513 .004 .000 .001 .000 
 
.488 .591 .482 . .666 .254 
N 54 54 54 54 54 54 54 54 54 3 3 3 
CTRLB
OWFN 
Pearson 
Correlatio
n 
.192 -.062 -.100 -.065 -.053 -.096 1 -.068 .064 .
b
 .
b
 .
b
 
Sig. (2-
tailed) 
.164 .654 .473 .640 .706 .488 
 
.616 .637 . .000 .000 
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N 54 54 54 54 54 54 57 57 57 3 3 3 
CTRLB
OWPG 
Pearson 
Correlatio
n 
-.064 .198 .080 -.064 -.031 -.075 -.068 1 -.053 .
b
 .
b
 .
b
 
Sig. (2-
tailed) 
.645 .152 .568 .644 .825 .591 .616 
 
.694 . .000 .000 
N 54 54 54 54 54 54 57 57 57 3 3 3 
CTRLB
OWTO
T 
Pearson 
Correlatio
n 
.079 .105 -.041 .237 .038 .098 .064 -.053 1 .
b
 .097 -1.000
*
 
Sig. (2-
tailed) 
.570 .448 .770 .084 .782 .482 .637 .694 
 
. .938 .018 
N 54 54 54 54 54 54 57 57 57 3 3 3 
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OWFN 
Pearson 
Correlatio
n 
.
b
 .
b
 .
b
 .
b
 .
b
 .
b
 .
b
 .
b
 .
b
 .
b
 .
b
 .
b
 
Sig. (2-
tailed) 
. . . . . . . . . 
 
. . 
N 3 3 3 3 3 3 3 3 3 3 3 3 
PATHB
OWPG 
Pearson 
Correlatio
n 
1.000
**
 1.000
**
 -.495 .
b
 .
b
 -.501 .
b
 .
b
 .097 .
b
 1 -.124 
Sig. (2-
tailed) 
.000 .000 .671 .000 .000 .666 .000 .000 .938 . 
 
.921 
N 3 3 3 3 3 3 3 3 3 3 3 3 
PATHB
OWTO
T 
Pearson 
Correlatio
n 
-.124 -.124 .924 .
b
 .
b
 .921 .
b
 .
b
 -1.000
*
 .
b
 -.124 1 
Sig. (2-
tailed) 
.921 .921 .250 .000 .000 .254 .000 .000 .018 . .921 
 
N 3 3 3 3 3 3 3 3 3 3 3 3 
**. Correlation is significant at the 0.01 level (2-tailed). 
*. Correlation is significant at the 0.05 level (2-tailed). 
a. DIAGNOSIS = Healthy 
b. Cannot be computed because at least one of the variables is constant. 
Tab.	20	Correlations	between	intestinal	and	gingival	conditions	in	control	group	
	
	
	
	
The	 aim	 of	 the	 intestinal	 samples	 analysis	 was	 to	 evaluate	 the	 presence	 of	 a	
statistically	 significative	 difference	 among	 the	 bacterial	 load	 in	 patients	 with	
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different	histological	conditions:	colorectal	cancer,	healty	mucosa	and	colorectal	
adenoma,	which	can	be	considered	a	pre-malignant	lesion.	Considering	colorectal	
carcinogenesis	the	development	of	a	tumor	is	often	precedeed	by	asymptomatic	
growing	polyps,	whose	early	detection	represents	a	fundamental	aim	of	screening	
colonscopy.	
Significative	 differences	 among	 the	 groups	 were	 found	 considering	
Fusobacterium	nucleatum	 load	 (P=0,003)	and	 the	 total	bacterial	 load	 (P=0,000)	
on	healty	 intestinal	mucosa.	The	Dunnett	Test	 confirmed	higher	Fusobacterium	
nucleatum	loads	and	total	bacterial	loads	on	healty	intestinal	mucosa	of	patients	
with	cancer	 	compared	to	 the	control	group	(healty	patients).	 It	 is	significant	 to	
observe	 that	 patients	 with	 adenomas	 show	 intermediate	 values.	 The	 stepwise	
growing	 pattern	 of	 this	 specific	 bacterial	 loads	 from	 normal	 mucosa	 to	 the	
precancerous	 lesions	 (adenomas)	 and	 from	polyps	 to	malignant	 tumoar	 tissues	
reflects	the	results	of		Rubinstein	and	Wang	analysis	[63].	
	
Fusobacterium	 nucleatum	 is	 a	 typical	 oral	 bacterium	 that	 is	 responsible	 for	
periodontal	 disease,	 however	 it	 has	 been	 found	 in	 high	 loads	 in	 this	 extra-oral	
area,	which	can	be	 reached	by	means	of	 ingestion	of	 food	and	swallowing	 from	
the	 oral	 mouth.	 The	 higher	 load	 in	 patients	 with	 cancer	 and	 adenomas	 (pre-
malignant	lesions)	compared	to	control	group	makes	us	reflect	on	the	role	of	this	
specific	 bacterium	 (and	 of	 the	 oral	 miocrobiota	 in	 general)	 in	 carcinogenesis,	
similarly	to	data	found	by	McCoy	and	Araujo-Perez	in	their	analysis	[59].	
On	the	other	hand	the	presence	of	Phopyromonas	gingivalis	does	not	seem	to	be	
particulary	relevant	at	the	moment,	looking	only	at	intestinal	mucosa.	
The	 same	 differences	 can	 not	 be	 appreciated	 if	 we	 consider	 the	 analysis	 of	
pathological	mucosa,	but	this	may	be	due	to	the	alterations	already	occurred	on	
these	 tissues,	 which	 do	 not	 let	 the	 detection	 of	 a	 specific	 microrganism.	 In	
addition	 the	 role	 of	 oral	 microbiota	 could	 represent	 a	 risk	 factor	 in	 the	 first	
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phases	 of	 tissutal	 alterations,	when	healty	mucosa	 starts	 to	mutate,	 stimulating	
the	beginning	of	the	carcinogenic	process.	
	
Looking	at	gingival	samples,	data	suggest	the	presence	of	a	significative	difference	
among	the	three	groups	considering	the	total	bacterial	load	(P=0.020	in	Kruskal-
Wallis	Test	and	P=0.022	in	the	Median	test).		
	
In	 addition	 the	 higher	 is	 the	 bacterial	 load	 in	 healty	 gingiva,	 the	 higher	 it	 is	 in	
periodontal	pocket	(P=0.000).	
	
Morover,	interesting	assessments	are	evaluable	in	these	bacteria	behaviour	from	
the	 correlations	 tables	 :	 the	 presence	 of	 a	 single	 bacterium	 seems	 to	 foster	 the	
development	 of	 the	 other,	 in	 a	 kind	 of	 cooperation,	which	 is	 typical	 of	 the	 oral	
biofilm,	but	is	detectable	also	in	the	intestinal	mucosa.	
	
Other	differences	emerge	 looking	at	correlations	performed	within	 the	group	of	
patient	with	diagnosis	of	adenoma	compared	to	those	of	the	control	group.	
The	 presence	 of	 Porphyromoas	 gingivalis	 in	 intestinal	mucosa	 is	 significatively	
linked	to	that	one	of	 the	same	bacterium	in	gingival	 tissue	only	 in	patients	with	
diagnosis	of	adenoma	(P=0.009),	compared	to	the	situation	of	the	control	group,	
where	such	a	correlation	is	not	detectable.	This	may	be	due	to	the	fact	that	a	high	
bacterial	 load	 in	 oral	 gums,	 representing	 a	 natural	 reservoir	 for	 the	
microrgnaism,	 could	be	 related	 to	 a	major	probability	 of	 transition	 through	 the	
digestive	tract	by	means	of	swallowing.	The	colonization	of	intestinal	mucosa	by	
oral	 bacteria	 might	 be	 one	 of	 the	 causes	 of	 development	 of	 polyps	 in	 these	
patients,	 even	 thogh	more	data	 are	needed	 to	 confirm	 this	hypothesis,	which	 is	
anyway	plausible.	
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In	 addition	 the	 same	 Phorphyromonas	 gingivalis	 intestinal	 load	 seems	 to	 be	
related	also	to	the	presence	of	Fusobacterium	nucleatum	in	periodontal	gums	of	
patients	 with	 diagnosis	 of	 adenoma	 (P=0.004),	 compared	 to	 the	 situation	 in	
healty	ones.	
Again	a	certain	cooperation	between	these	two	bacterial	pathogens	seems	to	be	
detectable,	 but	 in	 this	 case	 it	 is	 observable	 not	 only	 in	 the	 same	 area	 (as	 seen	
before	in	gingival	tissues	and	in	intestinal	tissues)	but	also	in	two	districts	which	
are	very	far	one	from	the	other.	
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2.5	CONCLUSIONS	
	
In	 conclusion,	 the	 results	 of	 the	 study	 suggest	 that	 oral	 microbiota	 and	 in	
particular	 a	 specific	 bacterium,	 Fusobacterium	 nucleatum,	 so	 important	 in	
pathogenesis	 of	 periodontal	 disease,	 can	 have	 a	 role	 in	 colorectal	 cancer;	 in	
particular	 this	 microrganism	 may	 participate	 in	 that	 complex	 and	 still	 non	
compleatly	 clear	 	 process	which	 is	 tumoral	 progression	 from	 healty	mucosa	 to	
adenoma	and	finally	to	carcinoma.		The	bacterial	load	of	this	oral	pathogen	seems	
to	be	different	on	the	intestinal	mucosa	of	patients	with	a	diagnosis	of	colorectal	
cancer	and	adenoma,	compared	to	the	healty	control	group.	
The	 role	 of	 Phorpyromonas	 gingivalis,	 another	 typical	 periodontal	 bacterium,	
although	 detected	 in	 both,	 oral	 and	 intestinal	 mucosa,	 does	 not	 seem	 to	 be	
directly	correlated	with	carcinogenesis	but	 further	analysis	are	needed	since	 its	
behaviour	 in	 extra-oral	 tissues	 has	 been	 analysed	 only	 in	 few	 studies	 at	 the	
moment.	However	this	 last	particular	pathogen	could	promote	the	development	
of	Fusobacterium	nucleatum,	as	observed	from	correlations	on	gingival	samples	
and,	 above	 all,	 from	 those	 emerged	between	 intestinal	 and	 gingival	 samples	 on	
patients	who	have	already	developed	an	adenoma,	compared	to	healty	patients.	
A	 cross	 sectional	 study	 let	us	observe	 the	oral	 and	 intestinal	 conditions	of	non-
affected	and	affected	patients,	however	further	prospective	cohort	studies	will	be	
necesarry	 in	 order	 to	 enstablish	 the	 presence	 of	 a	 clearer	 causal	 link	 in	 the	
pathogenetic	 mechanism	 of	 this	 tumor.	 Anyway,	 it	 seems	 increasingly	 evident	
that	 emerging	 correlations	 between	 oral	 microbiota	 and	 extra-oral	 systemic	
diseases,	 especially	 gastrointestinal	 diseases,	 are	 conceivable,	 since	 the	 oral	
mouth	represents	precisely	the	beginning	of	the	digestive	tract.	
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3.	SECOND	STUDY:	HELICOBACTER	PYLORI	AND	PERIODONTAL	DISEASE	
	
3.1	INTRODUCTION	
 
3.1.1	Helicobacter	pylori	
Helicobacter	 pylori	 is	 a	widespread,	 Gram-negative,	microaerophilic	 bacterium,	
generally	 associated	 with	 chronic	 gastritis	 but	 also	 with	 acute	 gastritis,	 peptic	
ulcer	and	gastric	cancer.	It	was	firstly	described	in	1886	by	Prof.	W.	Jaworski,	but	
only	 in	 1979	 Warren	 found	 the	 presence	 of	 this	 microorganism	 in	 gastric	
epithelium	 samples	 collected	 during	 gastric	 biopsies.	 	 Robin	Warren	 and	 Barry	
Marshall	won	the	Nobel	Prize	 for	 the	discovery	of	 this	bacterium	and	 its	role	 in	
chronic	gastritis	in	2005.	
	
  
Fig. 38 3D representation of  Helicobacter pylori on gastric mucosa  
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Bacterium	structure	
The	 motility	 of	H.	 pylori	is	 permitted	 by	 the	 presence	 of	 5-6	 unipolar	 flagella	
(molecular	weight	of	50,000-62,000).	The	shape	 is	helicoidal	 in	active	 form	and	
coccoid	in	latency.	It	shows	a	slighty	toxic	lipopolysaccharide	containing	Lipid	A	
and	 a	 glucidic	 portion	which	 stimulates	 autoimmune	 response	 in	 humans.	 This	
bacterium	shows	intense	oxydase,	catalase	and,	above	all,	urease	activities.		
	
  
 
Fig.39 Optical Microscope image of Helicobacter pylori with its flagella 
 
	
It	 is	 precisely	 the	 presence	 of	 Urease	 that	 lets	 the	microorganism	 colonize	 the	
gastric	mucosa,	 in	fact,	by	converting	urea	into	ammonia	and	bicarbonate,	 it	can	
counteract	 the	acidity	gastric	 enviroment.	Ammmonia	 is	 an	acceptor	 for	 the	H+	
ions	and	increases	the	local	pH.		Killer	T	cells	and	white	cells	cannot	easily	survive	
in	this	area,	so	defense	of	the	body	from	this	bacterium	is	hard.	
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Fig.40  H.pylori	colony	on	the	gastric	mucosa,	observed	by	SEM	and	processed	
with	digital	techniques.	
	
3.1.2	Epidemiology	
Although	 prevalence	 is	 reducing,	 about	 half	 of	 the	 worlwide	 population	 is	 still	
infected,	expecially	in	Southern	and	Eastern	Europe,	South	America	and	Asia.	
The	rate	of	infection	in	developing	countries	is	between	70	and	90%	and	here	the	
bacterium	 is	 generally	 acquired	 during	 childhood,	 before	 the	 age	 of	 10.	 In	
Western	countries	the	prevalence	of	infection	ranges	from	25	to	50%	[76].		
	In	developed	countries,	most	of	infected	individuals	are	those	with	poorer	social	
and	economical	conditions.	In	fact	the	way	of	transmission	is	mainly	oral	and/or	
oro-fecal,	so	the	lack	of	primary	hygienic	services	and	drinking	water	represents	
an	important	risk	factor.		
In	 industrialized	 countries	 incidence	 approximately	 coincides	 with	 age	 (for	
example,	in	the	age	group	between	40	and	50	years,	the	incidence	is	estimated	at	
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around	40-50%	of	the	population)	but	after	the	age	of	60-65	this	trend	changes,	
maybe	due	to	the	increase	in	older	people	of	atrophic	gastritis	 ,	a	disease	which	
creates	unfavourable	conditions	for	HP.	
	
	
	
  
Fig.	41	Prevalence	of	Helicobacter	Pylori	in	different	countries	
	
3.3.3	Pathogenesis	and	carcinogenesis	
H.pylori	 can	 survive	 in	 water	 for	 several	 days,	 so	 contaminated	 water	 could	
represent	an	important	reservoir	for	infection.	
Another	way	 of	 trasmission	 is	 the	 oro-oral	 one,	 in	 fact	 the	 bacterium	has	 been	
detected	in	dental	plaque	and	saliva.	
A	further	way	of	trasmission	is	the	iatrogenic	one,	caused	by	use	of	endoscopes	or	
other	infected	instruments	in	hospitals.	
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After	 the	 infection,	 the	 bacterium	 can	 survive	 in	 the	 stomach,	 maybe	 in	
asymptomatic	stage	,	if	an	effective	therapy	is	not	performed.	
	
Helicobacter	Pylori,	due	to	the	presence	of	flagelli,	can	move	across	the	stomach	
mucosa,	where	it	binds	to	the	MHC	type	II	complex	expressed	on	gastric	antrum	
epitelial	 cells,	 by	 means	 of	 bacterial	 adhesins.	 In	 this	 way	 it	 determines	
inflammation	and	apoptosis.	Howevere	the	inflammatory	response	is	not	able	to	
eradicate	the	infection	but	can	damage	the	stomach	mucosa.	
	
	
Fig.	42	Schematic	representation	of	Helicobacter	pylori	crossing	mucus	layer	of	
stomach	
	
The	 disease’s	 evolution	 could	 be	 very	 slow	 and	 it	 depends	 on	 different	 factors:	
host’s	 defenses,	 bacterial	 genomics	 ,	 genetic	 predisposition,	 smoking	 and	 food	
habits.	 Only	 10-15%	 of	 	 patients	with	 active	 chronic	 gastritis	 develop	 a	 gastric	
ulcer.	Other	manifestations	 include	duodenal	ulcer,	 non-ulcer	dyspepsia,	 gastric	
adenoma	 (2%),	 hyperplastic	 polyps,	 multifocal	 gastric	 atrophy	 and	 intestinal	
metaplasia.		
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Fig.43	Electron	microscopy	image	representing	a	colony	of	H.pylori	near	the	
gastric	mucosa	
	
In	 addition	 to	 its	 Urease	 activity,	 the	 bacterium	 produces	 dangerous	 virulence	
factors,	 which	 can	 play	 an	 important	 role	 in	 cytokines	 production	 and	
intracellular	pathways	alteration:	the	most	important	are	CagA,	VacA,	Heat	Shock	
Protein-B	and	Duodenal	promoting	gene-A.	It	is	precisaly	these	factors	which	are	
supposed	to	be	associated	with	increased	incidence	of	gastric	cancer	and	gastritis	
[77].	
	
In	 1994	Helicobacter	pylori	was	classified	 as	 a	 cancerogenic	 agent	 by	 the	World	
Health	Organization	[78].		
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Fig.44	Pathogenesis	of	gastric	after	Helicobacter	pylori	infection	
	
Gastric	 adenocarcinoma	 of	 the	 intestinal	 type1	 	 often	 develops	 from	 pre-
cancerous	 lesions	 (atrophic	 gastritis,	 intestinal	 metaplasia	 and	 dysplasia,	
respectively	associated	with	a	risk	of	developing	a	tumor	within	10	years	of	0.8%,	
1.8%,	32.7%)	.	
	
	
Correa	et	al	proposed	the	following	model	of	gastric	carcinogenesis	in	1975	[79]:		
normal	gastric	mucosa→		superficial	gastritis	(later	renamed	non-atrophic	
gastritis,	 NAG)	 →	 multifocal	 atrophic	 gastritis	 (MAG)	 without	 intestinal	
metaplasia	 →	 intestinal	 metaplasia	 of	 the	 complete	 (small	 intestine)	 type	 	 →	
intestinal	metaplasia	of	the	incomplete	(colonic)	type	→low-grade	dysplasia	(low-
grade	 noninvasive	 neoplasia)	 →high-grade	 dysplasia	 (highgradenoninvasive	
neoplasia)		→	invasive	adenocarcinoma	
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Fig.	45	Sequential	steps	of	the	precancerous	cascade	[79]	
	
Gastritis	 stage	 is	 characterized	 by	 infiltration	 of	 the	 lamina	 propria	 with	
mononuclear	 leukocytes	 and	 polymorphonuclear	 neutrophils,	 toghter	 with	
increase	 of	 cytokines	 ,	 interleukin	 (IL)-1b	 ,	 tumor	 necrosis	 factor	 (TNF)-a	 	 and	
interferon	(IFN)-g	.	
If	 gastritis	 is	not	 treated,	 it	may	evolve	 in	 two	ways:	 either	gastritis	 remains	as	
non-atrophic	or	it	progresses	with	several	damages	of	gastric	glands,	which	could	
finally	disappear	 (in	particular	 the	 cag-positive	vacA	 	 s1m1	strains	 seems	 to	be	
associated	with	galds	loss	and	precancerous	lesions)	[80].		
Fibrosis	 of	 the	 lamina	 propria	 is	 the	 following	 step,	 leading	 to	 a	 phenotypic	
change	of	normal	epithelial	 cells,	which	start	 showing	an	 intesinal	pattern.	Two	
main	morphological	kinds	of	Intestinal	metaplasia	are	known:	the	complete	type	
and	 the	 incomplete	 one.	 In	 complete	 type	 goblet	 cells	 interspersed	 among	
absorptive	 enterocytes	with	 apical	microvilli	 (conferring	 a	 typical	 brush	border	
feature)can	be	observed.	Paneth	cells	are	present,	too.		
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Fig.	46	Complete	intestinal	metaplasia,	Hematoxylin	and	Eosin	(HE)	stain	image	
	
As	the	metaplastic	transformation	progresses	a	new	phenotype	can	be	detected.	
It	 is	 called	 incomplete	 or	 colonic	 because	 it	 may	 resemble	 the	 large	 bowel	
phenotype	epitelium.	Incomplete	type	is	generally	associated	with	a	higher	risk	of	
developing	a	gastric	cancer	[81].		
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Fig.	47	Dysplasia	starting	from	incomplete	intestinal	metaplasia,	HE	stain	image	
 
 
	
	An	 alteration	 in	 cell	 morphology	 and	 architectural	 organization	 characterize	
dysplasia	 (or	non	 invasive	neoplasia).	Epithelium	appears	enlarged,	mitoses	are	
frequent,	 hyperchromatic	 and	 crowded	 nuclei	 can	 be	 observed,	 glands	 show	
irregular	 shapes.	 Different	 grades	 of	 dysplasia	 are	 known,	 according	 to	 several	
classifications.	 In	 any	 case	 cells	 remain	 within	 the	 bounds	 of	 the	 basement	
membrane.	 When	 this	 borders	 are	 crossed	 and	 degradation	 of	 intracellular	
matrix	occurs,	the	disease	becomes	an	invasive	carcinoma.	
Furthermore,	 Helicobacter	 pylori	 infection	 is	 correlated	with	MALT	 lymphoma,	
syderopenic	 anaemia,	 gynecological	 and	 dermatological	 diseases,	 idiopathic	
thrombocytopenic	 purpura,	 cardiovascular	 and	 neurological	 diseases,		
autoimmune	tyroiditis,	oropharingeal	diseases,	obesity	and	bowel	diseases	[82].		
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Fig.48		Extra-gastric	manifestations	of	HP	infection	
	
	
3.3.4Diagnosis	
HP	 infection	 can	 be	 dectected	 by	 means	 of	 both,	 invasive	 and	 non-invasive	
methods.	
Invasive	 procedures	 includes	 esophagogastroduodenoscopy	 (associated	 with	
biopsy	for	histological	evaluation),	microbiological	examination	and	urease	rapid	
test.	
Non-invasive	 diagnostic	methods	 are	 based	 on	 serological	 analysis	 ,in	 order	 to	
detect	 specific	 serum	 IgM	 by	 means	 of	 Latex	 agglutination	 test,	 Elisa-test	 and	
Western	Blotting	Test.		
C-Breath	 Test	 Urea	 (C-BTU)	 measures	 the	 urease	 production	 of	 Hp.	 Enzyme	
urease	 metabolizes	 urea	 to	 ammonia	 and	 carbon	 dioxide.	 The	 carbon	 dioxide	
produced	diffuses	into	the	blood	vessels	and	is	transported	into	the	lungs	where	
is	expelled	as	CO2.	So	the	test	principle	is	the	following:	
the	patient	swallows	carbon	labeled	urea	(	either	radioactive	carbon-14	or	non-
radioactive	 carbon-13)	 on	 an	 empty	 stomach.	 If	 Helicobacter	 pylori	 is	 present,	
labeled	 CO2will	 be	 collected	 in	 exhaled	 air.	 In	 the	 absence	 of	microorganism,	
labeled	urea	is	absorbed	from	the	gastrointestinal	tract	and	subsequently	voided	
[83].		
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	In	addition,	a	pre-urea	baseline	breath	sample	is	required	in	order	to	compare	it	
with	the	post-urea	sample,	with	at	least	25	minutes	duration	between	them.		
The	 difference	 between	 the	 pre-	 and	 post	 measurements	 is	 necessary	 to	
determine	infection.		
	
	
	
Fig.	49	Schematic	representation	of	C-UBT	
	
The	 test	measures	active	H.	pylori	 infection	with	high	sensibility	and	specificity.	
Antibiotics	 can	 reduce	 the	 amount	 of	H.	pylori	 present,	 as	well	 as	 proton	pump	
inhibitors	(PPI)	can	reduce	the	Urease		reaction,	so	this	test	should	be	performed	
only	14	days	after	 stopping	PPI	medication	or	28	days	after	 stopping	antibiotic	
treatment,	 as	 indicated	 by	 guidelines	 (Acts	 of	 the	 IV	 edition	 of	
Maastricht/Florence	Consensus)	[84].		
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3.1.5	Therapy	
	
Triple	 therapy	 is	 the	most	 used	 intervention	 regimen	 and	 it	 consists	 of	 double	
antibiotic	 medication	 (clarithromycin	 plus	 amoxicillin	 or	 metronidazole)	 and	 a	
Proton	Pump	Inhibitor	(PPI)	.	Duration	should	be	at	least	14	days.	
According	 yo	 guidelines	 elaborated	 during	 the	 Toronto	 Consensus	 Conference,	
[85]	therapy	is	reccomended	in	case	of:	gastric	or	duodenal	ulcer,	gastric	cancer	
and	 MALT	 lymphoma,	 chronic	 gastritis,	 non-ulcer	 dyspepsia,	 metaplasia,	
extragastric	 manifestations	 (idiopathic	 thrombocytopenic	 purpura)	 and	 for	
prevention	in	patient	at	high	risk	of	developing	gastic	cancer.	
Considering	 recent	 prevalence	 of	 clarithromycin	 and	metronidazole	 resistances	
(20%	 and	 30%	 of	 cases	 respectively),	 a	 quadruple	 therapy	 (metronidazole	
,bismuth	 ,tetracyclin,	 PPI)	 can	 be	 performed.	 Despite	 this,	 recent	 studies	 have	
shown	that	today	eradication	rates	are	at	their	lowest	level	in	history,	maybe	due	
to	incomplete	elimination	of	the	microorganism	[86].		
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Fig.	 50	 American	 College	 of	 Gastroenterology	 Guideline	 in	 eradication	 of	 HP	
gastric	infection,	2017	
	
	
	
Fig.51	Flowchart	of	medication	protocol	in	Helicobacter	pylori	infection	
	
	
3.1.6	Helicobacter	pylori	and	periodontal	disease	
Considering	 the	 recurrence	 rate,	 some	 authors	 hypotized	 the	 presence	 of	 a	
possible	extra-gastric	reservoir	of	infection,	which	could	contribute	to	relapses	of	
gastric	infection.	
“Reinfection”	(relapse	of	the	disease	caused	by	infection	of	new	bacterium	strain)	
has	 to	 be	 distinguished	 from	 “recrudescence”	 (relapse	 due	 the	 presence	 of	 the	
same	bacterial	strain	some	weeks	after	the	eradication	therapy	ended);	the	first	
one	is	typical	of	developing	countries	while	the	second	one	prevails	in	developed	
areas.	
	Several	 studies	 have	 been	 conducted	 in	 order	 to	 understand	 if	 oral	 cavity	 and	
tonsils	 may	 represent	 a	 reservoir	 for	 HP	 and	 so	 a	 potential	 element	 for	
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recrudescence	of	 the	disease	 [87,88],	but	opinions	are	very	different.	 In	2011	A	
meta-analysis	reported	the	presence	of	a	significant	link	between	HP	found	in	the	
stomach	and	in	the	oral	cavity	[89].		
On	the	other	way,	Nélio	Vega	et	al	refused	the	hypotesis	of	a	correlation	between	
gastric	and	oral	cavity	relapses,	saying	that	the	presence	of	the	bacterium	in	the	
mouth	could	be	a	consequence	of	gastro-esophageal	reflux	disease	[90].		
	
Anyway,	the	presence	of	this	bacterium	in	the	oral	cavity	was	firstly	described	in	
1989	[91];	later	it	has	been	found	in	saliva,	tongue	dental	plaque	and	tonsils	[92].		
	
In	case	of	oral	presence	of	HP,	the	classical		triple	eradication	therapy	is	not	very	
effective,	 as	 shown	 by	 eradication	 rates	 which	 are	 below	 40%	 [93],	 and	 it	 is	
precisely	 this	 situation	which	could	cause	recrudescence	of	Hp	 infection.	 In	 fact	
the	presence	of	 	 an	organised	dental	plaque	biofilm	represents	a	 strong	barrier	
against	antibiotics	and	drugs	and	only	a	mechanical	removal	of	this	element	could	
destroy	resident	bacteria,	including	Hp	[94].		
	
Even	though	the	microbiologic	examination	 is	still	considered	the	gold	standard	
analysis	 in	 order	 to	 valuate	 the	 presence	 of	 this	 bacterium	 in	 the	 oral	 cavity,	
sesibility	 and	 specificity	 rates	 are	 not	 so	 high;	 that	 is	 why	 nowadays	 PCR-RT	
technique	is	getting	more	and	more	important	to	detect	Hp	presence	in	saliva	and	
dental	plaque.	
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	3.2	AIM	
	
Firstly,	the	aim	of	this	study	was	to	evaluate	the	relatioship	between	the	presence	
of	Helicobacter	pylori	 in	the	stomach	and	in	the	oral	cavity	 in	patients	with	and	
without	gastric	infection,	in	order	to	verify	the	role	of	oral	health	and	oral	hygene	
in	 this	 gastric	 disease.	 Secondly,	 the	 goal	 was	 to	 verify	 if	 periodontal	 pockets	
could	represent	a	reservoir	of	bacteria,	involved	in	gastric	disese	recrudescence,	
after	a	proper	eradication	therapy.	
	
3.3	MATERIALS	AND	METHODS	
	
This	 study	 was	 conducted	 at	 the	 Department	 of	 Surgical	 and	 Morphological	
Sciences,	University	 of	 Insubria,	 ASST	dei	 Sette	 Laghi,	Unit	 of	Gastroenterology,	
Varese,	Italy.	
The	experimental	protocol	has	been	evaluated	by	the	Institutional	review	Board.	
	
Phase1	
102	patients	with	age	between	18	and	80	were	recruited	in	the	current	study.	
Inclusion	 criteria	 were:	 the	 presence	 of	 the	 signed	 informed	 consent,	 good	
cooperation,	 good	 general	 health	 conditions,	 presence	 of	 theeth	 in	 the	 four	
quadrants	of	the	oral	cavity	for	periodontal	analysis;	exclusion	criteria	regarded	
the	assumption	of	antibiotics	or	proton-pump	inhibitors	(PPI)	during	the	60	days	
before	the	breath	test,	abscence	of	theet	in	oral	cavity	quadrants.	
An	informed	consent	was	read,	understood	and	approved	by	all	patients.	
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Fig.	52	Informed	consent		to	the	study	
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A	 questionnaire	 was	 completed	 for	 each	 patient	 in	 order	 to	 register	 medical	
history	 (in	 particular	 previous	 infection	 with	 HP	 was	 investigated),	 medicines,	
smoking		and	oral	hygene	habits.	Data	were	collected	in	individual	registers.	
	
	
	
Fig.		53	Individual	register	for	each	patient	
	
	
C-	Urea	Breath	 test	was	 performed:	 the	 patient	 swallowed	 carbon	 labeled	 urea	
(with	 non-radioactive	 carbon-13)	 on	 an	 empty	 stomach	 and	 exhaled	 air	 was	
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collected	in	two	tubes.	The	exam	was	repeated	after	30	min.	A	mass	spectrometer	
analysis	was	performed.	
	
Then	a	dental	clinician	proceeded	with	periodontal	examination	for	every	patient,	
by	use	of	a	dental	probe,	in	all	the	four	quadrants,	in	order	to	detect	the	presence	
of	periodontal	pockets.	
	
Afterwards,		in	each	quadrant,	2	sterile	paper	cone	were	inserted	for	30	seconds	
in	the	gingival	sulcus	of	the	theeth	with	the		deepest	periodontal	pockets	.	Cones	
were	then	put	in	a	sterile	tube.	
In	addition,	saliva	was	collected	through	the	spitting	method:	the	patient	was	
sitting	on	a	chair	and	was	asked	to	spit	the	salivary	content	of	his	mouth	every	
minute	for	at	least	10	minutes	in	a	sterile	tube.	
Tubes	were	sent	to	the	laboratory	for	a	microbiological	evaluation.	
Specimens	 were	 processed	 to	 extract	 and	 purify	 DNA	 using	 a	 method	 that	
includes	 two	 consecutives	 incubations	 with	 lysozime	 and	 proteinase	 K.	 Once	
extracted,	 DNA	 was	 purified	 through	 a	 silica	 spin-column	 (Sigma-Aldrich,	 St.	
Louis,	MO,	 USA).	 Quantitative	 PCR	 of	 16S	 rRNA	 genes	was	 performed	with	 the	
hydrolysis	probes	method	to	identify	and	evaluate	the	amount	sequences	of	16S	
rRNA	 gene	 of	 the	 Human	 Oral	 Microbiome	 Database	 (HOMD	 16S	 rRNA	 RefSeq	
Version	10.1).	All	sequences	were	aligned	to	find	either	a	consensus	sequence	or	
less	 preserved	 spots,	 useful	 to	 optimize	 the	 specificity	 of	 primers	 and	 dual	
labelled	hydrolysis	probes.	Absolute	quantification	assays	were	performed	using	
a	 7500	 Sequence	 Detection	 System	 (Applied	 Biosystems).	 The	 thermal	 cycle	
included	 10	minutes	 incubation	 at	 95	 °C	 to	 activate	 polymerase,	 followed	 by	 a	
two-steps	 amplification	 of	 15s	 at	 95	 °C	 and	 60	 s	 at	 57	 °C	 for	 40	 cycles.	 Each	
experiment	 included	 non-template	 controls	 to	 exclude	 reagents	 contamination	
and	 serial	 diluitions	 of	 the	 specific	 synthetic	 template	 (Eurofin	 MWG	 Operon,	
Ebersberg,	Germany).	
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Plasmids	 containing	 bacterial	 target	 sequences	 were	 used	 to	 obtain	 standard	
curves	(Eurofin	MWG	Operon,	Ebersberg	Germany).	The	total	amount	of	bacterial	
charge	was	estimated	using	the	Thermo	Scientific	Nanodrop	spectrophotometer.	
Standard	 curves	 were	 created	 with	 serial	 diluitions	 between	 107	 and	 101	
plasmids	copies.	
The	 total	 quantification	 of	 absolute	 bacterial	 charges	 determined	 the	 relative	
amount	 of	 Helicobacter	 pylori.	 Under	 10	 U	 the	 results	 were	 considered	 as	
negative.	
Comparative	 statistics	 among	 the	 different	 groups	was	 performed	 by	 using	 the	
IBM	 SPSS	 version	 20.0,	 SPSS	 Inc,	 Chicago,	 IL,	 USA,	 with	 the	 same	 methods	 of	
Fusobacterium	nucleatum	study.	
	
	
Phase	2		
Among	102	total	patients	of	phase	1,	on	the	base	of	UBT	results	and	periodontal	
disease	 results,	 60	 patients	 were	 selected	 in	 order	 to	 perform	 a	 second	
perspective	phase	of	the	research.	The	goal	was	again	to	evaluate	the	role	of	oral	
Hp	 (present	 in	 oral	 cavity),	 in	 gastric	 primary	 infection	 and	 gastric	 reinfection	
(after	 a	 proper	 eradication	 therapy);	 in	 addition,	 the	 preventive	 role	 of	 oral	
hygene	procedures	in	gastric	infection/reinfection	is	evaluated.	
	
Patients	were	divided	into	two	groups:		
- Group	1	:	UBT	negative,	Oral	Hp		positive	(on	the	base	of		Hp	load	in	saliva;)	
- Group	2	(control):	UBT	negative,	Oral	Hp	negative	
	
The	presence	of	oral	Hp	was	evaluated	according	to	the	bacterium	load	in	saliva,	
since	it	is	precisely	this	oral	fluid	that	can	reach	the	stomach	by	swallowing.	
Patients	were	contacted	again	after	some	months	(a	minimum	of	6-8	months	and	
maximum	 of	 2	 years)	 from	 the	 phase	 1	 analysis.	 Data	 concerning	 medical	
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therapies,	 previous	 BT	 result,	 pharmacological	 therapies,	 gastrointestinal	
symptoms,	 prfoessional	 and	 home	 oral	 hygene	 procedures,	 smoking	 habits	
changes	were	collected.		
	
Fig.	54	Individual	register	for	phase	2	
With	regard	to	oral	hygene	information	both	professional	and	home	oral	hygene	
habits	were	 investigated:	 patients	were	 asked	how	many	 times	 a	 day	 they	 	 are	
used	to	brushing	their	teeth,	how	many	times	a	year	they	are	used	to	undergoing	
a	professional	oral	hygene	and	when	the	last	professional	oral	hygene	procedure	
was	performed.	
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A	new	U-	BT	(time	1)	and	new	salivary	and	crevicular	fluid	analysis	(time	1)	were	
performed	with	the	same	methods	used	in	the	first	phase.		
	
At	the	moment	this	second	phase	of	the	study		is	still	in	progress:		
17	patients	has	been	recalled	and	divided	into	the	groups:	11	patients	were	
inserted	 in	Group	2	 	 (BT	negative	 and	Oral	Hp	negative)	while	6	patients	were	
inserted	in	Group	1	(BT	negative	and	Oral	Hp	positive).	
	
The	microbiological	statistical	analysis	were	performed	in	the	same	way	and	with	
the	same	methods	of	phase	1.		
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3.4	RESULTS	AND	DISCUSSIONS	
	
Phase	1	
A	total	number	of	102	patients	underwent	the	experimental	procedure:	37	males	
and	65	females.	
According	to	Breath	test,	executed	in	that	moment	at	the	beginning	of	this	study	
(time	 0)	 ,	 42	 were	 found	 with	 a	 positive	 result	 (group	 A)	 and	 60	 who	 were	
negative	(group	B).	
Ages	registered	assessed	between	16	and	78,	with	mean	age	of	52	years.	
Among	 the	 37	 males,	 12	 resulted	 positive	 and	 25	 negative	 at	 the	 Breath	 test,	
while	among	65	females	30	resulted	positive	and	35	negative.	
Age	ranged	between	16	and	76	among	negative	patients	(mean	age	of	50	years)	
while	it	was	between	21	and	78	among	positive	patients	(mean	age	of	55	years).	
	
	
Plot	1	Males	and	female	distribution	among	the	two	groups	
	
Of	the	102	patients	selected	only	11	were	smokers,	5	were	ex-smokers	and	the	
the	remaining	86	ere	non-smokers.	
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Considering	oral	hygene,	patients	reported	an	average	tooth	brushing	frequency	
of	2	times	a	day,	with	a	minimum	value	of	1	and	maximum	of	3.	
Avarage	 time	since	 the	 last	oral	professional	hygiene	was	estimated	14	months,	
with	a	minimum	value	of	1	month	and	a	value	of	maximum	of	120	months.		
Further	 data	 regarded	 previous	 experience	 of	 infection	 by	 Helicobacter	 pylori,	
previous	eradication	treatment	and	the	presence	of	gastrointestinal	symptoms	at	
the	moment	of	the	first	sampling.	
Only	 14%	 of	 patients	 had	 no	 symptoms	 clinically	 associated	 with	
gastroesophageal	disorders,	while	86%	of	the	patients	reported	at	least	one	of	the	
following:	nausea,	gastritis,	gastroesophageal	reflux,	acidity,		dyspepsia.	
	
	
Plot	2	Gastrointestinal	symptoms	distribution	among	the	two	groups	
	
Of	the	88	patients	with	gastro-esophageal	clinical	symptoms,	38%	(33)	
was	positive	for	C-UBT,	while	63%	(55)	was	negative	for	C-UBT.	
Of	 the	 14	 patients	 who	 did	 not	 report	 significant	 symptoms,	 64%	 (9)	 were	
positive	for	C-UBT	and	only	36%	(5)	were	negative.	
86%	
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Gastrointestinal	symptoms	
POSITIVE	
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Previous	Helicobacter	pylori	infection	(Time	“-1”)	analysis:	
This	part	of	the	analysis	was	performed	dividig	the	patients	into	2	main	groups,	
on	 the	 base	 of	 their	 previous	 infection	 with	 Hp,	 reported	 during	 the	 initial	
interview.	
Of	a	total	of	102	patients,	62	had	a	history	of	previous	infection	with	Helicobacter	
pylori	(positive	medical	history,	i.e.	time	-1),	and	only	40	patients	did	not	report	it	
(negative		medical	history,	i.e.	time	-1).	
All	62	patients	with	confirmed	previous	infection	underwent	eradication	therapy	
with	 the	 intake	 of	 1,	 2	 or	 3	 antibiotics	 and	 IPP.	 The	 efficacy	 of	 the	 eradication	
therapy	was	evaluated	on	the	basis	of	the	C-UBT	performed	immediately	after	the	
interview	(time	0).	
	
On	 the	 basis	 of	 these	 data	 (UBT	 results	 at	 time	 -1,	 UBT	 results	 at	 time	 0	 and	
gastrointestinal	symptoms),	it	was	possible	to	divide	the	patients	into	2	different	
groups	and	4	subgroups:	
	
1)	Group	α	:	40	patients	without	previous	Hp	infection:	
- Group	α1	:	22	patients	with	negative	C-Urea	Breath	Test	result	at	time	0	
o 	All	reported	gastroenteric	symptoms	
- Group	α2	:	18	patients	with	positive	C-Urea	Breath	Test	result	at	time	0	
o 13	with	gastrointestinal	symptoms	
o 5	without	gastrointestinal	symptoms	
	
	
2)	Group	β	:	62	patients	with	previous	Hp	infection	(UBT	positive	at	time	-1):	
- Group	β1	 :	 38	patients	with	previous	 infection	 treated	with	 success	 (UBT	
changed	from	positive	to	negative,	in	fact	UBT	at	time	0	is	negative):	
o 32	patients	with	reported	gastric	symptoms	
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o 	6	patients	without	reported	gastric	symptoms	
- Group	 β2	 :	 24	 patients	with	 previous	 infection	 treated	with	 failure	 (UBT	
remained	positive	also	at	time	0):	
o 20	patients	with	gastric	symptoms	reported	
o 	4	patients	without	reported	gastric	symptoms	
	
	
	
Plot	3	Previous	infection	with	Hp	among	the	two	groups	
	
So	a	comparison	has	been	made	between	the	current	situation,	recorded	at	time	0	
-that	 is	 the	 time	 of	 sampling	 (UBT	 and	 salivary	 samples)-	 with	 the	 previous	
history	situation	reported	by	the	patient	(time	-1)	:	
Of	62	Patients	who	reported	a	history	of		prior	infection	(time	-1),	all	treated	with	
eradication	therapy,	only	38	 	resulted	negative	and	24	positive	at	time	0	C-UBT,	
highlighting	a	percentage	of	gastric	recurrence	of	38.71%	.	
Of		40	patients	whithout		history	of	previous	infection,	only	22	were	negative		
at	time	0	and	18	resulted	positive.	
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group	aplha	
group	beta	
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Plot.	4	UBT	results	at	time	0	in	patients	with	positive	and	negative	history	of	Hp	
infection.	
	
In	order	to	evaluate	a	statistical	correlation	between	the	two	groups	a	Chi-Square	
test	was	applied,	comparing	the	result	of	the	UBT	at	time	-1	(anamnesis)	with	the	
UBT	executed	at	time	0.	
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contingency table PREGHP*BTZERO 
 BTZERO Total 
,00 1,00 
PREG
HP 
 ,00 22 18 40 
 1,00 38 24 62 
TOTAL  60 42 102 
	
chi-square PREGHP*BTZERO 
 Valore df Asynt Sig.. 
(2 ways) 
Exact. Sig. 
(2 ways) 
Exact. Sig. 
(1 way) 
Pearson’s Chi-square 0,397a 1 ,529   
Continuity correction 0,180 1            ,671   
Likelihood ratio 0,396 1 ,529   
Fisher exact test    ,544 ,335 
Lin-lin association 0,393 1 ,531   
Valid cases 102     
	
Tab.	21	Contingency	table	and	Chi-square	test	between	UBT	at	time	-1	and	UBT	at	
time	0	
	
The	test	confirmed	that	there	 is	no	statistically	significant	correlation	(P=0.529)	
between	the	previous	infection	and	the	current	infection:	the	fact	that	a	patient	is	
postitive	at	UBT	at	time	0	is	independent	from	his/her	medical	history.	
	
Separated	statistical	analysis	were	performed	for	each	group:	
	
Statistical	Analysis	Group	α	(patients	without	previous	Hp	infection):	
	
This	group	consists	of	40	patients	with	a	negative	medical	history	for	
infection	with	H.pylori.	Among	them	22	were	negative	to	time	0	BT	and	18	were	
positive.	
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1	 -	Microbiological	 Analysis	 -	 Breath	 Test,	 Salivary	 and	 Periodontal	 analysis:	 the	
aim	 was	 to	 compare	 the	 bacterial	 load	 of	 Hp	 in	 the	 oral	 cavity,	 saliva	 and	
crevicular	 fluid	 (samples	 collected	 at	 time	0)	 in	 those	patients	 	with	 a	 negative	
history	of	gastric	Hp	infection.	
Firstly	 the	 presence	 of	 Helicobacter	 pylori	 in	 saliva	 was	 evaluated	 in	 all	 102	
patients:	results	ranged	from	0	to	103	HP	units	(average	11	U).	In	particular	67	of	
these	 had	 less	 than	 	 10	U	 and	were	 classified	 as	 negative,	while	 35,	with	more	
than	10	U,	were	considered	positive.	
Then	T-Student	test	was	performed	comparing	the	prescence	of	Hp	in	saliva	
(detected	 at	 time	 0)	 and	 the	 results	 of	 the	 BT	 (performed	 at	 time	 0),	 in	 alpha	
group	(those	patient	without	a	medical	history	for	Hp	infection).	
T-student independent variable BT and HPSALIVA Time 0 
 BTZERO N Mean St deviation St error mean 
HPSALIV
AZERO 
NEG 22 11,3182 18,31311 3,90437 
POS 18 10,2222 17,76499 4,18725 
	
 Levene’s Test T-test 
F Sig. t df Sig. (2-
tailed) 
Mean 
differen
ce 
Std Error 
differenc
e 
Confidence 
interval 
Lower Upper 
HP
SA
LIV
AZ
ER
O 
Equal 
variances 
assumed 
,013 ,910 ,191 38 ,850 1,09596 5,74301 -10,53015 12,72202 
Equal 
variances not 
assumed 
  
,191 36,85
7 
,849 1,09596 5,72513 -10,50578 12,69770 
	
Tab.	22	T-student	and	comparative	analysis	of	salivary	Hp	load	values	and	UBT		
	
The	 result	 is	 P=0.850,	 so	 there	 is	 no	 statistically	 significant	 difference	 between	
the	 salivary	 load	 of	 Helicobacter	 pylori	 and	 the	 Breath	 Test	 results	 in	 patients	
with	a	negative	medical	history	for	Hp	infection.	
	 136	
In	 order	 to	 confirm	 this	 data,	 a	 Chi-Square	 test	 has	 been	 performed	 (this	 test	
represents	a		qualitative		analysis):	
contingency table ORALSALIVAPOSNEG*BTZERO 
 BTZERO Total 
,00 1,00 
ORALS
ALIVAP
OSNEG 
 ,00 14 13 27 
 1,00 8 5 13 
TOTAL  22 18 40 
	
	
	
	
	
	
	
	
Tab.	 23	 Contingency	 table	 and	 Chi-square	 test	 between	 UBT	 at	 time	 -1	 and	
salivary		bacterium	load	
	
In	this	case	P=	0,	564,	so	there	is	not	a	stastically	significant	difference	between	
the	two	groups.		The	previous	data	are	confirmed.	
	
The	 same	 analysis	 was	 performed	 on	 crevicular	 fluid	 samples,	 collected	 from	
periodontal	pockets:	
T-student independent variable BT and HPMEAN Time 0 
 BTZERO N Mean St deviation St error mean 
HPMEAN
ZERO 
NEG 22 31,5455 43,25641 9,22230 
POS 18 15,3889 24,69375 5,82037 
	
 Levene’s Test T-test 
chi-square ORALSALIVAPOSNEG *BTZERO 
 Valore df Asynt Sig.. 
(2 ways) 
Exact. Sig. 
(2 ways) 
Exact. Sig. 
(1 way) 
Pearson’s Chi-square 0,333a 1 ,564   
Continuity correction ,056 1 ,812   
Likelihood ratio ,335 1 ,563   
Fisher exact test    ,737 ,408 
Lin-lin association ,324 1 ,569   
Valid cases 40     
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F Sig. t df Sig. (2-
tailed) 
Mean 
differen
ce 
Std Error 
differenc
e 
Confidence 
interval 
Lower Upper 
HP
ME
AN
ZE
RO 
Equal 
variances 
assumed 
,3,571 ,066 1,406 38 ,168 16,1565
7 
11,4892
8 
-7,10226 39,41540 
Equal 
variances not 
assumed 
  
1,482 34,33
2 
,148 16,1565
7 
10,9053
9 
-5,99795 38,31108 
	
Tab.	24	T-student	and	comparative	analysis	of	crevicular	Hp	loads	and	UBT		
	
This	 test	 confirmed,	 with	 a	 P=0.168,	 that	 there	 is	 no	 statistically	 significant	
difference	between	the	periodontal	load	of	Helicobacter	pylori	and	the	
Breath	Test	(performed	at	time	0)	in	patients	with	a	negative	medical	history	for	
Hp	infection.	
Again	the	qualitative	Chi-Square	test		confirmed	the	data	with	P=0,119:	
contingency table ORALPAROPOSNEG*BTZERO 
 BTZERO Total 
,00 1,00 
ORAL
PARO
POSN
EG 
 ,00 8 11 19 
 1,00 14 7 21 
TOTAL  22 18 40 
	
	
	
Ta
b.	
25	
Co
nti
chi-square ORALPAROPOSNEG *BTZERO 
 Valore df Asynt Sig.. 
(2 ways) 
Exact. Sig. 
(2 ways) 
Exact. Sig. 
(1 way) 
Pearson’s Chi-square 2,431a 1 ,119   
Continuity correction 1,540 1 ,215   
Likelihood ratio 2,454 1 ,117   
Fisher exact test    ,203 ,107 
Lin-lin association 2,371 1 ,124   
Valid cases 40     
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ngency	 table	 and	 Chi-square	 test	 between	 UBT	 at	 time	 -1	 and	 crevicular	 fluid	
bacterium	load	
	
These	data	are	useful	to	analyse	the	presence	of	Helicobacter	pylori	in	saliva	and	
periodontal	pockets	in	relation	to	the	Breath	Test	result	in	the	alpha	group	(i.e.	
patients	without	previous	gastric	infection	);	however	the	presence	of	periodontal	
disease	is	not	considered	yet.	
	
2	-	Periodontal	Analysis	-	Helicobacter	pylori	and	Periodontal	Pockets:		
	
Firstly,	the	average	periodontal	pocket	depth	was	calculated	for	each	of	the	
102	patients:	 a	healty	 condition	was	 represented	by	a	value	of	average	probing	
depth	below	4	mm,	while	the	presence	of	Periodontal	Disease	was	represented	by	
a	value	>/=	4	mm.		The	maximum	periodontal	pocket	depth	was	also	calculated	in	
order	to	have	a	parameter	showing	the	severity	of	the	disease.	
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Plot	 5	 Periodontal	 pockets	 depth	 in	 4	 quadrants	 (blue:	 I	 quadrant-	 green:	 II	
quadrant-	yellow:	III	quadrant-	orange:	IV	quadrant)	
	
According	to	this	periodontal	analysis	of	102	patients	it	resulted	that:	69	patients	
were	 considered	 periodontally	 Healthy	 (Negative),	 while	 33	 were	 affected	 by	
Periodontal	Disease	(Positive).	
	
Similarly	to	the	previous	analysis,	a	Chi-Square	test	was	conducted	comparing	the	
presence	or	absence	of	periodontal	disease	(	based	on	the	average	periodontal	
pocket	depth)	with	the	result	of	the	Breath	Test	at	time	0,	in	patients	without	a	
positive	hisory	for	Hp	infection	(alpha	group):	the	result	was	P=0,131.		
contingency table PERIO*BTZERO 
 BTZERO Total 
,00 1,00 
PERIO 
 ,00 15 8 23 
 1,00 7 10 17 
TOTAL  22 18 40 
	
	
Ta
b.	
26	
Co
nti
nge
ncy	table	and	Chi-square	test	between	UBT	at	time	-1	and	average	pocket	depth	
	
Furthermore,	a	Chi-Square	test	was	conducted	comparing	the	presence	or	
absence	of	periodontal	disease	(this	tame	based	on	the	maximum	periodontal	
pocket	depth)	with	the	result	of	the	Breath	Test	at	time	0,	in	pathients	without	a	
chi-squarePERIO *BTZERO 
 Valore df Asynt Sig.. 
(2 ways) 
Exact. Sig. 
(2 ways) 
Exact. Sig. 
(1 way) 
Pearson’s Chi-square 2,283a 1 ,131   
Continuity correction 1,415 1 ,234   
Likelihood ratio 2,296 1 ,130   
Fisher exact test    ,200 ,117 
Lin-lin association 2,226 1 ,136   
Valid cases 40     
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positive	hisory	for	Hp	infection	(alpha	group):	the	result	was	P=0,332.		
	
contingency table MPMAX*BTZERO 
 BTZERO Total 
,00 1,00 
MPMA
X 
 ,00 8 4 12 
 1,00 14 14 28 
TOTAL  22 18 40 
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table	and	Chi-square	test	between	UBT	at	time	-1	and	maximum	pocket	depth	
	
So	in	both	cases	there	is	no	stastistically	significant	difference	between	BT	results	
and	presence	of	periodontal	disease	(represented	by	periodontal	pocket	depth).	
	
3-	Symptoms	analysis	
A	statistical	analysis	was	performed	to	evaluate	the	reliability	of	the	
reported	symptoms	in	relation	to	the	BT	results	at	time	0,	in	the	group	of	40	
patients	with	a	negative	history	for	Hp	infection	(alpha	group).	
All	22	patients	negative	for	BT	at	time	0		reported	gastrointestinal	symptoms,	
while,		within	the	group	of	18	patients	positive	for	BT,	only	13	reported	
symptoms.	
Chi-Square	test	was	performed,	comparing	the	presence	or	absence	of	symptoms	
with	the	outcome	of	BT	at	time	0:	
chi-squareMPMAX *BTZERO 
 Valore df Asynt Sig.. 
(2 ways) 
Exact. Sig. 
(2 ways) 
Exact. Sig. 
(1 way) 
Pearson’s Chi-square ,943 1 ,332   
Continuity correction ,390 1 ,533   
Likelihood ratio ,959 1 ,328   
Fisher exact test    ,491 ,268 
Lin-lin association ,919 1 ,338   
Valid cases 40     
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contingency table SYMPTOMS*BTZERO 
 BTZERO Total 
,00 1,00 
SYMP
TOMS 
 ,00 0 5 5 
 1,00 22 13 35 
TOTAL  22 18 40 
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ngency	table	and	Chi-square	test	between	UBT	at	time	-1	and	symptoms	
	
A	statistically	significant	value	of	P=	0,008	is	obtained,	which	represents	the		
reliability	of	reported	symptoms.	A	patients	positive	for	Hp	infection	has	a	major	
probability	to	report	gastrointestinal	symptoms.	
	
4-	Sex	
Chi-Square	test	was	performed	in	alpha	group,	comparing	the	sex	of	the	patients	
with	the	outcome	of	BT	at	time	0,	in	order	to	assess	whether	the	the	first	could	
have	
some	influence	on	positive	rates.	
The	result	of	the	statistical	test	is	P=0.576,	which	is	a	value	that	indicates	the	
absence	of	a	significant	difference	between	being	a	woman	or	a	man	with	respect	
to	the	gastric	reinfection	rates.	
	
5-Smoking	
 chi-square SYMPTOMS *BTZERO 
 Valore df Asynt Sig.. 
(2 ways) 
Exact. Sig. 
(2 ways) 
Exact. Sig. 
(1 way) 
Pearson’s Chi-square 6,984 1 ,008   
Continuity correction 4,675 1 ,031   
Likelihood ratio 8,871 1 ,003   
Fisher exact test    ,013 ,013 
Lin-lin association 6,810 1 ,009   
Valid cases 40     
	 142	
Finally	Chi-Square	test	was	performed	in	alpha	group,	comparing		BT	results	(at	
time	0)	with	smoking	habits	in	order	to	assess	the	role	of	smoking	in	gastric	
reinfection.	
The	result	was	P=0,247	which	indicates	the	absence	of	such	a	correlation.		
	
	
Statistical	Analysis	Group	β		(patients	with	previous	Hp	infection):	
This	group	consisted	of	62	patients	with	a	positive	medical	history	for	
infection	 with	 H.pylori.	 All	 of	 them	 were	 treated	 with	 eratication	 therapy,	
however	only	38	resulted	negative	to	BT	at	time	0	while	24	were	positive.	
Similarly	 to	 the	 apha	 group,	 a	 statistical	 analysis	was	 performed	 in	 beta	 group	
patients,	 comparing	 the	 results	 of	 the	 BT	 (performed	 at	 time	 0)	 with	
microbiological	condition	(Hp	load	in	saliva	and	periodontium),	with	periodontal	
disease,	with	reported	symptoms,	with	sex	and	with	smoking.	
The	results	in	beta	group	showed	the	absence	of	a	significant	correlation	between	
BT	results	and	Hp	load	in	saliva	(P=0,650	T-stdent,	P=0,409	Chi-square).	
	
Considering	crevicular	fluid	samples,		T-student	result	was	P=0,906:	
T-student independent variable BT and HPMEAN Time 0 
 BTZERO N Mean St deviation St error mean 
HPMEAN
ZERO 
NEG 38 31,0526 59,87281 9,71265 
POS 18 33,6667 113,93693 23,25728 
	
	
 Levene’s Test T-test 
F Sig. t df Sig. (2-
tailed) 
Mean 
differen
ce 
Std Error 
differenc
e 
Confidence 
interval 
Lower Upper 
HP
ME
AN
Equal 
variances 
assumed 
,602 ,441 -
0,118 
60 ,906 -
2,61404 
22,1039
0 
-46,82841 41,60034 
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ZE
RO 
Equal 
variances not 
assumed 
  
-
0,104 
31,13
4 
,918 -
2,61404 
25,2039
0 
-54,000879 48,78072 
	
Tab	 29	 T-student	 and	 comparative	 analysis	 of	 crevicular	 Hp	 loads	 and	 UBT	 at	
time	0	
	
However,	the	Chi-square	test	between	UBT	and	Hp	load	in	crevicular	fluid,	
showed	a	statistically	significant	value(	P=0,027),	differently	from	t-student	
result:	
contingency table ORALPAROPOSNEG*BTZERO 
 BTZERO Total 
,00 1,00 
ORAL
PARO
POSN
EG 
 ,00 16 17 33 
 1,00 22 7 29 
TOTAL  38 24 62 
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bacterium	load	
	
	
The	meaning	of	this	last	result	seems	to	be	paradoxically	inverted:		patients	with	
a	positive	periodontal	load	of	Hp		are	those	with	a	negative	BT	at	time	0.	
This	could	indicate	that	the	H.pylori	in	the	mouth	may	play	a	protective	role	
chi-square ORALPAROPOSNEG *BTZERO 
 Valore df Asynt Sig.. 
(2 ways) 
Exact. Sig. 
(2 ways) 
Exact. Sig. 
(1 way) 
Pearson’s Chi-square 4,876a 1 ,027   
Continuity correction 3,791 1 ,052   
Likelihood ratio 4,990 1 ,026   
Fisher exact test    ,037 ,025 
Lin-lin association 4,798 1 ,028   
Valid cases 62     
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against	the	stomach	reinfection	or	this	significant	value	is	due	to	the	case	without	
any	correlation	to	explain	it.	At	the	moment	it	is	not	possible	to	
confirm	with	certainty	one	of	these	hypotheses;	it	could	be	done	by	a	prospective	
analysis	of	the	patients.	
	
Considering	periodontal	conditions,		in	beta	group	data	showed	again	the	absence	
of	a	significant	correlation	between	periodontal	pocket	depth	and	BT	results	at	
time	0	(P=0,191	considering	average	pocket	depth	and	P=0,806	considering	
maximum	pocket	depth).	
	
Similarly,	the	absence	of	a	stastisically	significant	correlation	between	BT	results	
and	sex	(P=0,126)	and	between	BT		and	smoking	habits	(P=0,550)	was	confirmed	
also	in	beta	group.	
	
Considering	gastrointestinal	symptoms,	the	chi-square	test,	comparing	
gastrointestinal	symptoms	with	BT	results,	showed	the	abscence	of	a	valid	
correlation	(P=0,702),	differently	from	the	alpha	group.	
	
	
	
Current	Helicobacter	pylori	infection	(Time	“0”	analysis):	
	
The	aim	of	this	second	statistical	analysis	is	to	compare	BT	results	performed	at	
time	 0	 	 with	 the	 current	 periodontal	 condition,	 without	 considering	 patients’	
history	of	previous	infection.	
	
In	 order	 to	 reduce	 possible	 byas	 a	 specific	 preliminary	 statistical	 analysis	 was	
performed:	
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- Age:	A	quantitative	statistical	T-Student	test	was	conducted	to	exclude	the	
role	of	age	in	BT	results.		A	value	of	P=0,125	confirmed	the	absence	of	such	
a	correlation.	
- Sex:	chi-square	test	was	conducted	to	exclude	the	role	of	sex	in	BT	results.		
A	value	of	P=0,176	confirmed	the	absence	of	such	a	correlation.	
- Smoking	 habits:	 chi-square	 test	 was	 conducted	 to	 exclude	 the	 role	 of	
smoking	habits	in	BT	results.		A	value	of	P=0,199	confirmed	the	absence	of	
such	a	correlation.	
- Professional	 oral	 hygene	 procedures:	 T-Student	 test	 was	 conducted	 to	
exclude	 the	 role	 of	 Professional	 oral	 hygene	 procedures	 in	 BT	 results;	 in	
particular	BT	data	were	 compared	with	number	of	months	 	 elapsed	 from	
the	 last	oral	hygene.	 	A	value	of	P=0,798	confirmed	 the	absence	of	 such	a	
correlation.	
- Home	oral	hygene	proedures:	T-Student	test	was	conducted	to	exclude	the	
role	 of	 Home	 oral	 hygene	 procedures	 in	 BT	 results.	 	 A	 value	 of	 P=0,985	
confirmed	the	absence	of	such	a	correlation.	
- Previous	 BT:	 chi-square	 test	 was	 conducted	 to	 evaluate	 a	 correlation	
between	results	of	BT	performed	at	time	-1	with	those	of	BT	performed	at	
time	0.	A	value	of	P=0,529	confirmed	the	absence	of	such	a	correlation.	
- Gastrointestinal	 symptoms:	 chi-square	 test	 was	 conducted	 to	 evaluate	 a	
correlation	 between	 gastrointestinal	 symptoms,	 reported	 by	 the	 patients,	
and	BT	 results.	During	 the	 visit,	 only	14	patients	 reported	 the	 absence	of	
symptoms,	while	88	patients	resulted	symptomatic.	Of	the	88	symptomatic	
patients,	33	showed	a	positive	C-UBT,	while	the	55	a	negative	one.	Of	the	14	
asymptomatic	patients	9	were	positive	for	C-UBt	and	only	5	negative.	
	
	
contingency table SYMPTOMS*BTZERO 
 BTZERO Total 
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,00 1,00 
SYMP
TOMS 
 ,00 5 9 14 
 1,00 55 33 88 
TOTAL  60 42 102 
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ntingency	table	and	Chi-square	test	between	UBT	at	time	0	and	symptoms	
	
	
The	result	was	a	value	of	P=0,059	(near	 to	0,05	 limit).	Similarly	 to	 the	previous	
analysis	at	time	-1,	the	reported	symptoms	are	almost	reliable.	
	
1	-	Microbiological	Analysis	-	Breath	Test,	Salivary	and	Periodontal	analysis:	in	this	
case	the	aim	was	to	compare	the	bacterial	load	of	Hp	in	the	oral	cavity	(saliva	and	
crevicular	fluid,	both	collected	at	time	0)	with	time	0	BT	results	(60	negative	and	
42	positive	at	UBT	at	time	0).		
Firstly,	 T-Student	 test	 was	 performed	 comparing	 the	 prescence	 of	 Hp	 in	 saliva	
(detected	at	time	0)	and	the	results	of	the	BT	(performed	at	time	0).	
	
	
	
	
T-student independent variable BT and HPSALIVA Time 0 
 BTZERO N Mean St deviation St error mean 
chi-square SYMPTOMS *BTZERO 
 Valore df Asynt Sig.. 
(2 ways) 
Exact. Sig. 
(2 ways) 
Exact. Sig. 
(1 way) 
Pearson’s Chi-square 3,578 1 ,059   
Continuity correction 2,557 1 ,110   
Likelihood ratio 3,525 1 ,060   
Fisher exact test    ,080 ,056 
Lin-lin association 3,543 1 ,060   
Valid cases 102     
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HPSALIV
AZERO 
NEG 60 11,8500 18,62095 2,40395 
POS 42 10,0476 18,01348 2,77954 
	
 Levene’s Test T-test 
F Sig. t df Sig. (2-
tailed) 
Mean 
differen
ce 
Std Error 
differenc
e 
Confidence 
interval 
Lower Upper 
HP
SA
LIV
AZ
ER
O 
Equal 
variances 
assumed 
,000 ,995 ,488 100 ,627 1,80238 3,69667 -5,53171 9,13647 
Equal 
variances not 
assumed 
  
,490 90,20
4 
,625 1,80238 3,67489 -5,49821 9,10297 
	
Tab.	32	T-student	and	comparative	analysis	of	salivary	values	and	UBT	at	time	0	
	
The	 result	 is	 P=0.627	 ,	 i.e.	 there	 is	 no	 statistical	 difference	 with	 regard	 to	 the	
presence	of	Hp	in	saliva	and	BT	test	performed	at	time	0.	
In	order	to	confirm	this	data,	a	Chi-Square	test	has	performed:		
	
contingency table ORALSALIVAPOSNEG*BTZERO 
 BTZERO Total 
,00 1,00 
ORALS
ALIVAP
OSNEG 
 ,00 37 30 67 
 1,00 23 12 35 
TOTAL  60 42 102 
chi-square ORALSALIVAPOSNEG *BTZERO 
 Valore df Asynt Sig.. 
(2 ways) 
Exact. Sig. 
(2 ways) 
Exact. Sig. 
(1 way) 
Pearson’s Chi-square 1,045a 1 ,307   
Continuity correction ,656 1 ,418   
Likelihood ratio 1,056 1 ,304   
Fisher exact test    ,397 ,209 
Lin-lin association 1,034 1 ,309   
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Tab.	33	Contingency	table	and	Chi-square	test	between	UBT	at	time	0	and	salivary	
bacterial	load	
	
In	this	case	P=	0,	307,	so	it	 is	confirmed	that	there	is	not	a	stastically	significant	
difference	between	the	two	groups.			
	
The	 same	 analysis	 was	 performed	 on	 crevicular	 fluid	 samples,	 collected	 from	
periodontal	pockets.	
T-student	 test,	 with	 a	 P=0,701,	 showed	 that	 there	 is	 no	 statistically	 significant	
difference	 between	 the	 periodontal	 load	 of	 Helicobacter	 pylori	 and	 the	 Breath	
Test	performed	at	time	0	in	all	patients.	
Again	 a	 qualitative	Chi-Square	 test	 	was	performed:	 in	 this	 case,	 as	 occurred	 in	
time	-1	analysis,	a	significative	value	of	P=0,008	was	achived.	
	
2-	Periodontal	Analysis	–	Gastric	Helicobacter	pylori	and	Periodontal	Pockets:		
	
Similarly	to	the	previous	analysis,	a	Chi-Square	test	was	conducted	comparing	the	
presence	or	absence	of	periodontal	disease	(	based	on	the	average	periodontal	
pocket	depth)	with	the	result	of	the	Breath	Test	at	time	0,	in	all	patients:	the	
result	was	P=0,859.	
	
Furthermore,	a	Chi-Square	test	was	conducted	comparing	the	presence	or	
absence	of	periodontal	disease	(this	time	based	on	the	maximum	periodontal	
pocket	depth)	with	the	result	of	the	Breath	Test	at	time	0:	the	result	was	P=0,675.		
So	in	both	cases	there	is	no	stastistically	significant	difference	between	BT	results	
and	periodontal	disease	(represented	by	periodontal	pocket	depth).	
	
Valid cases 102     
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3-	Oral	mouth	Analysis	-Oral	Helicobacter	pylori	and	Periodontal	Pockets	depth:		
	
In	 this	 further	 statistical	 analysis	 the	 goal	 was	 to	 evaluate	 the	 relationship	
between	 periodontal	 conditions	 and	 the	 oral	 load	 of	 H.pylori,	 particularly	
referring	 to	 pocket	 depth.	 First	 of	 all,	 a	 statistical	 comparison	 (t-student)	 was	
made	 between	 the	 average	 value	 of	 bacterial	 load	 of	 Hp	 in	 the	 periodontium,	
measured	at	time	0,	with	average	pocket	depth	(the	cut-off	value	for	periodontal	
disease	was	an	average	pocket	depth	>/=	4mm).	Among	all	102	patients	analysed,	
33	were	positive	for	periodontal	disease	and	69	negative.	Of	the	33	patients	with	
periodontal	 disease	 19	 resulted	 positive	 for	 periodontal	 Hp	 infection	 (14	were	
negative);	 of	 the	 69	 patients	 without	 periodontal	 disease,	 31	 resulted	 infected	
with	Hp	(38	were	negative).	
	
 
T-student independent variable BT and HPMEAN Time 0 
 
MALATTIA
PARO 
N Mean St deviation St error mean 
HPMEAN
ZERO 
NEG 69 17,2754 33,33162 4,012265 
POS 33 53,5455 108,98942 18,97262 
	
	
 Levene’s Test T-test 
F Sig. t df Sig. (2-
tailed) 
Mean 
differen
ce 
Std Error 
differenc
e 
Confidence 
interval 
Lower Upper 
HP
ME
AN
ZE
RO 
Equal 
variances 
assumed 
15,231 ,000 -
2,539 
100 ,013 -
36,2700
9 
14,2870
3 
-64,61515 -7,92504 
Equal 
variances not 
assumed 
  
-
1,870 
34,89
4 
,070 -
36,2700
9 
19,3923
1 
-75,64286 3,10267 
	
Tab	 34	 T-student	 and	 comparative	 analysis	 of	 crevicular	Hp	 loads	 and	 average	
pocket	depth	
	 150	
	
The	 result	 would	 be	 significant	 (P=0.013),	 however,	 considering	 correction	 of	
ANOVA,	a	value	of	P=0.070	is	achived	;	it	is	no	longer	significant	but	very	close	to	
the	significance	limit	which	is	0.050.	
Nevertheless,	it	is	possible	to	observe	that	the	average	Hp	load	in	the	patients	
who	have	periodontal	disease	is	53.54,	while	that	of	patients	without	periodontal	
disease	is	17.27;	therefore	there	is	a	high	difference,	showing	how	Hp	is	related	to	
the	presence	of	disease.	So	patients	with	pockets	deeper	than	4mm	(i.e.	patients	
with	periodontal	disease)	show	higher	loads	of		Hp	than	those	with	healty	gums.	
	
To	confirm	this	evaluation,	a	Chi	square	test	was	performed:	the	result	of	the	test	
was:	P=0,232.	
Proportionally	to	periodontal	pockets	depth	,H.pylori	load	increases	its	value	and	
this	area	becomes	a	reservoir	for	the	micrornganism.	
	
	Finally,	a	statistical	comparison	(t-student)	was	made	between	the	average	value	
of	bacterial	 load	of	Hp	in	the	periodontium,	measured	at	time	0,	with	maximum	
pocket	depth:	a	significant	result	(P=0,004)	was	again	achived,	so	the	deeper	is	a	
periodontal	pocket	,	the	higher	is	Hp	load	in	that	area.	
 
T-student independent variable Time 0 
 MPMAX N Mean St deviation St error mean 
HPMEAN
ZERO 
NEG 29 8,8621 8,30544 1,54228 
POS 73 37,0137 80,50647 9,42257 
	
	
 Levene’s Test T-test 
F Sig. t df Sig. (2-
tailed) 
Mean 
differen
ce 
Std Error 
differenc
e 
Confidence 
interval 
Lower Upper 
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HP
ME
AN
ZE
RO 
Equal 
variances 
assumed 
8,043 ,006 -
1,874 
100 ,064 -
28,1516
3 
15,0256
6 
-57,96211 1,65885 
Equal 
variances not 
assumed 
  
-
2,948 
75,77
0 
,004 -
28,1516
3 
9,54796 -47,16986 -9,13429 
	
	
Tab	35	T-student	and	comparative	analysis	of	crevicular	Hp	loads	and	maximum	
pocket	depth	
	
	
	
	
4-	Periodontal	Analysis	-	Helicobacter	pylori	and	Saliva:		
In	 this	 analysis	 the	 average	 bacterial	 load	 of	 Hp	 in	 the	 periodontium	 was	
compared	to	the	load	detected	in	saliva.		
	
 
 
ORALPAR
OPOSNEG 
N Mean St deviation St error mean 
HPSALIV
AZERO 
NEG 52 4,7500 7,79360 1,08078 
POS 50 17,7200 23,23618 3,28609 
 Levene’s Test T-test 
F Sig. t df Sig. (2-
tailed) 
Mean 
differen
ce 
Std Error 
differenc
e 
Confidence 
interval 
Lower Upper 
HP
ME
AN
ZE
RO 
Equal 
variances 
assumed 
21,898 ,000 -
3,809 
100 ,000 -
12,9700
0 
3,40502 -19,72547 -6,21453 
Equal 
variances not 
assumed 
  
-
3,749 
59,50
5 
,000 -
12,9700
0 
3,45926 -19,89073 -6,04927 
	
Tab	36	T-student	and	comparative	analysis	of	crevicular	and	salivary	Hp	loads	
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The	result	was	P=0.000.	So	the	higher	 is	 the	bacterial	 load	 in	periodontum	 ,	 the	
higher	 it	 is	 in	 saliva.	 Hp	 can	 move	 from	 periodontum	 to	 the	 saliva,	 and,	 from	
there,	it	can	reach	the	stomach	by	swallowing.	
In	order	to	confirm	the	data	a	Chi-Square	test,	was	performed	(the	cut	off	value	
for	bacterial	load	was	10U):	
	
contingency table ORALSALIVAPOSNEG*ORALPAROPOSNEG 
 BTZERO Total 
,00 1,00 
ORALS
ALIVAP
OSNEG 
 ,00 42 25 67 
 1,00 10 25 35 
TOTAL  52 50 102 
	 	
	
Ta
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ncy	table	and	Chi-square	test	between	crevicular	and	salivary	Hp	loads	
	
The	result	is	confirmed:	P=0,001.	
	
	
Phase	2	
	
At	 the	 moment	 17	 patients	 has	 been	 recalled	 and	 divided	 into	 the	 groups:	 11	
patients	(4	males	and	7	females)	were	inserted	in	Group	2		(BT	negative	and	Oral	
chi-square ORALSALIVAPOSNEG * ORALPAROPOSNEG 
 Valore df Asynt Sig.. 
(2 ways) 
Exact. Sig. 
(2 ways) 
Exact. Sig. 
(1 way) 
Pearson’s Chi-square 10,707 1 ,001   
Continuity correction 9,385 1 ,002   
Likelihood ratio 10,963 1 ,001   
Fisher exact test    ,002 ,001 
Lin-lin association 10,602 1 ,001   
Valid cases 102     
	 153	
Hp	negative)	while	6	patients	 (1	male	and	5	 females)	were	 inserted	 in	Group	1	
(BT	negative	and	Oral	Hp	positive).	
The	total	average	age	of	the	17	patients	is	56	years,	with	a	minimum	value	of		37	
and	a	maximum	of	56	years.	
The	 average	 age	of	 group	1	 is	51	years,	while	 the	 avergae	 age	of	 group	2	 is	59	
years.	
All	 patients	 had	 	 a	 negative	 result	 at	 UBT,	 performed	 at	 time	 0.	 All	 of	 them	
underwent	a	professional	oral	hygene	procedure	between	phase	1	and	2.	
UBT	was	repeated	at	time	1	(second	phase):	one	patient	of	group	1	had	a	positive	
result	while	all	the	other	had	a	negative	result.	
Periodontal	 analysis	 were	 repeated	 at	 time	 1	 in	 saliva	 and	 crevicular	 fluid:	 6	
patients	resulted	positive	for	the	presence	of	Hp	in	the	saliva	(average	load	
higher	than	10U)	and	11	negative.	On	the	other	hand	10	patients	resulted	positive	
for	the	presence	of	Hp	in	the	crevicular	fluid	(average	load	higher	than	10U)	and	7	
negative.	
A	 chi-square	 test	 was	 performed	 to	 compare	 Hp	 load	 in	 saliva	 and	 crevicular	
fluid:	
	
	
contingency table SALIVAPOSNEGUNO*PAROPOSNEG 
 BTZERO Total 
,00 1,00 
ORALS
ALIVAP
OSNEG 
 ,00 7 4 11 
 1,00 0 6 6 
TOTAL  7 10 17 
 
 Valore df Asynt Sig.. 
(2 ways) 
Exact. Sig. 
(2 ways) 
Exact. Sig. 
(1 way) 
Pearson’s Chi-square 6,491 1 ,011   
Continuity correction 4,129 1 ,042   
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Tab
.	 38	 Contingency	 table	 and	 Chi-square	 test	 between	 salivary	 and	 crevicular	 Hp	
loads	at	time	1	
	
The	presence	of	a	significat	correlation	between	Hp	load	in	saliva	and	crevicular	
fluid	is	confirmed	at	the	moment	(P=0,011).	
	
	
	
	
	
	
	
	
	
	
	
	
This	 study	 represents	 a	 preliminary	 approach	 on	 the	 role	 of	 oral	Helicobacter	
pylori	(present	in	saliva	and	periodontal	pockets)	in	gastric	infection.	
The	 real	 problem	 with	 this	 infection	 is	 the	 high	 rate	 of	 relapse,	 despite	
eradication	 protocols,	 as	 confirmed	 by	 a	 second	 Breath	 Test,	 performed	 some	
months	after	the	antimicrobical	therapy.	
It	is	estimated	that	infection	with	Helicobacter	pylori,	the	main	cause	of	gastritis	
and	peptic	ulcer,	affects	about	50%	of	the	world's	population.	
The	 oral	 cavity	 could	 represents	 a	 reservoir	 of	 the	 bacterium,	 providing	 an	
optimal	 environment	 for	 its	 proliferation	 and	 protection	 against	 specific	
antibiotic	therapies.	
This	 study	 was	 conducted	 in	 order	 to	 evaluate	 the	 role	 of	 H.pylori	 in	 the	 oral	
cavity	and	its	relationship	with	gastric	infection	recurrence.	
The	study	was	structured	in	two	phases	of	research,	one	descriptive	(Phase	1)	
Likelihood ratio 8,614 1 ,003   
Fisher exact test    ,035 ,017 
Lin-lin association 6,109 1 ,013   
Valid cases 17     
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followed	by	a	perspective	(Phase	2).	
102	patients	were	recruited:	medical	history	data	were	registered,	a	Breath	Test	
was	performed,		saliva	and	crevicular	fluid	sampes	were	collected.	
The	statistical	evaluation	of	the	results	was	divided	into	3	stages:	
- time	-1,	on	the	base	of	anamnesis	reported	by	patients(	regarding	previous	
experience	of	gastric	H.pylori	infection	and	C-UBT	at	time	-1)		
- time	0:	that	is	the	moment	when	this	study	began:	C-UBT	and	oral	sampling	
was	performed	(both	at	time	0).	
- time	1,	which	corresponds	 to	 the	prospective	phase	of	 the	study:	selected	
patients	were	 recalled	 and	 another	 C-UBT	 and	 periodontal	 sampling	was	
performed	(both	at	time	1).	
	
Time	-1:	
In	this	first	phase	evaluations	were	performed	on	the	base	of	medical	history:	
102	recruited	patients	recruited	were	divided	into	two	groups	according	to	their	
previous	infection	by	Helicobacter	pylori	.		
62	patients	reported	a	positive	history	of	gastric	infection	(BT	performed	at	time	-
1	was	positive)and	 they	were	all	 treated	with	eradication	 therapy;	on	 the	other	
hand	40	patients	reported	a	negative	history	of	infection.	
Among	the	patients	without	a	history	of	previous	Hp	infection	some	of	them	had	a	
negative	result	in	UBT	performed	at	time	-1,	others	never	needed	to	undergo	the	
test.		
Among	the	62	patients	with	a	positive	history	of	Hp	infection,		38	are	healty	at	the	
moment	when	this	study	began	(according	to	BT	result	executed	at	time	0	),	while	
24	 remained	 positive	 despite	 the	 eradication	 therapy.	 The	 infection	 rate	 is	
38,71%	in	the	first	group	and	45%	in	the	other.	It	was	possibile	to	verify	that	the	
current	 BT	 result	 (time	 0)	 is	 not	 conditioned	 by	 the	 prior	 infection	 with	 Hp	
(P=0,529).	
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The	 objective	 of	 the	 preliminary	 phase	 of	 the	 study	 is	 to	 find	 out	 if	 there	 is	 a	
difference	 in	 medical	 history	 of	 patients	 and	 evaluate	 the	 effectiveness	 of	 the	
therapy,	with	regards	to	periodontal	conditions.	
In	 the	group	of	62	patients	with	previous	H.pylori	 infection	(called	beta	group),	
there	were	no	significant	differences	between	BT	results	and	the	presence	of	Hp	
in	 the	 saliva	 (P=0.650,	 P=0.409),	 the	 presence	 of	 Hp	 in	 the	 periodontium	 (T-
student	 P=0.906),	 the	 presence	 of	 periodontal	 disease	 (pockets	 >/=	 4mm,	 MP	
mean	P=0.191,	MP	max	P=0.806)	and	the	anamnestic	components	(sex	P=0.126	
and	 smoking	 P=0.550).	 Actually,	 to	 be	 precise,	 one	 difference	was	 found	 (	 Chi-
Square	test),	between	BT	and	the	presence	of	Hp	in	the	periodontium	(P=0,027)	
but	 this	 results	 has	 an	 inverse	 meaning:	 patients	 with	 positive	 Hp	 loads	 in	
periodontum	showed	a	negative	BT	result	at	time	0.	The	meaning	of	this	data	has	
to	 be	 investigated	 in	 the	perspective	 phase	 of	 the	 study,	 in	 order	 to	 clarify	 if	 it	
may	be	due	to	chance	or	the	oral	presence	of	bacterium	can	play	a	preventive	role	
against	gastric	reinfection.	
In	 the	 group	 of	 the	 40	 patients	 with	 a	 negative	 history	 of	 Hp	 infection	 (alpha	
group)	 ,	 22	 remained	 negative	 and	 18	 became	 positive,	 according	 to	 BT	
performed	at	time	0.	
In	 this	 group	 there	were	 no	 significant	 differences	 between	 BT	 results	 and	 the	
presence	of	Hp	 in	 the	 saliva	 (P=0.850,	P=0.564),	 in	 the	periodontium	 (P=0,168,	
P=0,119),	 the	 presence	 of	 periodontal	 disease	 (pockets	 >/=	 4mm,	 MP	 mean	
P=0.131,	 MP	max	 P=0.332)	 and	 the	 anamnestic	 components	 (sex	 P=0,676	 and	
smoking	P=0.247).	However	it	should	be	considered	the	difference	between	PCR	
and	UBT	methods,	not	allowing	to	detect	a	proper	causal	determination	(see	the	
following	“time	0”	paragrapgh	considerations	about	this	topic).	
	
Looking	 exclusively	 at	 the	 oral	 mouth	 	 it	 was	 not	 possible	 to	 compare	 the	
conditions	at	time	-1	with	those	at	time	0,	since	we	did	not	have	the	data	of	the	
periodontal	initial	situation	(at	time-1).	
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The	 most	 intresting	 conclusions	 of	 this	 part	 of	 the	 analysis	 concerned	
gastrointestinal	symptoms	reported	by	patients.	
Considering	all	102	patients,	it	emerges	that	there	is	a	correspondence	(although	
not	 completely	 significant:	 P=0.059,	 this	 value	 is	 near	 to	 0,05	 cut	 off)	 between	
symptoms	 reported	 and	 clinical	 situation.	 However	 the	 symptoms	 become	
completely	 reliable	 (P=0.008)	 in	 patients	 with	 negative	 history	 of	 Hp	 infection	
and	 current	 positive	 BT	 (BT-1	 negative	 and	 BT	 0	 positive);	 on	 the	 contrary	 a	
value	of	P=0.702resulted	in	patients	positive	both	at	UBT	at	time	-1	and	at	time	0.	
So	symptoms	are	useful	for	diagnostic	purposes	only	in	patients	who	developed	a	
infection	 for	 the	 first	 time,	 passing	 from	 a	 situation	 of	 health	 to	 one	 of	 disease	
(from	BT-1	negative	 to	BT0	positive):	before	 the	symptom	was	not	present	and	
then	appears,	therefore	it	corresponds	to	the	clinical	reality.	
On	 the	 other	 hand,	 the	 symptoms	 have	 no	meaning	 in	monitoring	 the	 therapy	
against	the	Hp,	because	patients	with	a	positive	history	for	gastric	infection,	who	
managed	 to	 eradicate	 the	 infection,	 sometimes	 keep	 on	 beeing	 symptomatic	 ,		
even	though	the	infection	is	absent.		
So	 if	 a	 patient	 develops	 an	 infection	 for	 the	 first	 time	 or	 gets	 sick	 again	 the	
symptoms	have	a	clear	meaning,	but	if	the	patient	had	already	the	infection,	the	
symptoms	do	not	indicate	whether	or	not	he/she	is	still	ill.	
That	is	why	the	only	way	to	evaluate	the	effectiveness	of	an	eradicating	therapy	is	
the	C-UBT.	
This	 situation	 partially	 explains	 why	 so	 many	 gastroprotectors	 are	 prescribed	
even	in	patients	who	do	not	have	the	infection.		
	
Time	0:	
The	aim	of	second	part	of	the	statistical	analysis	 is	the	evaluation	of	the	current	
situation	(at	time	0),	both	in	the	stomach	and	in	the	oral	mouth,	and	of	the	role	of	
Hp	in	periodontal	disease.	A	preliminar	specific	statistical	analysis,	conducted	to	
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reduce	byas,	states	that	previous	Hp	infection	(P=0,529),	eradication	therapy,	age	
(P=0,125)	 ,sex	 (P=0,798),	 smoking	 habits	 (P=0,199),	 drugs	 (exclusion	 criteria),		
professional	 oral	 hygene	 procedures	 (P=0,798),	 home	 oral	 hygene	 procedures	
(P=0,985)	do	not	influence	the	result	of	this	part	of	the	study.	
Firstly,	the	presence	of	Hp	in	saliva	was	compared	with	the	result	of	BT	in	the	two	
groups	(BT+	and	BT-)	showing	the	absence	of	a	significant	correlation,	according	
to	T-Student	test	(P=0.627)	and	Chi-Square	test	(P=0.307).	
The	same	analysis	was	performed	considering	Hp	loads	in	crevicular	fluid	
	(T-student	 P=0.701).	 However,	 similarly	 to	 time	 -1	 analysys,	 a	 significant	
correlation	(according	to	Chi-square:	P=0,008)	between	Hp	loads	in	periodontum	
and	 BT	 results	 at	 time	 0	 is	 confirmed.	 This	 significance,	 in	 reverse	 relation,	
between	 periodontal	 infection	 by	 Hp	 and	 gastric	 infection	 could	 be	 again	
interpreted	 in	 this	 way:	 the	 presence	 of	 the	 bacterium	 in	 periodontal	 pockets	
might	prevent	a	gastric	infection.	
In	order	to	have	a	confirmation	of	this	thesis	it	is	necessary	to	wait	for	the	results	
of	the	second	phase	of	the	study.	
It	 should	 be	 considered	 that	 Urea	 Breath	 test	 and	 PCR-RT	 are	 two	 different	
methods	of	bacterial	detection,	with	differents	specificity	and	sensitivity.	
The	UBT	measures	of	 the	urease	activity	 and	discriminates	 among	positive	 and	
negative	 results	 (in	 a	 dicotomic	 way),	 while	 PCR-RT	 is	 quantitatively	 more	
accurate	in	detecting	bacterial	 loads;	however	this	 last	method	requires	a	direct	
prelevation	of	the	fluid	nearby	the	bacterium	reservoir.		This	procedure	could	be	
invasive	in	the	stomach	due	to	the	necessity	of	esophago-gastro-duodenoscopy.	
For	 this	 reason	 a	 less	 invasive,	 but	 equally	 effective,	 diagnostic	 examination	 as	
UBT	it	 is	preferred	for	the	diagnosis	and	follw-up	of	gastric	 infection,	but	 in	the	
oral	cavity	 	PCR	analysis	 	 is	 the	most	suitable	and	predictable	 technique	 for	 the	
detection	of	a	specific	bacterium.	
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The	detection	of	an	infection	in	the	stomach	and	in	the	oral	mouth	with	different	
methods	 does	 not	 allow	 to	 effectuate	 a	 causal	 determination	 (similarly	 to	 the	
situation	in	time	-1	analysis),	as	emerged	from	Navabi’s	review.	[95]	
	
Then	the	periodontal	condition,	defined	according	to	the	“mean”	and	“maximum”	
periodontal	 pockets	 depth	 values	 of	 all	 102	 patients,	 was	 compared	 with	 UBT	
results	 at	 time	 0,	 in	 order	 to	 	 evaluate	 whether	 the	 presence	 of	 periodontal	
disease	 (average	 or	maximum	 pocket	 depth	 >/=	 4mm)	may	 play	 a	 key	 role	 in	
gastric	infection.	
The	 comparison	between	UBT	 results	 and	periodontal	 disease	does	not	 show	a	
significant	 correlation	 (P=0.859	 for	 mean	 depth	 and	 P=0,675	 for	 maximum	
depth);	however	 if	we	compare	the	load	of	Hp	in	periodontum	with	periodontal	
pocket	depth	a	significant	P	value	of	0,013	is	obtained.	
This	means	that	patients	who	have	an	average	pocket	depth	of	more	than	4mm	
(therefore	periodontal	disease),	showed	higher	loads	of	Hp	in	periodontum	than	
patients	with	healty	gums.	
In	confirmation	of	that,	a	significant	relationship	between	the	average	Hp	load		in	
periodontum	and	 the	maximum	periodontal	pocket	depth	(P=0.004)	was	 found.	
As	the	periodontal	pockets	become	deeper,	they	represent	a	real	reservoir	for	this	
bacterium	and	an	association	of	the	presence	of	Hp	in	stomach	and	oral	mouth	is	
likely	as	Czesnikiewicz-Guzik	and	Karczewska	found	out.	[96]	
Finally	 it	was	found	that	the	 load	of	Hp	in	saliva	 increases	proportionally	to	the	
periodontal	 load	(t-student,	P=0.000);	a	confirmation	came	form	chi-sqaure	 test	
performed	comparing	Hp	loads	in	saliva	and	crevicular	fluid	(P=0,001).	
In	 the	 pockets,	 the	 bacterium	 can	 proliferate	 in	 favourable	 conditions,	 slipping	
away	from	human	immune	system	surveillance;	once	a	periodontal	reservoir	has	
been	 created	 and	 a	 sufficent	 load	 is	 reached,	 Hp	 can	migrate	 from	 the	 gingival	
sulcus	into	the	oral	cavity	and	it	is	distributed	in	the	saliva.	
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Considering	that	the	saliva	is	swallowed	and	goes	down	into	the	stomach,	the	oral	
cavity,	in	particular	periodontal	pockets,	can	represent	an	extra-gastric		reservoir	
of	 Helicobacter	 pylori	 and	 this	 can	 be	 one	 of	 the	 main	 causes	 of	 gastric	
reinfection.	A	direct	causality	has	to	be	evaluated	in	the	second	phase	of	the	study	
but,	at	the	moment,	we	can	exclude	the	hypotesis	of	a	possibile	retrograde	path	of	
the	Hp	from	the	stomach	to	the	oral	cavity	by	means	of	gastroesophageal	reflux,	
as	was	said	in	literature	by	some	authors	[90].	
	
Time	1:	
In	the	second	phase	of	the	study,	we	moved	from	a	descriptive	evaluation	of	the	
condition	 to	 a	 prospective	 one,	 aiming	 again	 to	 evaluate	 the	 role	 of	 H.pylori	 in	
gastric	 reinfections	 and	 trying	 to	 find	out	 if	 oral	hygene	procedures	 can	 reduce	
the	relapse	retes.	
If	patients	with	gastric	recurrence	can	be	statistically	associated	with	an	increase	
load	of	oral	Helicobacter	pylori,	 it	will	be	possible	 to	 confirm	a	new	key	 role	of	
periodontum	in	human	health.	
Some	of	the	102	patients	were	selected	on	the	base	of		the	results	obtained	from	
the	time	0	Breath	Test	and	salivary	sampling;	between	oral	 fluids,	 	saliva	rather	
then	crevicular	 fluid	was	 chosen	as	 fundamental	parameter	 to	be	 considered	 in	
the	 choice	 of	 recruited	 patients,	 since	 it	 is	 exacty	 this	 fluid	 that	 can	 reach	 the	
stomach	 by	 swallowing,	 causing	 a	 possible	 relapse	 of	 the	 disease;	 in	 addition	
peridodontal	 Hp	 load	 has	 been	 demostrated	 to	 be	 proportional	 to	 salivary	 Hp	
load	in	the	“time	0	analysis”.		
So,	 on	 the	 base	 of	 these	 data,	 patients	 were	 divided	 into	 two	 groups:	 group	 1	
included	23	patients	with	negative	UBT	(time	0)	and	positive	Hp	 loads	 in	saliva	
examination	 (performed	 at	 time	 0);	 group	 2	 (the	 Control	 Group)	 involves	 37	
Naive	 patients:	 they	 had	 	 negative	 results	 in	 both	 the	 oral	 cavity	 and	 in	 the	
stomach	regarding	infection	with	Helicobacter	pylori	at	time	0.	
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These	patients	were	included	in	a	recall	program	in	order	to	perform	a	second	BT	
(time	1)	and	a	new	collection	of	oral	 fluids	samples	 	 (both	saliva	and	crevicular	
fluida	at	 time	1).	Minimum	time	between	phase	1	and	2	 is	6	months.	Currently,	
this	 prospective	 phase	 of	 the	 study	 is	 at	 a	 preliminary	 stage;	 of	 the	 60	 patient	
considered	suitable,	based	on	the	results	of	 the	first	tests,	17	have	been	already	
recruited:	6	were	included	in	Group	1	and	11	in	Control	group.	A	cut	off	value	of	
10	U	of	Hp	detected	with	PCR-RT	was	chosen.	
A	professional	oral	hygene	performed	within	the	time	0	and	time	1	represents	an	
important	paramter	 in	order	 to	understand	 if	 this	procedure	can	reduce	gastric	
recurrence	 rates	by	 eliminating	 the	oral	 reservoir	of	 the	bacterium.	The	 results	
could	be	compared	with	Butt	and	Kahan	anlysis.[97]	
If	 gastric	 recrudescence	was	 reduced	 by	 a	 proper	 periodontal	 therapy	 (scaling,	
rooth	 planing,	 etc.),	 then	 these	 oral	 procedures	 could	 be	 associated	 with	
conventional	 antimicrobial	 theraphy	 in	 order	 to	 increase	 its	 effectiveness	 by	
removing	 extra-gastric	 bacterial	 reservoirs,	 aiming	 at	 reducing	 the	 problem	 of	
relapse.	This	could	determine	a	reduced	need	for	antibiotic	treatments,	with	less	
risks	for	the	patients	and	less	costs	for	the	National	Health	Service.	
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3.5	CONCLUSIONS	
 
The	results	of	this	research	project	have	confirmed		the	relationship	between	the	
oral	mouth		and	Helicobacter	pylori,	which	has	been	demostrated	to	be	present	in	
the	oral	 cavity	and	 is	not	 related	 to	gastro-esophageal	 reflux,	 like	some	authors	
adfirmed	 in	 the	 literature.	 In	 addition	 to	 gastric	 mucosa,	 this	 bacterium	 can	
colonize	 oral	 periodontum,	 expecially	 in	 patients	 suffering	 from	 periodontal	
disease.	This	 area	 represents	 a	 favourable	 enviroment	where	 the	microrganism	
can	replicate,	slipping	away	from	human	immune	system	surveillance.		The	more	
severe	are	oral	conditions,	the	higher	are	Helicobacter	pylori	loads.	Furthermore,	
from	this	extra-gastric	reservoir	the	pathogen	can	spread	within	saliva	and	reach	
the	 stomach	 during	 swallowing.	 Further	 anaysis	 in	 patients	 suffering	 from	 this	
oral	disease	but	negative	at	 gastric	Urea-Breath	Test,	 started	 in	 the	perspective	
phase	 of	 the	 current	 research,	 may	 lead	 to	 the	 discovery	 of	 a	 direct	 causal	
relationship	between	oral	microbiota	and	gastric	infection	recurrence	and	to	the	
evaluation	 of	 the	 role	 of	 	 preventive	 oral	 hygene	 procedures	 .	 From	 this	
perspective	 the	 manteinance	 of	 oral	 health	 and	 professional	 oral	 hygene	
procedures,	 combinable	 with	 standard	 eradication	 protocols,	 acquire	 greater	
importance,	 allowing	 to	 reduce	 the	 recurrence	 rate	 and	 the	widespread	 use	 of	
antibiotics,	with	less	side	effects	for	patients	and	less	costs	for	the	National	health	
Service.	
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4.	FINAL	CONSIDERATIONS	
	
Our	 results	 suggest	 that	 oral	 microbiota	 could	 paly	 an	 important	 role	 in	
gastrointestinal	 diseases	 like	 colorectal	 cancer	 and	 Helicobacter	 pylory	 gastric	
infection.		
Some	 oral	 bacteria	 have	 developed	 the	 ability	 to	 escape	 the	 host	 immune	
surveillance	and	to	induce	inflammatory	responses	leading	to	dangerous	systemic	
effects.		
Periodontitis	 represents	 a	 wide-spread	 common	 disease,	 caused	 by	 dangerous	
bacteria	 like	Fusobacterium	nucleatum	and	Helicobacter	pylori,	detected	in	high	
loads	in	pathological	gums	of	affected	patients.	This	conditions	is	charachterzied	
by	 the	presence	of	periodontal	pockets,	which	 represent	a	natural	 reservoir	 for	
these	 microrganism,	 where	 they	 can	 replicate	 away	 from	 immune	 system,	 be	
poured	into	saliva	and	finally	reach	the	stomach	and	the	intestine	by	swallowing.	
Thus	the	manteinance	of	good	oral	hygiene	could	be	essential	to	prevent	bacterial	
dissemination	 and	 profoessional	 oral	 procedures	 should	 be	 associated	 to	
standard	 medical	 protocols,	 in	 order	 to	 reduce	 risk	 of	 developing	 dangerous	
extra-oral	diseases.	
Further	 studies	 are	 needed	 to	 elucidate	 the	 specific	 role	 of	 these	 bacteria	 in	
systemic	health,	 in	 fact	new	virulence	mechanisms	and	components	continue	 to	
emerge,	even	from	well-known	oral	bacteria.	Only	when	a	clear	understanding	of	
oral	 bacterial	 mechanisms	 in	 extra-oral	 infections	 will	 be	 achived	 new	
multidisciplinary	effective		therapies	could	be	designed.	
	
	
	
	
	
	
	
	
	
	
	 164	
	
5. AKNOWLEDGMENTS	
	
First	 of	 all,	 I	would	 like	 to	 thank	Professor	Loredano	Pollegioni,	Director	 of	 the	
Doctoral	 Programme	of	Biotechnologies,	 Biosciences	 and	 Surgical	 Technologies,	
for	 the	 support	 during	my	 studies.	 A	 special	 thanks	 to	 Prof	 Paolo	 Castelnuovo,	
responsible	 for	 the	 doctoral	 surgical	 curriculum,	 and	 to	 Professor	 Lucia	
Tettamanti,	 Supervisor	 of	my	 scientific	 project	 and	 guide	 for	many	 years	 in	my	
studies,	my	work	and	my	life.		
Heartfelt	 thanks	 and	 gratitude	 are	 addressed	 to	 my	 master,	 Prof	 Angelo	
Tagliabue,	who	has	represented	a	guide	and	a	mentor	all	over	these	years.	Then,	I	
would	like	to	express	my	deep	gratitude	to	Dr	Sergio	Segato,	who	let	this	project	
become	 possible	 and	 to	 Daria,	 Irene	 and	 Anais	 for	 their	 constant	 application.	
Morover,	all	 the	analyses	performed	 in	this	study	would	not	have	been	possible	
without	the	aid	of	the	whole	staff	of	our	laboratory.		
A	special	thought	goes	to	Lorenzo	Azzi,	great	professional	doctor	and	true	friend,	
who	has	always	supported	my	work	and	to	all	my	friends	and	companions	in	the	
department:	Vittorio,	Fabio,	Marta	and	Alessandro.	
Moreover,	I	would	like	to	thank	all	my	friends	and	especially	my	family,	for	their	
tireless	support,	assistance,	love	and	trust.	
	
Finally,	I	would	like	to	dedicate	this	work	to	Professor	Aldo	Macchi,	director	of		
the	Dental	Clinic	of	Insubria	University,	passionate	teacher	and	tireless	dreamer,	
who	has	taught	me	that	“The	world	needs	dreamers	and	the	world	needs	doers.	
But	above	all,	the	world	needs	dreamers	who	do”.	
	
	
	
	
	 165	
6. BIBLIOGRAPHY	
	
1. Varoni	EM,	Federighi	V,	Decani	S,	Carrassi	A,	Lodi	G,	Sardella	A.	The	effect	of	
clinical	 setting	on	 the	unstimulated	salivary	 flow	rate.	Arch	Oral	Biol.	2016	
Sep;69:7-12		
2. Sreebny	LM,	Vissink	A.	Dry	Mouth:	the	malevolent	symptom:	a	clinical	guide.	
Ames,	Iowa:	Wiley-Blackwell	Ed.	2010	
3. Morales	 I,	 Domínguez	 P,	 López	 RO.	 Devices	 for	 saliva	 collection	 from	 the	
major	 salivary	 glands.	 Results	 in	 normal	 subjects.	 Rev	 Med	 Chil.	
1998;126(5):538-47	
4. Griffiths	GS.	 Formation,	 collection	 and	 significance	 of	 gingival	 crevice	 fluid.	
Periodontol	2000.	2003;	31:32–42.		
5. Salonen	JI,	Paunio	KU.	Scand	J	Dent	Res	.	An	intracrevicular	washing	method	
for	collection	of	crevicular	contents.	1991	Oct;99(5):406-12.	
6. Herbert	F.	Wolf;	Klaus	H.	Rateitschak	.	Periodontology.	Thieme.	2005.		
7. Schroeder	H.E.	Development,	Structure,	and	Function	of	Periodontal	Tissues.	
In:	The	Periodontium.	Handbook	of	Microscopic	Anatomy	 .	 vol	 5;	 Springer,	
Berlin,	Heidelberg.	1986	
8. Paster,	B.	J.,	S.	K.	Boches,	J.	L.	Galvin,	R.	E.	Ericson,	C.	N.	Lau,	V.	A.	Levanos,	A.	
Sahasrabudhe,	 and	F.	E.	Dewhirst.	Bacterial	diversity	 in	human	subgingival	
plaque.	J.	Bacteriol.	2001.	183:3770–3783	
9. Dewhirst,	 F.E.,	 Chen,	 T.,	 Izard,	 J,	 Paster,	 B.J.,	 Tanner,	 A.C.R.,	 Yu,	 W.-H.,	
Lakshmanan,	A.,	Wade,	W.G.	The	Human	Oral	Microbiome.	J.	Bacteriol.	2010;	
192:	5002-5017.	
10. Jenkinson,	H.	 F.,	 and	R.	 J.	 Lamont.	Oral	microbial	 communities	 in	 sickness	
and	in	health.	Trends	Microbiol.	2005;	13:589–595.	
11. Flemming	 H,	 Wingender	 J.	 The	 biofilm	 matrix.	 Nat	 Rev	 Microbiol.	
2010;8:623–633.	
	 166	
12. Socransky,	 S.	 ,	Haffajee,	A.	 ,	 Cugini,	M.	 ,	 Smith,	C.	 and	Kent,	R.	L.	Microbial	
complexes	in	subgingival	plaque.	Journal	of	Clinical	Periodontology.1998;	25:	
134-144.		
13. Do	T,	Devine	D,	Marsh	PD.	Oral	biofilms:	molecular	analysis,	challenges,	and	
future	prospects	in	dental	diagnostics.	Clin	Cosmet	Investig	Dent.	2013;5:11–
19.		
14. 1999	 International	Workshop	 for	 a	 Classification	 of	 Periodontal	 Diseases	
and	Conditions.	Papers.	Oak	Brook,	Illinois,.	
15. C.	B.	Wiebe,	E.	E.	Putnins.	The	periodontal	disease	classification	system	of	
the	American	Academy	of	Periodontology-an	update.	J	Can	Dent	Assoc.	2000.		
16. Tonetti,	 Greenwell,	 Kornman.	 Staging	 and	 Grading	 Periodontitis	 J.	
Periodontol.	2018.	
17. Ferlay	J,	Shin	HR,	Bray	F,	Forman	D,	Mathers	C,	Parkin	DM.	Cancer	incidence	
and	mortality	worldwide.	Globocan.	2008.	
18. Siegel	 R,	 DeSantis	 C,	 Virgo	 K,	 et	 al.	 Cancer	 treatment	 and	 survivorship	
statistics.	CA	Cancer	J	Clin.	2012	
19. Center	MM,	Jemal	A,	Smith	RA,	Ward	E.	Worldwide	variations	in	colorectal	
cancer.	CA	Cancer	J	Clin.	2009;	59:	366–78.	
20. Stock	C,	Pulte	D,	Haug	U,	Brenner	H.	Subsite-specific	colorectal	cancer	risk	
in	the	colorectal	endoscopy	era.	Gastrointest	Endosc.	2012;	75:	621–30.	
21. Rishabh	Sehgal	et	al	.	Lynch	Syndrome:	An	Updated	Review.	2014.	
22. Castells	A,	Marzo-Castillejo	M,	Mascort	JJ	et	al.	Gastroenterol	Hepatol.	2009.	
23. Luis	Bujanda	et	al.	Malignant	colorectal	polyps.	World	J	Gastroenterol.	2010.	
24. Hampel	 H.,	 Frankel	 W.L.,	 Martin	 E.,	 Arnold	 M.,	 Khanduja	 K.,	 Kuebler	 P.,	
Clendenning	 M.,	 Sotamaa	 K.,	 Prior	 T.,	 Westman	 J.A.,	 et	 al.	 Feasibility	 of	
screening	for	Lynch	syndrome	among	patients	with	colorectal	cancer.	J.	Clin.	
Oncol.	2008;	26:5783–5788	
25. J.	 Wennstrom,	 E.R.	 Pierce,	 V.A.	 McKusick.	 Hereditary	 benign	 and	
malignantlesions	of	the	large	bowel.	1974.	
	 167	
26. Kinzler	KW,	Vogelstein	B.	Lessons	from	hereditary	colorectal	cancer.	1996.		
27. Fearon	ER.	Molecular	genetics	of	colorectal	cancer.	Annu	Rev	Pathol	2011;	
6:	479–507	
28. Sehgal,	Rishabh	.	Lynch	Syndrome:	An	Updated	Review.	2014.			
29. Latchford	AR,	Neale	K,	Phillips	RK,	Clark	SK.	Juvenile	polyposis	syndrome:	a	
study	 of	 genotype,	 phenotype,	 and	 long-term	 outcome.	 Dis	 Colon	 Rectum.	
2012,	55:	1038-1043.	
30. Lichtenstein	P,	Holm	NV,	Verkasalo	PK,	et	al.	Environmental	and	heritable	
factors	 in	 the	 causation	 of	 cancer—analyses	 of	 cohorts	 of	 twins	 from	
Sweden,	Denmark,	and	Finland.	N	Engl	J	Med.	2000;	343:	78–85.	
31. Nicholas	 J.	 Ollberding,	 Abraham	 M.Y.	 Nomura,	 Laurence	 N.	 Kolonel.	
Racial/Ethnic	Differences	 in	Colorectal	Cancer	Risk:	The	Multiethnic	Cohort	
Study.	Int	J	Cancer.	2011.	
32. 	Chan	DSM,	Lau	R,	Aune	D,	Vieira	R,	Greenwood	DC,	et	al.	Red	and	Processed	
Meat	and	Colorectal	Cancer	Incidence:	Meta-Analysis	of	Prospective	Studies.	
PLOS	ONE.	2011.		
33. G.	Pöschl,	H.	K.	 Seitz,	Alcohol	 and	 cancer.	Alcohol	 and	Alcoholism.	 Volume	
39.	2004	
34. Botteri	E,	et	al.	Smoking	and	colorectal	cancer:	a	meta-analysis.	JAMA.	2008.	
35. JD	Potter,	RM	Bostick,	GA	Grandits,	L	Fosdick,	P	Elmer,	J	Wood,	P	Grambsch	
and	T	A	Louis.	Hormone	replacement	therapy	is	associated	with	lower	risk	of	
adenomatous	 polyps	 of	 the	 large	 bowel:	 the	Minnesota	 Cancer	 Prevention	
Research	Unit	Case-Control	Study.	Cancer	Epidemiol	Biomarkers	Prev.		1996.	
	 168	
36. González-Pérez	 A,	García	 Rodríguez	 LA,	López-Ridaura	 R.	 Effects	 of	 non-
steroidal	anti-inflammatory	drugs	on	cancer	sites	other	than	the	colon	and	
rectum:	a	meta-analysis.	BMC	Cancer.	2003.	
37. Graham	A.	 Colditz,	 Carolyn	 C.	 Cannuscio,	 and	 A.	 Lindsay	 Frazier.	 Physical	
activity	 and	 reduced	 risk	 of	 colon	 cancer:	 implications	 for	 prevention.	
Cancer	Causes	and	Control.	1997.		
38. Cooper	K,	Squires	H,	Carroll	C,	Papaioannou	D,	Booth	A,	Logan	RF,	Maguire	
C,	Hind	D,	Tappenden	P.	Chemoprevention	of	colorectal	cancer:	systematic	
review	and	economic	evaluation.	Health	Technol	Assess.	2010.		
39. Qaseem	A,	Denberg	TD,	Hopkins	RH	Jr,	et	al.	Screening	for	colorectal	cancer:	
a	 guidance	 statement	 from	 the	 American	 College	 of	 Physicians.	 Clinical.	
Guidelines	Committee	of	the	American	College	of	Physicians.2012.	
40. Von	Karsa	L,	Patnick	J,	Segnan	N,	et	al,	and	the	European	Colorectal	Cancer	
Screening	 Guidelines	 Working	 Group.	 European	 guidelines	 for	 quality	
assurance	 in	 colorectal	 cancer	 screening	 and	 diagnosis:	 overview	 and	
introduction	to	the	full	supplement	publication.	Endoscopy.	2013	
41. Al-Sukhni	 E,	 Milot	 L,	 Fruitman	 M,	 et	 al.	 Diagnostic	 accuracy	 of	 MRI	 for	
assessment	 of	 T	 category,	 lymph	 node	 metastases,	 and	 circumferential	
resection	margin	 involvement	 in	 patients	with	 rectal	 cancer:	 a	 systematic	
review	and	meta-analysis.	Ann	Surg	Oncol.	2012;	19:	2212–23.	
42. Kaur	H,	 Choi	H,	 You	 YN,	 et	 al.	MR	 imaging	 for	 preoperative	 evaluation	 of	
primary	 rectal	 cancer:	 practical	 considerations.	 Radiographics	 2012;	 32:	
389–409.	
43. Astler	 VB,	 Coller	 FA.	 The	 prognostic	 significance	 of	 direct	 extension	 of	
carcinoma	of	the	colon	and	rectum.	Ann	Surg	139:846.	1954.	
44. Turnbull	RB	Jr,	Kyle	K,	Watson	FR,	et	al.	Cancer	of	the	colon:	the	influence	of	
the	 no	 touch	 isolation	 technique	 on	 survival	 rates.	 Ann	 Surg	 166:420-7.	
1967.	
	 169	
45. Jass	J.	R.	Classification	of	colorectal	cancer	based	on	correlation	of	clinical,	
morphological	and	molecular	features.	Histopathology.	2011.	
46. Heald	RJ,	Ryall	RD.	Recurrence	and	survival	after	total	mesorectal	excision	
for	rectal	cancer.	Lancet	.1986;	1:	1479–82.	
47. Kuhry	E,	Schwenk	WF,	Gaupset	R,	Romild	U,	Bonjer	HJ.	Long-term	results	of	
laparoscopic	 colorectal	 cancer	 resection.	 Cochrane	 Database	 Syst	 Rev.	
2008.	
48. Trastulli	 S,	Cirocchi	R,	Listorti	C,	 et	 al.	 Laparoscopic	vs	open	 resection	 for	
rectal	 cancer:	 a	meta-analysis	of	 randomized	 clinical	 trials.	Colorectal	Dis.	
2012.	
49. Van	 Gijn	 W,	 Marijnen	 CA,	 Nagtegaal	 ID,	 et	 al,	 and	 the	 Dutch	 Colorectal	
Cancer	 Group.	 Preoperative	 radiotherapy	 combined	with	 total	mesorectal	
excision	for	resectable	rectal	cancer:	12-year	 follow-up	of	 the	multicentre,	
randomised	controlled	TME	trial.	Lancet	Oncol	2011;	12:	575–82.	
50. Hofheinz	RD,	Wenz	 F,	 Post	 S,	 et	 al.	 Chemoradiotherapy	with	 capecitabine	
versus	 fl	 uorouracil	 for	 locally	 advanced	 rectal	 cancer:	 a	 randomised,	
multicentre,	non-inferiority,	phase	3	trial.	Lancet	Oncol.	2012	
51. Kostic	AD,	Chun	E,	Robertson	L,	et	al.	Fusobacterium	nucleatum	potentiates	
intestinal	 tumorigenesis	 and	 modulates	 the	 tumor-immune	
microenvironment.	Cell	Host	Microbe.	2013;14:207-215.	
52. Rubinstein	MR,	Wang	X,	 Liu	W,	 et	 al.	 Fusobacterium	nucleatum	promotes	
colorectal	carcinogenesis	by	modulating	E-cadherin/beta-catenin	signaling	
via	its	FadA	adhesin.	Cell	Host	Microbe.	2013.		
53. Kostic	 AD,	 Gevers	 D,	 Pedamallu	 CS,	 et	 al.	 Genomic	 analysis	 identifies	
association	 of	 Fusobacterium	 with	 colorectal	 carcinoma.	 Genome	 Res.	
2012;22:292-298.	
54. Han	YW,	Wang	X.	Mobile	microbiome:	oral	bacteria	in	extra-oral	infections	
and	inflammation.	J	Dent	Res.	2013;92:485-491.		
55. Mitsuhashi	 K,	Nosho	 K,	Sukawa	 Y,	Matsunaga	 Y,	Ito	 M,	Kurihara	 H,	Kanno	
	 170	
S,	Igarashi	 H,	Naito	 T,	Adachi	 Y.	Association	 of	 Fusobacterium	 species	 in	
pancreatic	 cancer	 tissues	 with	 molecular	 features	 and	
prognosis.	Oncotarget.	2015;6:7209-7220.	
56. Yarden-Bilavsky	 H,	Raveh	 E,	Livni	 G,	Scheuerman	 O,	Amir	 J,	Bilavsky	
E.	Fusobacterium	 necrophorum	 mastoiditis	 in	 children	 -	 emerging	
pathogen	in	an	old	disease.	Int	J	Pediatr	Otorhinolaryngol.	2013;77:92-96.		
57. Jensen	 A,	Hagelskjaer	 Kristensen	 L,	Prag	 J.	Detection	 of	 Fusobacterium	
necrophorum	subsp.	funduliforme	in	tonsillitis	in	young	adults	by	real-time	
PCR.	Clin	Microbiol	Infect.	2007;13:695-701.	
58. Finegold	 SM,	Flynn	 MJ,	Rose	 FV,	Jousimies-Somer	 H,	Jakielaszek	
C,	McTeague	 M,	Wexler	 HM,	Berkowitz	 E,	Wynne	 B.	Bacteriologic	 findings	
associated	 with	 chronic	 bacterial	 maxillary	 sinusitis	 in	 adults.	Clin	 Infect	
Dis.	2002.	
59. McCoy	 AN,	 Araujo-Perez	 F,	 Azcarate-Peril	 A,	 et	 al.	 Fusobacterium	 is	
associated	with	colorectal	adenomas.	PLoS	One.	2013.	
60. Han	YW,	Wang	X.	Mobile	microbiome:	oral	bacteria	in	extra-oral	infections	
and	inflammation.	J	Dent	Res.	2013;92:485-491		
61. Xu,	 M.,	 Yamada,	 M.,	 Li,	 M.,	 Liu,	 H.,	 Chen,	 S.G.	 FadA	 from	 Fusobacterium	
nucleatum	 utilizes	 both	 secreted	 and	 nonsecreted	 forms	 for	 functional	
oligomerization	for	attachment	and	invasion	of	host	cells.	J	Biol.	2007	
62. Fardini,	Y.	 ,	Wang,	X.	 ,	Témoin,	S.	 ,	Nithianantham,	S.	 ,	Lee,	D.	 ,	Shoham,	M.	
and	 Han,	 Y.	 W.	 	Fusobacterium	 nucleatum	adhesin	 FadA	 binds	 vascular	
endothelial	 cadherin	 and	 alters	 endothelial	 integrity.	 Molecular	
Microbiology.	2011	
63. Rubinstein	MR,	Wang	X,	 Liu	W,	 et	 al.	 Fusobacterium	nucleatum	promotes	
colorectal	carcinogenesis	by	modulating	E-cadherin/beta-catenin	signaling	
via	its	FadA	adhesin.	Cell	Host	Microbe.	2013.	
64. Kostic	AD,	Chun	E,	Robertson	L,	Glickman	JN,	Gallini	CA,	Michaud	M,	Clancy	
TE,	 Chung	 DC,	 Lochhead	 P,	 Hold	 GL,	 El-Omar	 EM,	 Brenner	 D,	 Fuchs	 CS,	
	 171	
Meyerson	M,	 Garrett	WS.	 Fusobacterium	 nucleatum	 potentiates	 intestinal	
tumorigenesis	 and	 modulates	 the	 tumor-immune	 microenvironment.	 Cell	
Host	Microbe.	2013.	
65. Yang	 Y,	Weng	W,	 Peng	 J,	 Hong	 L,	 Yang	 L	 et	 al.	 Fusobacterium	 nucleatum	
Increases	Proliferation	of	Colorectal	Cancer	Cells	and	Tumor	Development	
in	Mice	by	Activating	Toll-Like	Receptor	4	Signaling	 to	Nuclear	Factor-κB,	
and	Up-regulating	Expression	of	MicroRNA-21.	Gastroenterology.	2017	
66. 	Kaplan	 CW,	 Ma	 X,	 Paranjpe	 A,	 Jewett	 A,	 Lux	 R,	 Kinder-Haake	 S,	 Shi	 W.	
Fusobacterium	nucleatum	outer	membrane	proteins	Fap2	and	RadD	induce	
cell	death	in	human	lymphocytes.	Infect	Immun.	2010.	
67. Gur	C,	 Ibrahim	Y,	 Isaacson	B,	Yamin	R,	Abed	J,	Gamliel	M,	Enk	J,	Bar-On	Y,	
Stanietsky-Kaynan	N,	 et	 al.	 Binding	 of	 the	 Fap2	 protein	 of	 Fusobacterium	
nucleatum	 to	 human	 inhibitory	 receptor	 TIGIT	 protects	 tumors	 from	
immune	cell	attack.	Immunity.	2015	
68. Hajishengallis	G	.	Porphyromonas	gingivalis-host	interactions:	open	war	or	
intelligent	guerilla	tactics?.	Microbes	and	Infection.	2009.			
69. Darveau	RP,	Hajishengallis	G	et	al.	Porphyromonas	gingivalis	as	a	potential	
community	activist	for	disease.	Journal	of	Dental	Research.	2012.	
70. Mangat	 P,	 Wegner	 N,	 Venables	 PJ,	 Potempa	 J.	 Bacterial	 and	 human	
peptidylarginine	 deiminases:	 targets	 for	 inhibiting	 the	 autoimmune	
response	in	rheumatoid	arthritis?	Arthritis	Res	Ther.	2010.	
71. Liao	F,	Li	Z,	Wang	Y,	Shi	B,	Gong	Z,	Cheng	X.	Porphyromonas	gingivalis	may	
play	 an	 important	 role	 in	 the	 pathogenesis	 of	 periodontitis-associated	
rheumatoid	arthritis.	Med	Hypotheses.	2009.	
72. Guyodo	H,	Meuric	V,	Le	Pottier	L,	Martin	B,	Faili	A,	Pers	JO,	Bonnaure-Mallet	
M.	 Colocalization	 of	Porphyromonas	 gingivalis	with	 CD4+	 T	 cells	 in	
periodontal	disease.	FEMS	Immunology	and	Medical	Microbiology.	2012	
73. Michelin	 MC,	 Teixeira	 SR,	 Ando-Suguimoto	 ES,	 Lucas	 SR,	 Mayer	 MP	
Porphyromonas	gingivalis	 infection	at	different	gestation	periods	on	 fetus	
	 172	
development	and	cytokines	profile.	Oral	Dis.	2012.	
74. Marchesan	JT,	Morelli	T,	Lundy	SK,	Jiao	Y,	Lim	S,	Inohara	N,	et	al.	Divergence	
of	 the	 systemic	 immune	 response	 following	 oral	 infection	 with	 distinct	
strains	of	Porphyromonas	gingivalis.	Mol	Oral	Microbiol.	2012.		
75. Belanger	M,	Reyes	L,	von	Deneen	K,	Reinhard	MK,	Progulske-Fox	A,	Brown	
MB.	Colonization	of	maternal	and	fetal	tissues	by	Porphyromonas	gingivalis	
is	strain-dependent	in	a	rodent	animal	model.	Am	J	Obstet	Gynecol.	2008.	
76. Marchildon	 P,	 Balaban	 DH,	 Sue	 M,	 Charles	 C.	 Doobay	 R,	 Passaretti	 N,	
Peacock	 J,	 Marshall	 BJ,	 Peura	 DA.	 Usefulness	 of	 serological	 IgG	 antibody	
determinations	for	confirming	eradication	of	Helicobacternpylori	infection.	
Am	J	Gastroenterol	1999;94:2105-8	
77. Backert	 S,	 Neddermann	 M,	 Maubach	 G,	 Naumann	 M.	 Pathogenesis	 of	
helicobacter	pylori	infection.	Helicobacter.	2016.	
78. IARC	monographs	on	the	evaluation	of	carcinogenic	risks	to	humans.	1994	
79. Correa	 P,	 Piazuelo	 M	 B	 .	 The	 gastric	 precancerous	 cascade.	 Journal	 of	
Digestive	Diseases.	2012.	
80. Uemura	N,	Okamoto	S,	Yamamoto	S	et	al.	Helicobacter	pylori	infection	and	
the	development	of	gastric	cancer.	N	Engl	J	Med.	2001	
81. Filipe	MI,	Munoz	N,	Matko	I	et	al.	Intestinal	metaplasia	types	and	the	risk	of	
gastric	cancer:	a	cohort	study	in	Slovenia.	Int	J	Cancer.	1994.	
82. Franceschi	F,	Gasbarrini	A,	Polyzos	SA,	Kountouras	J.	Extragastric	diseases	
and	Helicobacter	pylori.	Helicobacter.	2015	
83. Siddiqui	 I,	 Ahmed	 S,	 Abid	 S.	 Update	 on	 diagnostic	 value	 of	 breath	 test	 in	
gastrointestinal	and	liver	diseases.	World	J	Gastrointest	Pathophysiol.	2016.	
84. Evdokimova	 AG,	 Zhukolenko	 LV,	 Evdokimov	 VV.	 New	 approaches	 to	
therapy	of	Helicobacter	pylori	infection	(by	the	materials	of	the	Maasrticht	
Consensus-IV,	Florence,	2010).	Antibiot	Khimioter.	2013.	
85. Hunt	R,	Fallone	C,	Veldhuyzan	van	Zanten	S,	Sherman	P,	Smaill	F,	Flook	N,	
Thomson	A.	An	evidence-based	evaluation	of	six	topics	relevant	to	clinical	
	 173	
outcomes	 in	patients	evaluated	 for	H	Pylori	 infection.	Can	 J	Gastroenterol.	
2004.	
86. Oluwole	FS.	Helicobacter	pylori:	a	pathogenic	threat	to	the	gastric	mucosal	
barrier.	Afr	J	Med	Med	Sci.	2015.	
87. Adler	 I,	Muiño	A,	Aguas	S,	Harada	L,	Diaz	M,	Lence	A,	Labbrozzi	M,	Muiño	
JM,	 Elsner	 B,	 Avagnina	 A,	 Denninghoff	 V.	 Helicobacter	 pylori	 and	 oral	
pathology:	 relationship	 with	 the	 gastric	 infection.	 World	 J	 Gastroenterol.	
2014.	
88. Al	Sayed	A,	Anand	PS,	Kamath	KP,	Patil	S,	Preethanath	RS,	Anil	S.	Oral	cavity	
as	 an	 extragastric	 reservoir	 of	 Helicobacter	 pylori.	 ISRN	 Gastroenterol.	
2014.	
89. Navabi	N,	Aramon	M,	Mirzazadeh	A.	Does	the	presence	of	the	Helicobacter	
pylori	 in	 the	 dental	 plaque	 associate	 with	 its	 gastric	 infection?	 A	 meta-
analysis	and	systematic	review.	Dent	Res	J.	2011.	
90. Mattana	 CM,	 Vega	 AE,	 Flores	 G,	 de	 Domeniconi	 AG,	 de	 Centorbi	 ON.	
Isolation	 of	 Helicobacter	 pylori	 from	 dental	 plaque.	 Rev	 Agent	 Microbiol.	
1998;30:93-5	
91. Krajden	S,	Fuksa	M,	Anderson	 J,	Kempston	 J,	Boccia	A,	Petrea	C,	Babida	C,	
Karmali	M,	Penner	JL.	Examination	of	human	stomach	biopsies,	saliva,	and	
dental	plaque	for	Campylobacter	pylori.	J	Clin	Microbiol	.1989.	
92. Lauritano	 D,	 Cura	 F,	 Candotto	 V,	 Gaudio	 RM,	 Mucchi	 D,	 Carinci	 F.	
Periodontal	pockets	as	a	reservoir	of	Helicobacter	pylori	causing	relapse	of	
gastric	 ulcer:	 a	 review	 of	 the	 literature.	 J	 Biol	 Regul	 Homeost	 Agents.	
2015;29:123-6	
93. Song	 HY,	 Li	 Y.	 Can	 eradication	 rate	 of	 gastric	 Helicobacter	 pylori	 be	
improved	 by	 killing	 oral	 Helicobacter	 pylori?	 World	 J	 Gastroenterol.	
2013;19:6645-50	
94. Ren	Q,	Yan	X,	Zhou	Y,	Li	XW.	Periodontal	 therapy	as	adjunctive	 treatment	
for	gastric	Helicobacter	pylori	infection.	Cochrane	Database	Syst	Rev.	2016.	
	 174	
95. Navabi	N,	Aramon	M,	Mirzazadeh	A.	Does	the	presence	of	the	Helicobacter	
pylori	 in	 the	 dental	 plaque	 associate	 with	 its	 gastric	 infection?	 A	 meta-
analysis	and	systematic	review.	Dent	Res	J	(Isfahan).	2011	
96. Czesnikiewicz-Guzik	 E,	 Karczewska	 WB,	 Guzik	 TG,	 Kapera	 P,	 Targosz	 A,	
Konturek	SJ,	et	al.	Association	of	the	presence	of	Helicobacter	pylori	in	the	
oral	cavity	and	in	the	stomach.	J	Physiol	Pharmacol.	2004	
97. Butt	 AK,	 Khan	 AA,	 Izhar	 M,	 Alam	 A,	 Shah	 SW,	 Shafqat	 F.	 Correlation	
of	Helicobacter	 pylori	in	 dental	 plaque	 and	 gastric	 mucosa	 of	 dyspeptic	
patients.	J	Pak	Med	Assoc.	2002	
	
